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This thesis comprises studies of ultra high performance liquid chromatography 
(UHPLC) performance with a particular focus on the application of liquid 
chromatography-mass spectrometry (LC-MS) for the analysis of basic drugs. 
UHPLC-MS technologies are investigated to facilitate fast, sensitive and robust 
analysis of drugs in biological matrices, particularly those related to doping in 
human sport.  
 
Mobile phase solvent, pH and temperature significantly affect the chromatographic 
performance of hydrophilic, basic analytes. Manipulation of mobile phase pH 
suppresses the protonation of basic analytes for improved retention, peak shape and 
resolution. This is exemplified by the ephedrines, which are inherently difficult to 
separate by reversed-phase liquid chromatography (RPLC). A high pH RPLC 
separation is coupled with MS detection and validated for the identification and 
quantification of ephedrines in doping control analysis. The effects of mobile phase 
composition and pH on efficient and stable ionisation are studied for robust and 
sensitive analysis of basic analytes. Different mobile phase conditions are evaluated 
with electrospray ionisation (ESI) and atmospheric pressure chemical ionisation 
(APCI), with high pH eluents generating greater signal intensities for the basic 
analytes studied with ESI. 
 
Hydrophilic interaction liquid chromatography (HILIC) is evaluated as an 
alternative approach for accurate and robust quantification. A HILIC approach to 
separate the ephedrines is evaluated for robustness, and the validated method is 
iii 
 
compared with the high pH RPLC method in terms of linearity, accuracy, precision, 
matrix effects and sensitivity. 
 
Finally, a switching system comprising two different, complementary stationary 
phase materials is designed and evaluated to widen the elution window, allowing for 
the simultaneous analysis of both polar and non-polar analytes. A combination of 
Hypercarb and C18 stationary phases are used with UHPLC column switching, and 
the suitability of the approach is illustrated by the analysis of selected doping agents 
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1.1 Introduction to Liquid Chromatography-Mass Spectrometry (LC-MS) 
1.1.1 Advances in LC-MS 
Rapid advances in liquid chromatography and mass spectrometry have enabled the 
true benefits of the hyphenated technique (LC-MS) to be realised over the past 
decade. In the first place, significant improvements in chromatographic performance 
have been achieved in terms of analysis speed, resolving power and sensitivity as a 
consequence of reduced particle diameter and the advent of ultra-high pressure 
pumping systems. The influence of reducing particle size on column efficiency has 
been understood for many years. The van Deemter equation describes the 
relationship between column performance and particle size due to shorter diffusion 
distances. Since the introduction of HPLC, there has therefore been a continued trend 
in reducing particle size, from traditional 10 µm particles, down to 5 µm, 3 µm and 
more recently sub-2 µm. However, the use of smaller particle diameters comes at the 
expense of operating pressure, which is inversely proportional to the square of the 
particle size. The first reports of using very small particles (1.5 µm nonporous 
particles) and ultra-high pressures (59,000 psi) were published by MacNair et al. in 
1997 [1, 2]. The use very small particles (sub-2 µm) was therefore limited by the 
capability of conventional system pumps and autosamplers, not able to withstand 
ultra-higher pressure conditions. Additionally, the ability to operate at the elevated 
pressures associated with the reduction in particle diameter demands the technology 
to manufacture and pack particulate structures that are able to tolerate ultra-high 
pressures [3, 4]. A further consideration is the need for low system volume when 
migrating to the smaller column dimensions used with reduced particle diameter, 
where contributions from extra-column band broadening become paramount [5].  
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The evolution of UHPLC has been driven by the demand for faster separations and 
the need to separate more and more compounds in complex matrices [4]. 
Chromatographic resolution is influenced by several factors, but the most significant 
is plate count. It is therefore possible to achieve greater resolution with longer 
columns, although this has a negative impact on the speed of analysis and hence 
sample throughput. Consequently, various approaches have been used to achieve fast 
LC separations without sacrificing resolution. High-temperature LC has been used to 
reduce mobile phase viscosity, which enables the chromatographer to use longer 
column formats and increase flow rate while still working with the pressure limits of 
the system for a gain in resolution [6, 7]. Other approaches in column technology 
include the use of monoliths [8, 9] and core-shell particles [10-12]. Both techniques 
offer shorter diffusion distances and improved mass transfer, but without the 
inherently large back-pressures of small porous particles. While the commercial 
availability of monoliths remains limited, core-shell particles have been shown to be 
a promising alternative to sub-2 µm materials, offering similar gains in efficiency 
and resolution without requiring expensive, dedicated instrumentation [13-15]. 
Nevertheless, the advent of UHPLC technology has provided the most widespread 
and well-established approach, based on the use of sub-2 µm particles operated at 
ultra-high pressures (up to 15,000 psi). The extended pressure range of UHPLC 
instrumentation enables the chromatographic potential of sub-2 µm particles to be 
harnessed, providing significant improvements to analysis time, resolution and 
sensitivity [16-19]. The considerable developments in the evolution of UHPLC 
instrumentation over the past decade means the use of sub-2 µm particle materials 
and operation at pressures up to 15,000 psi is now becoming commonplace in many 
analytical laboratories. However, highly efficient UHPLC separations generate 
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inherently narrow peak widths (1-3 sec), demanding a fast scanning detector to 
record a sufficient number of data points for accurate peak definition (at least 15 for 
quantification).  
 
Mass spectrometry (MS) is the most commonly used detection technique with 
UHPLC for the rapid analysis of compounds present at low concentrations in 
complex matrices (employed in over 60 % of applications), combining sensitivity, 
selectivity and unambiguous identification [20]. It follows, therefore, that mass 
spectrometric technologies have had to evolve to enable fast acquisition rates to 
garner the benefits afforded by UHPLC. Tandem triple quadrupole MS remains the 
dominant approach for targeted screening, identification and quantification of small 
molecules in bioanalysis, providing unrivalled selectivity and sensitivity [21]. The 
need for fast scanning data capture when hyphenating UHPLC with MS has 
therefore resulted in the commercialisation of modern triple quadrupole mass 
analysers with reduced dwell times (5 ms) for improved acquisition rates. However, 
the past few years have seen a significant shift towards the use of high resolution 
accurate mass (HRAM) instrumentation coupled with UHPLC for targeted screening 
and even quantification assays [22]. Advances in MS technologies have resulted in 
HRAM instrumentation capable of very fast acquisition rates, which are also able to 
achieve acceptable sensitivity and the dynamic range required for quantification [23, 
24]. One example is the availability of improved time-of-flight (TOF) and hybrid 
quadrupole-TOF (QTOF) analysers, providing medium resolution and accurate mass 
measurements, which present an attractive alternative to triple quadrupole analysers 
for hyphenation with UHPLC, particularly for high-throughput screening assays [25-
28].   
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1.1.2 Application of LC-MS to bioanalysis 
There is a continued need in bioanalysis for more comprehensive, sensitive and 
faster detection tools, driving the improvement or development of new drug testing 
procedures. Such is the case in doping control analysis, with an ever-growing 
number and variety of substances to test for, and with restrictions on speed and cost 
of analysis, comprehensive, high-throughput assays are highly sought after. UHPLC 
offers the high resolution required to separate structurally related compounds from 
endogenous components in complex sample matrices, such as urine and plasma, and 
offers faster separations without sacrificing resolution. In addition, the increase in 
sensitivity with narrow peaks widths generated by less resistance to mass transfer, 
improve detection limits and in some cases permit longer detection times. As well as 
the importance of analysis time, bioanalytical assays must also meet rigorous criteria 
in selectivity, specificity, accuracy, precision and linearity which necessitates 
suitable sample preparation and validation to ensure robust, accurate methodologies.  
 
In the bioanalytical arena, gas-chromatography (GC) has long been established as the 
“gold standard” for the separation of small molecules. However, with the recent 
developments in LC-MS, this approach has become increasingly important for robust 
and reliable assays in the fields of clinical and forensic toxicology and doping 
control [29-33]. LC has become an attractive alternative to GC, with the ability to 
analyse hydrophilic, thermolabile and non-volatile analytes, which were not 
sufficiently covered by GC. Additionally, LC-MS offers a fast, sensitive and 
selective approach without the need for derivatisation. Omitting this step which can 
be labour-intensive and time-consuming is a vital advantage of LC, where the simple 
sample preparation is amenable to fast, high-throughput assays and limits potential 
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sources of error. This is particularly important considering the improvements to 
separation speed with UHPLC, where the limiting factor in total analysis time now 
lies in sample preparation.  
 
The flexibility of LC coupled with various types of MS detector has permitted 
qualitative and quantitative analysis, providing highly selective and sensitive assays 
capable of analysing a wide range of analytes from a variety of sample matrices. 
Consequently, LC-MS has become widely adopted as the leading technology in a 
variety of applications. For example, the field of doping control analysis is just one 
example of where fast, high-throughput methodologies are required, especially at 
large international events, where turn-around times can be as little as 24 hours. 
Typically, the analytical workflow comprises an initial generic screen to eliminate 
negative samples as early as possible, while any suspect sample is subjected to more 
rigorous, targeted analysis for identification and, where necessary, quantification.  
 
1.2 Theory of Liquid Chromatography 
1.2.1 Introduction to High Performance Liquid Chromatography (HPLC) 
Chromatography can be defined as a physical separation technique whereby the 
components to be separated are distributed between two phases, one of which is 
stationary (stationary phase) while the other (the mobile phase) moves in a definite 
direction [34]. First realised by Twsett in the early 1900s, chromatography has since 
evolved into the modern technique now referred to as high performance liquid 
chromatography (HPLC). Since its development in the 1960s, HPLC has become 
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one of the most powerful separation techniques in analytical chemistry. An 







                       
Figure 1.1. Components of a HPLC system.      
 
In LC, a sample is separated into its individual components by distribution between a 
fixed stationary phase and a mobile phase. Differences in the chemical and physical 
properties of each component determine the affinity for the stationary and mobile 
phases and so influence the degree of separation. The greater the affinity a solute has 
for a particular stationary phase, the longer it will be retained and hence the later it 







Figure 1.2. Representation of separation by liquid chromatography. 
Chromatogram 
Sample 
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1.2.2 Chromatographic parameters 
The detector in Figure 1.1 converts the digital information gained from the chemical 
separation of analytes into a visual form (chromatogram). Several important 
parameters can be determined from the chromatogram, useful in identifying and 
quantifying the components present. These are described in Figure 1.3 below: 
 
Figure 1.3. Chromatographic parameters. 
A chromatogram showing void time (t0), retention time (tR), peak width (wb), peak width at half 
height (w1/2) and peak height (h). 
 
1.2.2.1 Void time/volume (t0/v0) 
The first peak, or disturbance in the baseline of a chromatogram, represents the 
retention time of an unretained solute and indicates the void time (t0) or dead volume 
(v0). This is the time taken for the mobile phase to reach the column from the point 
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1.2.2.2 Retention time (tR) 
The retention time (tR) of a component is the time taken from injection of the sample 
to the peak maximum. The void time (t0) indicates the time spent by any component 
in the mobile phase, whereas tR is the total time the solute spends in the stationary 
phase and in the mobile phase. The retention time can be adjusted to give the time 
spent by the solute in the stationary phase:  
 
  
        
 
1.2.2.3 Retention factor (k) 
Retention, or capacity, factor can be defined as the degree of retention of an analyte 
relative to an unretained peak, calculated by: 
 
  




where tR is the retention time of the sample peak and t0 is the retention time of an 
unretained peak.  
 
Measuring retention factors will help determine whether retention shifts are due to 
the column (k changes with retention time) or the system (k remains constant with 
retention time changes). 
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1.2.2.4 Selectivity factor (α) 
The selectivity factor (α) is a measure of the difference in retention of two substrates 
in a separation, expressed as: 
 
  
     
     
 
     






where k1 and k2 are respective retention factors. 
 
Selectivity values must be > 1.0 for peak separation, a value of less than 1 illustrates 
no difference in the selectivity of analytes and therefore no separation between the 
two analytes. The selectivity is a function of column packing material and can be 
influenced by factors such as the mobile phase composition and temperature. 
 
1.2.2.5 Resolution (Rs) 
Resolution describes the degree of separation of two components, illustrating the 
ability of a column to separate chromatographic peaks. The resolution between two 
peaks in a separation can be measured by using the following equation: 
 
   
         
            
 
 
where tR is the retention time of the sample peak, and wb is the peak width at base, 
illustrated in Figure 1.4. 
 
 







Figure 1.4. Illustration of peak resolution parameters. 
 
A value of 1.5 typically indicates complete separation, although this assumes 
Gaussian peak shape and does not consider that one peak may correspond to more 
than one analyte. The boundaries between the baseline and the beginning and end of 
the peak are not well defined and depend on the threshold of the peak detection 
algorithm. For a Gaussian peak, the width of the peak is approximately equal to four 
times the standard deviation of the peak width (4σ) at the point if inflection which 
encompasses approximately 95 % of the peak area [35, 36]. 
 
1.2.2.6 Peak Symmetry: Asymmetry Factor (As) 
Under ideal conditions, chromatographic peaks should be symmetrical, but in reality 
most exhibit either fronting or tailing, as depicted in Figure 1.5. Peak tailing is more 
common, resulting in lower peak heights and therefore higher detection limits, and 
also gives rise to difficulty in integrating peaks leading to imprecise and 
irreproducible peak areas. Determining where the limits of peak integration are to be 
located is ambiguous, a problem that is exaggerated with large tailing factors, thus 
causing errors in quantification. This is of particular importance where there is 
considerable difference in the size of two peaks which elute close together. A small 
peak which elutes after a much bigger peak with a large tailing factor may be 
obscured, especially if background noise is high. 
tR2 tR1 
wb2 wb1 
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Figure 1.5. Illustration of peak fronting (A) and peak tailing (B). 
 
The most commonly used  method to quantify peak symmetry is the asymmetry 
factor (As), typically calculated using the peak width at 10 % of peak height:  
 





A value of 1 indicates a perfectly symmetrical peak, whereas a figure < 1.0 is a 
fronting peak and > 1.0 is a tailing peak. Peak tailing may result from several factors, 
including, band broadening and secondary interactions experienced between basic 
analytes and residual silanol groups on silica-based columns. 
 
1.2.2.7 Column efficiency/plate number (N) 
Also known as the number of theoretical plates, N is a measure of the quality of a 
separation that is based on a single peak and can be determined by various methods. 
 





      
  





where N is the number of theoretical plates, tR is the retention time, wb is the peak 
width at base and w1/2 is the peak width at half height. 
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Plate count is determined from the chromatogram and is a dimensionless parameter; 
it can be obtained from the peak width and retention time, provided that the 
migration velocity of the peak has been constant (isocratic chromatograms). Such a 
measurement, therefore, takes into account only peak dispersion, unlike resolution 
which is based on the distance between two peaks and their dispersion. 
 
1.2.2.8 Height Equivalent to a Theoretical Plate (HETP)  
The height equivalent to a theoretical plate (HETP or H) is a measure of a column’s 
efficiency and can be expressed as: 
 





where L is column length, in millimetres, and N is the number of theoretical plates. 
 
The theoretical plate concept originates from the distillation theory of gas 
chromatography which describes the number of plates in an industrial distillation 
column. Hence, the more plates per column, the better the separation. However, 
since the HETP is a function of many different parameters, the plate count is not a 
basic property of a column and therefore not a measure of column quality. 
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1.2.3 Theory of Band Broadening 
Upon injection, an analyte forms a narrow band on the top of a column, which 
broadens as the analyte migrates through a chromatographic system and becomes 
diluted in the mobile phase. The longer an analyte takes to travel through a column, 
the greater the spread of individual molecules and the wider the band, resulting in a 
broader chromatographic peak and less efficient separation. The extent of band 
dispersion is dependent upon several contributing factors – those from the column 
itself and extra-column sources which may broaden or distort peak shape, including 
the injector, connection tubing and detector. 
 
The van Deemter equation explains band broadening in chromatography due to the 
migration of an analyte through the column. The equation combines the individual 
sources of band broadening and represents them as the dependence of height 
equivalent to a theoretical plate (HETP) on the mobile phase linear velocity (u). 
 
1.2.4 Van Deemter Equation 
The van Deemter equation describes the dependence of plate height (H) on linear 
flow velocity (u), illustrating the relationship between the three different, 
independent contributions: 
     
 
 
    
 
where A represents the contribution of eddy diffusion, B represents the contribution 
from longitudinal or axial diffusion and C represents the contributions of mass 
transfer in the stationary and mobile phase.  
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1.2.4.1 Eddy Diffusion 
The eddy diffusion (A) term describes the multiple path dispersion of the individual 
solute molecules as they travel through a packed column; some molecules of the 
same compound will take longer paths while others, for instance those closer to the 
walls of the column, will take more direct paths and therefore elute first (Figure 1.6). 
This is a velocity-independent term which is a function of particle size and the 
distribution of interparticle channels and other non-uniformities in the packed bed; 
the A term is proportional to dp and is smaller in a well-packed column. A narrow 
particle size distribution reduces the effects of eddy diffusion since the interstitial 
space between particles is virtually homogenous, resulting in high column 
efficiencies. Smaller particles reduce the interstitial space between particles and 
therefore allow more uniform and higher quality packing. Variance contribution 
from multi-path dispersion to the overall variance per unit length of the column: 
 
       
 
where λ is a the packing factor, and dp is the particle diameter. 
 
The theory of eddy diffusion assumes that the solute molecules remain in one flow 
stream, however, molecules can move laterally from one flow stream to another 
(lateral diffusion) where the velocity may be different, as shown Figure 1.6. 
 
 
Figure 1.6. Illustration of Eddy diffusion. 
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1.2.4.2 Longitudinal Diffusion 
Longitudinal or axial diffusion (B term) is a result of natural diffusion of the solute 
molecules in the mobile phase along the column axis, leading to broadening of the 
chromatographic zone. The extent of this diffusion is dependent on the time spent by 
the solute in the column and the diffusion coefficient of the compound in the mobile 
phase. The longer a solute remains on the column, the greater the extent of axial 
diffusion, as illustrated in Figure 1.7. The time a solute remains in the column is 
inversely proportional to the linear velocity of the mobile phase, so it follows that the 
dispersion will be inversely proportional to the linear velocity. The variance 









where γ is an obstruction factor which allows for restriction due to the packed 
particle, Dm is the diffusion coefficient of the solute in the mobile phase and u is the 
linear velocity of the mobile phase. 
 
 
Figure 1.7. Illustration of longitudinal diffusion. 
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1.2.4.3 Resistance to Mass Transfer 
Resistance to mass transfer (C term) is the most important factor affecting column 
efficiency and can be divided into the resistance to mass transfer of a molecule in 
both the mobile phase and the stationary phase. During migration through a 
chromatographic column, the solute molecules are constantly diffusing between the 
mobile phase and the stationary phase. Inefficient attainment of equilibrium between 
the stationary and mobile phases because of mobile phase flow is the cause of such 
contributions. 
 
The resistance to mass transfer in the stationary phase is more or less the time 
needed for molecules to diffuse from the mobile phase into the stationary phase and 
back again. Differences in the depth of diffusion of solutes into the stationary phase 
results in a variable delay in the diffusion back into the mobile phase. The further 
into the stationary phase an analyte has diffused, the longer distance it will have to 
diffuse back into the mobile phase and the slower the rate of transfer compared with 
those that are close to the surface of the stationary phase. 
 
The resistance to mass transfer in the mobile phase is divided into moving and 
stagnant mobile phase mass transfer. Contributions from the moving mobile phase 
result from molecules in the same flow path moving at different speeds. The solute 
molecules that are close to the particle or column wall will move slower than those 
in the bulk of the stream, causing band dispersion. This is dependent on the eddy 
diffusion, which needs to be coupled to the moving mobile phase mass transfer, and 
lateral diffusion, with slow lateral diffusion increasing band broadening.  
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The diffusion of solute molecules through the mobile phase to the interface of the 
stationary phase is not instantaneous; it takes time for the molecules to diffuse 
through the mobile phase to the stationary phase. Molecules close to the stationary 
phase will diffuse into it much more quickly than those some distance away, and 
while the mobile phase is moving they are continually swept along the column and 
move away from the molecules that were close and entered the stationary phase 
immediately. Thus, molecules which were originally relatively close together are not 
spread out in the stationary phase. 
 
There are also contributions from the stagnant mobile phase situated in the pores of 
the packing material. Analytes that travel from the centre of the moving mobile 
phase to the surface of the particle must travel through the stagnant mobile phase in 
the pores to the stationary phase on the internal surface of the packing. This stagnant 
mobile phase reduces the distribution rate of the solutes between the stationary and 
mobile phases. Molecules that only diffuse a short distance into the pores will catch 
up with the bulk mobile phase more quickly than the ones diffusing further into the 
pores, causing band broadening. 
 
The combined contribution from mobile phase mass transfer is given by: 
 
   





where  λ is the packing factor which allows for restriction due to the packed particle, 
u is the linear velocity of the mobile phase, dp
2
 is the particle diameter and Dm is the 
diffusion coefficient of the solute in the mobile phase. 
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A typical van Deemter curve (HETP vs u), as shown in Figure 1.8 below, illustrates 
the point at which the total dispersion from the three effects produces a minimum 
(Hmin), giving the optimum linear velocity (uopt) and flow rate of the mobile phase. 
Since the lower the HETP value the higher the plate number and the more efficient 




Figure 1.8. Typical van Deemter curve showing contribution from three dispersion mechanisms. 
 
The faster the process of mass transfer, the better the efficiency of the column. Using 
smaller particulate packing material, less stationary phase, a less viscous mobile 
phase or higher temperatures can increase mass transfer. The effect of particle size 
on the van Deemter curve is illustrated in Figure 1.9, and it is this theory which has 
driven the reduction in particle diameter and the introduction of UHPLC hardware to 












Resulting van Deemter 




Figure 1.9. Van Deemter curves for different particle sizes (10, 5, 3 and 1.7 µm) [4]. 
 
1.2.5 Extra-column Effects 
In addition to the dispersion contributions to band broadening from the column, 
described above, several extra-column factors can have a significant effect on band 
spreading and therefore the performance of a chromatographic separation [37]. 
Extra-column sources of band broadening include the injector, connection tubing and 
detection. The detrimental effects to band broadening caused by such extra-column 
factors become more apparent when using smaller i.d. columns (< 2.1 mm), smaller 
particles (< 3 µm) and smaller injection volumes which place a higher demand on 
the HPLC system [5]. In order to realise the potential of these columns, modified or 
specially designed instruments which minimise extra-column effects are necessary.  
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Since all of these dispersion processes can be independent, each variance can be 
added to obtain the total variance of a peak:  
 
     
 
    
 
   
 




where i is the band spreading in the injector and caused by injection volume, f is the 
band spreading in the fluid path between injector and detector, c is the band 
broadening inside the column and d is the band spreading caused by the detector. 
 
1.2.6 Kinetic Performance Plots 
With the evolution of LC columns, particles and particle sizes in recent years, there 
has been an increased desire to compare different formats with one another. 
Although the classical plate height plot (H, u0) is useful for comparing phases of the 
same particle diameter, they do not consider the pressure drop, permeability or the 
time taken to realise a given number of theoretical plates. Consequently, kinetic plots 
have become a popular tool by which different supports can be compared. The basic 
kinetic plot of N versus analysis time (min), first used by Giddings in 1965 [38], has 
frequently been used to explain column performance and obtain information on the 
compromise between the analysis time and plate number that can be achieved for a 
given particle size and pressure limit. An example is given in Figure 1.10 which is 
used to compare kinetic plots for different particle sizes. It can be seen that, for short 
analysis times, the 2.5 µm particle always outperforms the 3.5 and 5 µm columns. 
However, with longer analysis times, the largest particle size provides the highest 
performance. This can be explained by the fact that for larger particles the diffusion-
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controlled section of the kinetic plot is reached at a longer analysis time than for 
smaller particles.  
 
Figure 1.10. Kinetic plots of plate number versus analysis time. 
Example of a plot of plate number versus analysis time for 2.5, 3.5 and 5 µm particles [39]. 
 
This simple plot was modified by Poppe who introduced the concept of plate time, 
the time required to generate one theoretical plate [40]. The tR versus N plot can be 
easily converted into a Poppe plot by first inverting the axis to give the plate number 
(N) on the x-axis and the time on the y-axis. The analysis time is also replaced with 
the retention time of an unretained peak, the column dead time (t0). This plot of t0 
versus N, as shown in Figure 1.11 (A), is commonly used to compare column 
performance under different chromatographic conditions. Dividing the dead time by 
the plate number to obtain the plate time (t0/N) and plotting against N gives the 
classical Poppe plot that shows the highest achievable plate number for a given 
particle size, as illustrated in Figure 1.11 (B). 
 





Figure 1.11. Kinetic plot of column dead time (A) and plate time (B) versus plate number [39]. 
Examples of a plot of column dead time versus plate number plots for 2.5 µm particles (A) and 
a Poppe plot of plate time versus plate number for 2.5 and 3.5 µm particles (B). 
 
However, the Poppe plot does not consider a link between the back-pressure required 
for operating a column and the column dead time, making it impossible to compare 
particles of different porosities. Desmet et al. further expanded upon the Poppe plot, 
using separation impedance (E) as a technique for evaluating column performance, 
originally proposed by Bristow and Knox [41], to generate a host of kinetic plots. 
The t0 plot suffers from a condensed y-axis, making it difficult to read easily. To 
enlarge the view of the y-axis, t0 can be divided by N
2
, giving a plot of t0/N
2
 versus 
N, as shown in Figure 1.12. The Desmet team also inverted the plate number (N) axis 
so that the plot resembles the familiar van Deemter curve, with higher mobile phase 








Figure 1.12. Kinetic plot created by Desmet illustrating the comparison of 2.5 and 3.5 µm 
particles [39]. 
 
1.3 Modes of HPLC 
Under the umbrella of liquid chromatography, there are various different modes of 
separation. Depending on the type of sample or analyte, various stationary and 
mobile phases can be employed to alter the mode of interaction and hence the 
separation of the particular analytes in question. The major modes of HPLC are 
normal-phase chromatography (NPC), reversed-phase liquid chromatography 
(RPLC), ion-exchange (IEC), size-exclusion (SEC) and more recently hydrophilic 
interaction liquid chromatography (HILIC). Additionally, mixed mode phases such 
as RP-HILIC and RP-IEC have been [43]. The use of supercritical fluid 
chromatography (SFC), a form of NPC which utilises supercritical carbon dioxide as 
the mobile phase, is frequently used for chiral separations [44]. However, this 
current work focuses on separations by RPLC and HILIC which will be discussed 
below. 
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1.3.1 Normal-phase chromatography  
The first mode of HPLC to be developed was normal-phase chromatography (NPC), 
which incorporates a polar stationary phase, typically silica, and non-polar solvents 
as the mobile phase, for example hexane. It relies on the interaction of polar 
functional groups of the analytes with polar functional groups on the surface 
packing. This interaction is mediated by the interaction of the mobile phase with the 
polar functional groups on the surface of the packing. The mechanisms of interaction 
are mostly dipole-dipole and hydrogen-bonding. Classical stationary phases are silica 
or alumina, capable of these interactions by the presence of Si-OH and Al-OH 
groups. However, there are several bonded phases available, including aminopropyl, 
cyanopropyl, diol and nitrophenyl. NPC offers a very powerful separation tool 
because of the wide range of solvents available to fine-tune selectivity, and has been 
shown to be particularly useful for the separation of non-polar compounds and 
isomers. However, the disadvantages associated with the technique have seen it fall 
out of favour, for example the complexities involved, lengthy re-equilibration and 
reproducibility problems. These are largely due to the sensitivity of the technique to 
the presence of small concentrations of polar contaminants in the mobile phase. 
However, these problems can be controlled to provide a superior technique because 
of the low viscosity solvents employed, but these tend not be environmentally 
friendly or compatible with MS. 
 
1.3.2 Reversed-phase chromatography  
Reversed-phase liquid chromatography (RPLC) is now the most commonly used 
form of LC, because of its ease of use, reproducibility and broad applicability, and is 
responsible for between 70-80 % of HPLC separations [35, 45]. In RPLC, separation 
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is based on an analyte’s partition coefficient between a non-polar stationary phase 
and a polar mobile phase. The stationary phase is commonly based on a silica 
support, to which hydrophobic ligands, such as octadecyl (C18) groups, are 
permanently bonded. The polar mobile phase is usually a mixture of a water-
miscible organic solvent, typically acetonitrile or methanol, with water or an aqueous 
buffer. Separation is primarily attributed to partitioning of the lipophilic portion of 
the analyte into the stationary phase. Based upon hydrophobic interactions, this 
mechanism results in analytes eluting in order of decreasing polarity; non-polar 
analytes being more strongly retained due to interactions with the hydrophobic 
groups of the stationary phase. The extent to which a compound is retained depends 
primarily upon its lipophilicity and is affected not only by the stationary phase, but 
also the nature of the mobile phase. The more polar the mobile phase, the quicker a 
component will elute from a reversed-phase column.  
 
1.3.2.1 Inorganic stationary phase materials 
Silica particles commonly act as the base of the stationary phase, composed of 
silicon atoms joined together by siloxane bonds (≡ Si – O – Si ≡). Bonded phases are 
formed by covalently attaching the desired organic moiety (e.g. C8, C18) with silanol 
groups on the silica surface. The nature of the organic moiety determines the 
chemistry of the stationary phase and hence the type of interaction that will take 
place between the solute and the surface. However, steric hindrance prevents these 
often bulky ligands from reacting completely with all silanols, resulting in only 
two-thirds of silanol groups being occupied after bonding. Unreacted silanol groups 
are undesirable and may act as adsorption sites, causing peak tailing and excessive 
retention [46, 47]. Therefore, a second reaction step, known as end-capping, is 
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performed to block such sites with small, highly reactive silanes such as 
trimethylsilanyl groups by treatment with trimethylchlorosilane Figure 1.13. End-
capping results in an additional third of active silanol groups being covered with the 
smaller silanes and, although effective in reducing silanol activity, steric hindrance 
prevents complete blockage of residual silanols with as many as 50 % of the original 
silanol groups remaining unreacted on a typical RP column. Since residual silanols 
are acidic, they can therefore interact with protonated bases via an ion-exchange 
mechanism causing peak tailing [48]. The manufacture of pure Type B silicas have a 
far lower metal content compared with older, less purified Type A silica supports, 
and therefore have reduced silanol acidity [48]. 
 
 
Figure 1.13. Bonded silica (C18) illustrating residual silanol groups and end-capping. 
 
Trimethylsilane “end-capping” 
Residual silanol group 
Bonded C18 ligand 
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1.3.2.2 Porous graphitic carbon 
Porous graphitic carbon (PGC), or Hypercarb as it is known commercially, is 
composed of flat sheets of hexagonally arranged carbon atoms. Hypercarb is 
different from traditional silica in its structure and retention properties, and is stable 
over the entire pH range. This stationary phase has previously shown good retention 
and separation of highly polar species [49], with a combination of two interaction 
mechanisms contributing to retention; adsorption and charge-induced interactions 
[50]. Dispersive interactions between the analyte and mobile phase and the analyte 
and graphite surface contribute to the strong retention, increasing as the 
hydrophobicity of the analyte increases. The polarisability of the surface of graphite 
explains the retention of polar analytes, resulting in a charge-induced dipole. 
 
1.3.2.3 Hybrid stationary phase materials 
The inorganic (silicon) and polymeric (carbon) stationary phase supports described 
above each have distinct advantages and disadvantages, as summarised in Table 1.1.  
Organic polymers offer advantages in improved peak shapes for basic analytes and 
high pH stability, but are characteristically less efficient and not as mechanically 
strong compared with silica-based supports [51]. Silica-based stationary phase 
materials have been the most commonly employed in RPLC separations, owing to 
their excellent efficiency, rigidity and stability [52]. However these stationary phase 
materials often constitute disadvantages for the analysis of basic compounds, 
resulting in broad, tailing peaks. The nature of silica-based sorbants being sensitive 
to pH restricts operation to between pH 2 and 7. Below pH 2, such adsorbents are 
susceptible to hydrolysis [53], whereas above pH 8, hydroxyl groups lead to 
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dissolution of the phase, causing loss of column efficiency, increased back-pressure 
and eventual collapse of the packing material [54].  
 
 
Table 1.1. Summary of inorganic and polymeric packing materials. 
 Advantages Disadvantages 
Inorganic  
(silicon) 
 Mechanically strong 
 High efficiency 
 Predictable retention 
 Wide particle size range 
 Limited pH range 
 Tailing peaks for bases 
 Chemically unstable 
Polymer 
(Carbon) 
 Wide pH range 
 No ionic interactions 
 Chemically stable 
 Mechanically unstable 
 Low efficiency 
 Unpredictable retention 
 Often limited particle size range 
 
The preferred stationary phase material would, therefore, combine the advantages of 
silica gel and polymer based materials. Over recent years, research has focused on 
synthesising alternative chromatographic media capable of operating at a high pH 
without sacrificing the excellent performance benefits of silica-based materials. 
Attempts to reduce interactions between residual silanol groups and ionised basic 
compounds, either by changing the internal or surface structure of packing materials 
or by shielding them from the analytes, have resulted in the development of novel 
modified silica-based supports. Such new generation materials include hybrid 
organic-inorganic phases, which combine both inorganic and organic elements, 
therefore sharing the benefits of both silica and organic polymers. The resulting 
materials have the mechanical strength and high efficiency of inorganic silica 
materials with the wide pH range and lack of tailing peaks provided by organic 
materials. These hybrid inorganic-organic phases include the ethylene bridged hybrid 





) from Waters, which incorporates ethyl groups 
throughout the phase as well as on the particle surface [55] (Figure 1.14). During 
synthesis, one in three silanols is replaced with an ethyl group giving the particles a 
bridged ethylsiloxane/silica hybrid structure and reduced silanol concentration. 
Fewer silanol groups mean fewer potential sites for interaction with ionised basic 
compounds, while the presence of ethyl groups also reduce the acidity of surface 
silanols by increasing their pKa (to > 8) compared to that typical of silica (pKa 3.5-
6.8), resulting in further suppression of silanol activity [56]. Presence of the organic 
polymer slows the rate of dissolution since there are fewer underivatised silanols on 
the silica surface, which limits potential sites of attack by hydroxyl groups. Hybrid 
particle phases therefore demonstrate exceptional lifetimes at high pH, which 
facilitates the manipulation of mobile phase pH for the separation of basic 
compounds. In addition, the high degree of cross-linking offers excellent mechanical 
strength providing BEH particles with the capacity to withstand the high pressures 




Figure 1.14. Bridged ethyl hybrid technology (BEH Technology
TM
, Waters Corporation) [57]. 
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1.3.3 Hydrophilic Interaction Liquid Chromatography 
Hydrophilic interaction liquid chromatography (HILIC) is a variant of NPC, so 
called by Alpert et al. in 1990 to distinguish the two techniques [58]. Although 
HILIC has been practised for a long time, it has recently emerged as an important 
technique for the analysis of very polar compounds such as carbohydrates and polar 
peptides. Inverse to RPLC, in HILIC, retention increases as analyte polarity 
increases and decreases as mobile phase polarity decreases. The stationary phases are 
polar and used with a highly organic mobile phase containing a small proportion of 
water or buffer, as illustrated in Figure 1.15. As for RPLC, the gain in popularity of 
HILIC has resulted in a variety of bonded phases available in addition to the 
traditional underivatised silica or hybrid materials, including amide, amino, diol and 
zwitterionic phases offering different properties for a range of applications. HILIC 
mobile phases generally contain more than 70 % acetonitrile and, for the formation 
of a hydrophilic layer on the surface of the packing, at least 3 % of the mobile phase 
should contain a polar solvent [59]. Additionally, HILIC mobile phases typically 
contain an additive or buffer to aid retention and peak symmetry.   
 
Alpert et al. proposed that the main mode of interaction was due to partitioning of 
solutes from the bulk organic mobile phase with the partially-immobilised aqueous 
layer at the stationary phase. The mechanisms behind this technique have been 
extensively reviewed and continue to be debated with several contributing modes of 
interaction now considered to influence retention, including hydrogen bonding, 
dipole-dipole interactions and electrostatic interactions [60]. Ion-exchange 
mechanisms are commonly encountered, since many of the stationary phases 
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employed have ion-exchange properties. However, this can be exploited to 
manipulate the selectivity of a separation.  
 
Figure 1.15. Illustration of hydrophilic interaction liquid chromatography (HILIC) [61]. 
 
1.3.4 HPLC Method Development 
The resolution (Rs) between two solutes can be affected by both thermodynamic 
factors (retention, k, and selectivity, α) and kinetic factors (peak width and column 
efficiency, N). Therefore the Purnell, or resolution equation, which relates to 
efficiency (N), selectivity factor (α) and the retention factors of the two solutes in a 
separation, is useful for improving the conditions that directly affect resolution: 
 





    
  




where Rs is the resolution, N is the number of theoretical plates, k2 is the retention 
factor of the second peak of the two solutes and α is the selectivity factor. 
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 To obtain the best resolution, all three terms must be maximised. For example, N 
can be increased by reducing particle size or increasing column length. The retention 
factor can be controlled by varying the mobile phase composition (% B). Ideally, k 
will be neither too small nor too large, with a typical goal of 2 ≤ k ≤ 10, providing 
sufficient retention to avoid overlap with matrix interferences, but still generating 
narrow and tall enough peaks for sensitive detection. However, the selectivity factor, 
α, is the most powerful term that can be varied to maximise resolution. Selectivity 
can be manipulated by changing the mobile phase composition, type of organic 
solvent used, column chemistry or column temperature and, in the case of ionisable 
compounds, mobile phase pH, buffer concentration or ion-pairing reagent 
concentration. 
 
1.3.4.1 Stationary phase selectivity 
With the wide complement of stationary phases now available, column selectivity 
offers a major parameter in method development and optimisation. Considering 
RPLC, there are many different bonded chemistries and brands of column packing 
materials, each differing in their hydrophobicity, silanophilic activity, shape 
selectivity, polar selectivity and metal content. Even stationary phases of the same 
chemistry vary from manufacturer to manufacturer, depending on the type of support 
used, degree of carbon loading and end-capping process.  
 
An additional advance in the stationary phase development is the incorporation of a 
polar functional group into the ligand, close to the surface of the silica, resulting in 
the polar-embedded phase [62, 63]. Such bonded ligands are effective in “shielding” 
silanol groups, preventing interaction with basic analytes through steric hindrance. 
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An additional benefit brought about by such chemistry is the improved wettability in 
highly aqueous mobile phases. With traditional hydrophobic ligands, it is necessary 
to maintain a degree of organic solvent in the mobile phase (> 5 %) to prevent phase 
de-wetting. Hence, such polar-embedded phases are advantageous for the analysis of 
highly polar analytes, which necessitate fully aqueous mobile phases to obtain 
sufficient retention.  
 
1.3.4.2 Mobile phase selectivity 
Changes in solvent strength, either the concentration or type of organic component 
used, provides a convenient means of altering selectivity. In RPLC, acetonitrile or 
methanol is usually a first choice, with acetonitrile presenting a stronger solvent and 
therefore typically generating smaller k values and less resolving power. For the 
separation of very polar analytes by RPLC, sufficient k can be achieved if minimal 
organic solvent is used. This historically resulted in phase de-wetting, due to 
expulsion of mobile phase from the pores of particles. However, the polar embedded 
phases now available are able to tolerate operation in fully aqueous mobile phases 
required for the retention of very polar species. 
 
The ability to modify mobile phase pH provides the chromatographer with an 
additional tool in order to achieve suitable retention and peak shape of basic 
analytes. The pH restrictions of traditional silica materials render basic analytes 
protonated under these conditions, which is detrimental to chromatography. 
However, the stability of newer stationary phase materials over a wide pH range 
allows the pH of the mobile phase to be increased in order to suppress analyte 
protonation, which inherently reduces secondary interactions between the positive 
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analyte charge and the negative silanol groups responsible for poor peak shape. In 
addition, retention is enhanced, since polarity is reduced as analyte ionisation is 
suppressed, permitting hydrophobic interactions to dominate the mechanisms of 
retention. This was previously not possible with the limited pH range of the 
stationary phase of between pH 2-7, since a pH of two units above the pKa of the 
analyte is required to completely suppress basic analyte ionisation. 
 
Ion-pair reagents provide another opportunity to affect selectivity. The use of 
trifluoroacetic acid (TFA) and triethylamine (TEA) have been show to improve 
chromatographic separations, although this option has become less popular because 
of the incompatibility with MS ionisation and detection. 
 
1.3.4.3 Temperature selectivity 
Column temperature is an important variable which can have a significant influence 
on selectivity, causing retention changes according to the van’t Hoff equation, 
expressed as: 
 
        
   
     
 
   
    
      
 
where ∆H0 and ∆S0 are the enthalpy and entropy of solute transfer, respectively, 
from the mobile phase to the stationary phase, T is the absolute temperature, R is the 
universal gas constant and Ø is the phase ratio of the column. 
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As temperature increases, retention often decreases, resulting in poorer separation, 
while peak heights increase, providing better sensitivity. However, in certain cases 
an increase in temperature can lead to an increase in retention, and changes in the 
order of elution can therefore be observed through varying column temperature [64-
66]. Separations are typically performed between ambient and 60 °C, although with 
the advent of more stable stationary phases, operation at temperatures in excess of 
100 °C are now possible [67, 68]. In addition, increased column temperature has the 
added kinetic benefits of lowering column back-pressure, since mobile phase 
viscosity is reduced. This enables the use of longer column formats if a higher plate 
number is required for improved resolution, or the use of faster flow rates to reduce 
analysis time. However, while increased column temperature offers these 
advantages, certain disadvantages should also be considered such as analyte stability 
and stationary phase hydrolysis. 
 
1.4 Mass Spectrometry 
Mass spectrometry (MS) is an unequalled analytical method for sensitive analyte 
detection, identification and quantification. Molecules are ionised to generate 
charged molecules, or charged molecular fragments, which are measured according 
to their mass-to-charge (m/z) ratios in a high vacuum. This enables the determination 
of isotopic molar mass, elemental composition and elucidation of chemical structure. 
 
The ions produced must be in the gas phase so they can be manipulated by the 
application of either electric or magnetic fields to enable separation. A conceptual 
illustration of a mass spectrometer is given in Figure 1.16, comprising three 
modules: an ion source where ions that exist in solution are moved into the gas 
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phase, a mass analyser which separates ions by their m/z ratios and a detector which 
records the current generated when a charged particle hits the detector to obtain a 
mass spectrum.  
 
 
Figure 1.16. Conceptual illustration of the mass spectrometer. 
 
1.4.1 Ionisation 
The initial connection of HPLC with MS was a huge challenge, convoluted by 
thermally labile and/or non-volatile analytes. With sample dissolved in a solvent, 
such as that eluting from a LC platform, an interface is required to transform the 
mobile phase from the liquid to the gas phase. The development of an LC-MS 
interface has resulted in a collection of ionisation modes conducted at atmospheric 
pressure (API), including electrospray ionisation (ESI) [69], atmospheric pressure 
chemical ionisation (APCI) and atmospheric pressure photoionisation (APPI). The 
development of API techniques, in particular ESI, enabled LC-MS to finally gain 
popularity as one of the most powerful analytical platforms. The ionisation 
techniques employed in this thesis will be discussed below. 
 
Ionisation m/zAnalyser Detector 
IONS IONS 
Vacuum 
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1.4.1.1 Electrospray Ionisation  
Electrospray ionisation (ESI) was a pioneering advancement in the hyphenation of 
LC with MS and remains the most commonly used ionisation technique in LC-MS 
due to its wide applicability. This soft form of ionisation produces minimal 
fragmentation and is used for ionic, neutral and polar compounds. As illustrated in 
Figure 1.17, the LC eluent passes, at atmospheric pressure, through a capillary tube 
to which a large voltage is applied in order to produce a spray of fine droplets. The 
potential difference applied, typically several thousand volts, generates an electric 
field between the capillary and the counter electrode (cone). Depending on the 
analytes of interest, this voltage may be positive (positive ionisation) or negative 
(negative ionisation). This potential serves to provide charge separation of the ions at 
the surface of the liquid at the tip of the capillary to form a “Taylor cone”. Through 
gentle desolvation by a heated drying gas, typically nitrogen, droplets continue to 
diminish in size with the evaporation of solvent. The charge accumulates at the 
surface of the droplet, since ions (which are involatile) are retained and the 
concentration of the analyte increases. There are then two debated mechanisms 
which occur, referred to as the charge residue model (CRM) [70] and the ion 
evaporation model (IEM) [71, 72]. A decrease in droplet size increases the repulsive 
forces between the excess charge in the droplet, promoting “Coulombic explosion”. 
In the CRM, this process continues until the point where the charge repulsion on the 
surface of the droplet overcomes the surface tension, known as the Rayleigh limit. 
This mechanism eventually results in single ionised molecules and assumes that the 
increased charge density due to solvent evaporation causes large droplets to divide 
into smaller and smaller droplets. The second proposed IEM mechanism assumes 
that the increased charge density that results from solvent evaporation eventually 
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causes Coulombic repulsion to overcome the liquid’s surface tension, resulting in a 











Figure 1.17. Illustration of positive electrospray ionisation (ESI). 
 
1.4.1.2 Atmospheric pressure chemical ionisation 
Atmospheric pressure chemical ionisation (APCI) is another form of soft ionisation, 
mainly applied to the analysis of polar and relatively non-polar compounds. In 
APCI, the analyte in solution is introduced into a pneumatic nebuliser and desolvated 
in a heated quartz tube before interacting with a corona discharge to create ions. 
Ionisation occurs in the gas phase, as described in Figure 1.18, with the corona 
discharge providing low-energy electrons to initiate the gas-phase reactions. These 
low-energy electrons ionise a reagent gas from solvent molecules (e.g. N2, O2, H2O, 
etc) that, through a complex series of ion/molecule reactions, efficiently produce 
positive and negative ions of the analyte. Secondary reactant gas ions (e.g. H3O
+
) 
undergo repeated collisions with the analyte, resulting in the formation of analyte 
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thermalisation of the analyte ions. APCI results in spectra of predominantly 
molecular species and adduct ions with very little fragmentation.  
 
Figure 1.18. Illustration of APCI [73]. 
(Obtained from http://www.bris.ac.uk/nerclsmsf/images/apci2.gif) 
 
1.4.2 Mass Analysers 
Once formed, ions are accelerated and focused into a mass analyser where they are 
separated according to their m/z ratio. Several types of mass analysers have been 
developed which can be interfaced with LC. However, in the current study, 
quadrupole transmission and time-of-flight (TOF), including tandem and hybrid 
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1.4.2.1 Quadrupole analysers 
The quadrupole mass analyser consists of four parallel rods to which two varying 
electrostatic fields are applied at right angles to each other; one direct current (DC) 
and one radiofrequency (RF) (Figure 1.19). Ions produced in the source of the 
instrument are focused and passed through the centre of the four rods. Ions are able 
to transverse the field-free region along the centre of the axis of the rods where the 
oscillations amongst the poles result in ion trajectories dependent on the m/z of the 
ions. Ions with a particular m/z have a stable trajectory and pass to the detector, 
whereas those with an unstable trajectory will hit the quadrupoles and not be 
detected. The mass range and resolution of the instrument is dependent on the length 
and diameter of the rods. The full mass range is normally achieved by scanning the 
RF voltage and DC voltage together so that the RF/DC ratio is constant.  
 
Figure 1.19. Schematic representation of a quadrupole mass filter [74]. 
(Obtained from http://www.chm.bris.ac.uk/ms/theory/quad-massspec.html) 
 
1.4.2.2 Tandem mass spectrometry 
Quadrupoles are often combined in sequence to provide a tandem process which 
enables fragmentation studies to gain additional structural information. The most 
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common configuration is three quadrupoles coupled in series, referred to as tandem 
or triple quadrupole (QQQ) mass spectrometry, which enables basic ion 
fragmentation (tandem MS/MS). Figure 1.20 illustrates a triple quadrupole analyser, 
where the first quadrupole (Q1) selects the precursor ions, which are then transferred 
into the second quadrupole (Q2), an ion guide where collision with an inert gas, 
typically argon or nitrogen, promotes analyte fragmentation. The fragments, or 
product ions, are then separated by the third quadrupole (Q3) to give a characteristic 







Figure 1.20. A schematic representation of a triple quadrupole mass analyser. 
 
The triple quadrupole mass spectrometer is still the most commonly used detection 
technique for quantitative analysis of small drug molecules owing to its unrivaled 
sensitivity and selectivity in addition to the high ion throughput obtainable. 
 
1.4.2.3 Time-of-flight analysers 
Time-of-flight (TOF) mass spectrometry is one of the earliest type of instruments but 
was limited because of the speed of early electronics and ionisation techniques. TOF 
mass analysers rely on separation of ions, after their initial acceleration through an 
electric field, according to their velocities as they transverse through a field-free 
region called the flight tube. Acceleration by an electric field of a known strength 
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results in ions of the same charge having the same kinetic energy. The time taken for 
ions to move through the flight tube of a known distance to the detector determines 
their m/z ratios. This depends on their velocity, with larger ions reaching lower 
speeds and taking longer to reach the detector. The advantage of a TOF is the ability 
to detect all ions, compared with other mass analysers that filter selected ions. Since 
the operation of TOF MS relies on the drift of ions, the length of the flight tube is of 
major importance for resolution, with the longer the flight, the greater the resolution 
obtained. Analytical use of the technique has historically been limited by the length 
of the flight tube required to achieve adequate mass resolution. However, the use of 
reflectrons now provides increased resolving power, since the effective length of the 
flight tube can be doubled when ions are reflected at the end of the flight tube. 
Latterly, TOF-MS has gained further popularity because of the high resolving power 
that could be achieved through reflectron technology and accurate mass capabilities, 
and advances in superior ion transmission have resulted in improved detection limits. 
The rapid spectral acquisition rates of the TOF are another important feature, with 
the ability to produce several thousands of spectra per second. TOF instruments have 
been traditionally used for the analysis of relatively high molecular mass 
compounds, such as proteins, but with recent innovation there has recent interest in 
the application of these instruments for small molecule analysis. 
 
1.4.2.4 Quadrupole time-of-flight analysers 
Several mass spectrometers combine different types of analysers, referred to as 
hybrid instruments. Tandem mass spectrometry is feasible with a TOF instrument, 
typically combining a quadrupole and collision cell between the source and the TOF 
analyser (Figure 1.21). Such hybrid quadrupole TOF (QTOF) mass analysers have 
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become increasingly popular over recent years, providing the attractive combination 
of the ability to select ions for MS/MS fragmentation with high resolution and 
accurate mass measurements. Traditionally, these instruments have mainly been used 
for qualitative work due to their inherent limited dynamic range, although 
improvements in gating mechanisms have recently improved this. The tandem 
QTOF mass spectrometer has been used extensively for proteomics but has also 
found many uses in the area of small molecule analytical chemistry [75-77]. 
 
Figure 1.21. Illustration of the QTOF instrument [78]. 
(Obtained from http://www.whri.qmul.ac.uk/PAU/MSunit_QTOF.htm) 
 
1.4.3 Considerations for LC-MS hyphenation 
Stable MS spray and analyte ionisation can be affected by several parameters; the 
instrument hardware or design, analyte characteristics and the LC conditions 
employed before the sample is introduced into the source. Mobile phase composition 
and flow rate are important considerations when coupling LC with MS. The use of 
mobile phase additives and buffers can not only dramatically affect the 
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chromatography, but also the MS response. Although the mechanisms surrounding 
ESI are still not fully explained, there are several reports on how mobile phase 
composition and components of the sample matrix can impact on the results of MS 
analysis. 
 
1.4.3.1 Mobile phase composition 
The influence of the solvent composition has a significant effect on ESI signal and is 
a feature of the separation developed to introduce the sample to the MS. Increasing 
the organic content in the mobile phase results in increased ionisation due to 
changing the solvent characteristics such as viscosity, conductivity and surface 
tension [79]. Many of the buffers or ion-pairing agents commonly employed to 
improve chromatographic separation are not compatible with MS detection. Even the 
use of volatile buffers can introduce more surface-active electrolytes, which will 
compete with the target compound and suppress ionisation, and the pH as well as the 
type of additive affects the amount and type of ions formed [79-82]. Ion-pairing 
agents, such as TFA and TEA, have been shown to have a negative impact on 
ionisation, where the ion pair may not fully dissociate and therefore appear as a 
neutral species, resulting in ion suppression [83-85].  
 
1.4.3.2 Ion Suppression 
An important consideration for a selective method is the assessment and 
quantification of sample matrix effects, where co-eluting endogenous species have 
the potential to suppress, or enhance, ionisation. This is of particular importance in 
bioanalysis, where complex matrices, such as urine, plasma and serum, are 
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frequently analysed. While ion suppression has been observed with both APCI and 
ESI, APCI has been shown to be less susceptible to matrix effects [86].  
The investigation of how matrix effects are reflected in MS response is paramount 
when developing LC-MS methodology, especially if quantification is required. Once 
identified, matrix effects can be minimised, if not eliminated, through appropriate 
sample pre-treatment or chromatographic optimisation. The use of selective sample 
preparation, including solid phase extraction (SPE) and liquid-liquid extraction 
(LLE), is often an important step in further minimising matrix effects that could 
occur with ESI-MS. However, where sensitivity is not of great importance, LC is 
compatible with a simple dilution and injection approach. There are several reports 
illustrating the success of direct sample dilution, centrifugation and injection for fast, 
high-throughput analysis without any negative impact on the MS signal, although 
much attention must be paid to ensure there are minimal matrix effects if this 
approach is taken [31, 87]. Since UHPLC offers enhanced resolution, the risk of co-
elution is reduced, which in turn results in a lower risk of ion suppression, improving 
MS sensitivity and reliability. Van de Steene et al. have compared the degree of 
matrix effects when using HPLC-MS/MS with UPLC-MS/MS for nine 
pharmaceuticals, concluding that with UHPLC matrix effects were either minor or 
totally eliminated [88]. 
 
1.5 Aims 
The purpose of this thesis was to investigate novel approaches to chromatographic 
separations using sub-2 µm stationary phases with the latest UHPLC technology, 
enabling fast, sensitive and robust drug analysis. There was a particular focus on the 
research of chromatographic techniques interfaced with MS, in order to establish the 
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application of UHPLC-MS to improve existing methods of bioanalysis which are 
mostly based on GC-MS. Examples are taken from doping control, where the 
challenges associated with analysing hydrophilic, basic analytes by RPLC, while 
maintaining MS operation, are addressed, and methodology is developed for the 
reliable and robust quantification of such analytes. Alternative approaches are 
studied based on advances in stationary phase materials, such as hybrid supports and 
HILIC, and MS technology, including the shift from tandem MS/MS to the use of 
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2.1.1 Separation of Basic Compounds 
High performance liquid chromatography (HPLC) continues to be dominated by 
reversed-phase applications. However, the analysis of basic compounds remains a 
major challenge for reversed-phase liquid chromatography (RPLC), a particular 
problem since the majority of pharmaceutical compounds comprise ionic, nitrogen-
containing functional groups. The ephedrines (norephedrine (cathine), 
norpseudoephedrine (phenylepropanolamine, PPA), ephedrine, pseudoephedrine and 
methylephedrine) are examples of such basic compounds which are difficult to 
separate by RPLC, the structures and pKa values of which are shown inFigure 2.1. 
Frequently found in pharmaceutical preparations and nutritional supplements, these 
analytes have stimulant effects and for this reason their use is restricted in human 
sport [89]. Administration of these substances is controlled in competition, with the 
World Anti-Doping Agency (WADA) prohibiting their use above threshold 
concentrations [90]. Due to the identical elemental composition of the 
diastereoisomeric pairs (PPA-cathine and ephedrine-pseudoephedrine), they share 
virtually identical mass spectra and therefore require chromatographic separation for 
unambiguous identification and accurate quantification. Previously, this separation 
has been performed by HPLC-UV [91] or GC-MS, which relies upon a sample pre-
concentration liquid-liquid extraction followed by complex derivatisation in order to 
distinguish PPA from cathine and ephedrine from pseudoephedrine [92]. However, 
as previously discussed, LC-MS has assumed an important role in bioanalysis over 
the last 15 years, having advantages in simple sample preparation, faster analysis 




































































Figure 2.1. Chemical structures showing stereoisomerism, IUPAC nomenclature and pKa values 
of the ephedrine compounds considered in this study. 
 
* 
(1S,2S)-norpseudoephedrine (cathine), pKa 9.4 
(1S,2S)-2-amino-1-phenylpropan-1-ol 
(1R,2R)-norpseudoephedrine (cathine), pKa 9.4 
(1R,2R)-2-amino-1-phenylpropan-1-ol 
(1R,2S)-norephedrine (phenylpropanolamine), pKa 9.4 
(1R,2S)-2-amino-1-phenylpropan-1-ol 
(1S,2R)-norephedrine (phenylpropanolamine), pKa 9.4 
(1S,2R)-2-amino-1-phenylpropan-1-ol 
(1R,2S)-ephedrine, pKa 9.6 
(1R,2S)-2-methylamino-1-phenylpropan-1-ol 
(1S,2R)-ephedrine, pKa 9.6 
(1S,2R)-2-methylamino-1-phenylpropan-1-ol 
(1R,2S)-methylephedrine, pKa 9.3 
(1R,2S)-2-(dimethylamino)-1-phenylpropan-1-ol 
(1S,2R)-methylephedrine, pKa 9.3 
(1S,2R)-2-(dimethylamino)-1-phenylpropan-1-ol 
(1S,2S)-pseudoephedrine, pKa 9.8 
(1S,2S)-2-methylamino-1-phenylpropan-1-ol 






















Previous alternative approaches to overcoming the inherent challenges associated 
with analysing basic compounds by RPLC include the use of various different 
stationary phase chemistries and mobile phase additives. As is the case with the 
ephedrines, the analysis of ionisable compounds which are also hydrophilic is even 
more problematic. With typical acidic mobile phases, such cases require very low 
amounts of organic modifier in order to achieve acceptable retention of protonated 
bases, or organic additives in order to achieve acceptable peak shapes [24, 96, 97]. 
The low percentage of organic solvent content (< 5 %) necessary to achieve suitable 
retention can often cause issues such as phase de-wetting, where the hydrophobic 
ligands bonded to the silica stationary phase collapse. This may result in retention 
time shifts and requires regeneration every several injections, thereby limiting 
sample throughput. Additionally, such highly aqueous conditions are not ideal for 
MS detection, particularly with electrospray ionisation (ESI), owing to poor 
desolvation of the eluent, which results in poor analyte ionisation and hence reduced 
sensitivity. Organic additives, including trifluoroacetic acid (TFA) and triethylamine 
(TEA), are also frequently employed as counter-ions to interact with the analyte and 
the stationary phase. Although successful in considerably improving retention, peak 
shape and separation for ionic and polar analytes, these additives cause ion 
suppression and have a lingering ion-pair effect that is difficult to remove from a 
LC-MS system and may even require dedicated instrumentation [98, 99]. 
  
An alternative approach to separating basic compounds by RPLC which has recently 
emerged is to use a high pH mobile phase so as to suppress analyte ionisation, and 
thus polarity, which allows enhanced retention with reduced peak tailing [48, 100, 




limited, due to the instability of conventional silica-based stationary phases 
susceptible to dissolution in high pH conditions [54]. While non-silica phases, such 
as PGC and polymeric materials, offer stability over a wide pH range and therefore 
permit the use of high pH mobile phases, their poor efficiency and mechanical 
stability has limited their use. However, the development of chemically stable 
phases, such as hybrid inorganic/organic materials, facilitates the use of mobile 
phases of high pH to suppress the ionisation of basic analytes [51, 102, 103]. The 
possibility of using mobile phase pH to achieve symmetrical peak shapes and 
acceptable retention factors for these compounds with an MS compatible system to 
maintain LC-MS operation is highly desirable. The ability to manipulate mobile 
phase pH above the analyte pKa enables suppression of analyte ionisation and 
permits enhanced retention and resolution in addition to significantly improved peak 
shapes due to the lack of secondary interactions with ionised silanol groups. In 
addition, it has previously been reported that in their unionised form, analytes are 
better able to tolerate the detrimental effects of column overloading [104-107]. 
Contrary to traditional theory, the use of high pH mobile phases to separate basic 
compounds in their neutral form has not proven to be detrimental to ionisation in 
MS, with several reports that such conditions even enhance MS ionisation [108-110]. 
 
The present chapter describes the manipulation of mobile phase pH in developing a 
method to separate phenylpropanolamine (PPA), cathine, ephedrine, 
pseudoephedrine and methylephedrine. Although capillary electrophoresis might 
prove a beneficial alternative for the separation of these closely related basic 
analytes, a method compatible with MS detection was sought after. Therefore, 




(pH 3), mid (pH 7) and high (pH 10) pH mobile phases are studied to investigate the 
effects on retention, peak shape, resolution and the sample loading capacity of basic 
compounds in RPLC. Additional parameters affecting chromatographic 
performance, including the organic content and temperature, are also investigated 
with respect to high pH conditions in order to evaluate the effects on retention, 
resolution, peak shape and column efficiency. In particular, the effects of combining 
high mobile pH with elevated temperatures are evaluated. Increasing column 
temperature results in reduced viscosity and back-pressure and increased diffusion 
coefficients, providing a decrease in resistance to mass transfer [66, 111-113]. These 
benefits are obvious with van Deemter curves displaying flatter slopes and therefore 
generating higher optimal linear velocities. Faster flow rates can therefore be 
realised, leading to faster analysis times without sacrificing efficiency, and the lower 
back-pressures at higher temperature permit the use of longer or coupled columns in 
order to generate high plate numbers [7, 114].  
 
The generation of van Deemter curves at low and high pH demonstrates the effect of 
pH and temperature on the efficiency of separation to obtain the optimal conditions. 
In addition, kinetic plots are used to evaluate the differences in kinetic performance 
between low and high pH mobile phase conditions. An optimised HPLC separation 










Methanol (HPLC grade), acetonitrile (HPLC grade), ammonium hydroxide solution 
(35 % w/w) and ammonium bicarbonate were obtained from Fisher Scientific 
(Loughborough, UK). Formic acid (99-100 %) was purchased from VWR 
(Leicestershire, UK). Ammonium acetate and ammonium formate were purchased 
from Sigma (Poole, UK). Norephedrine (phenylpropanolamine, PPA), 
norpseudoephedrine (cathine), ephedrine, pseudoephedrine and methylephedrine 
were purchased as hydrochloride salts from Sigma (Poole, UK). Water was purified 
by an ultra-pure water system (Millipore, UK).  
 
2.3.2 Solutions 
2.3.2.1 Mobile phase 
10 mM solutions of ammonium formate, ammonium acetate and ammonium 
bicarbonate were prepared in purified water. Ammonium formate was adjusted to 
pH 3 with formic acid and ammonium bicarbonate was adjusted to pH 10 with 
ammonium hydroxide solution. 
 
For the final method, a stock solution of ammonium bicarbonate buffer was prepared 
at 25 mM in purified water and adjusted to pH 9.8 with ammonium hydroxide 
solution (35 % w/w). This buffer was then used for the preparation of the final 
mobile phase, which consisted of 10 mM ammonium bicarbonate pH 9.8 in water 
(A) and 10 mM ammonium bicarbonate pH 9.8 in 60 % methanol (B). For the 




to 600 mL of water in order to achieve a 10 mM buffer solution. For the preparation 
of mobile phase B, 200 mL of the stock buffer was added to 300 mL of methanol.  
 
2.3.2.2 Samples 
Stock solutions were prepared at a concentration of 1 mg/mL for cathine, ephedrine 
and methylephedrine and 10 mg/mL for pseudoephedrine in methanol and stored at 
-20 °C. Standard working solutions were prepared by diluting stock solutions with 
the appropriate mobile phase. 
 
2.3.3 LC conditions 
All separations were carried out on an Acquity UPLC
®
 system (Waters, Milford, 
MA, USA) with an XBridge C18 2.5 µm, 2.1 x 50 mm column or an Acquity BEH 
C18 1.7 µm, 2.1 x 50 mm column provided with a 0.2 µm in-line filter. Unless 
otherwise stated, investigations were carried out using 20:80 v/v CH3OH: aqueous 
buffer with a flow rate of 400 µL/min and a column temperature of 30 °C.  
 
For the final optimised method, the run time was 6.5 minutes including the re-
equilibration time. The mobile phase consisted of 10 mM ammonium bicarbonate 
pH 9.8 in water (A) and 10 mM ammonium bicarbonate pH 9.8 in 60 % methanol 
(B). The flow rate was 500 µL/min and column temperature was set at 45 °C. The 
weak and strong needle wash lines of the Acquity UPLC
®
 system were placed in 
90:10 H2O/CH3OH 0.2 % formic acid and 10:90 H2O/CH3OH 0.2 % formic acid 
respectively. The injection volume was 2 µL and injections were performed in the 




B, increasing to 41.7 % over 3.2 minutes and to 91.7 % at 5.2 minutes, returning to 
16.7 % for a 1.3 minute re-equilibration.  
 
2.3.4 Detection 
An Acquity PDA detector (Waters, Milford, MA, USA) was connected to the outlet 
of the UPLC
®
. The detector was equipped with a 500 nL flow cell and solutes were 
detected at 210 nm with a sample rate of 40 Hz. The chromatograms were processed 
using Empower software (Waters, Milford, MA, USA). 
 
2.3.5 Construction of van Deemter and kinetic plots 
Experimental plate height, H, and mobile phase linear velocity, u0, values were 
obtained using a 5 cm column at pH 3 and 10 at 30 °C, and for pH 10 at column 
temperatures of 45 and 60 °C. The test mixture was composed of uracil (void volume 
marker), PPA, ephedrine and methylephedrine. All experiments were conducted in 
the isocratic mode using pre-mixed mobile phases. The organic content of the mobile 
phases was varied between pH 3 and pH 10 in order to maintain similar retention 
factors, hence 5:95 v/v CH3OH: ammonium formate and 20:80 v/v 
CH3OH:ammonium bicarbonate were used at pH 3 and pH 10, respectively. All 
injections were made in duplicate and the results averaged. The theoretical plate 
count (N) for each analyte was calculated from the peak widths at half height using 
Empower
TM
 software (Waters, Milford, MA, USA). The u0 and H values were 















where L is the column length, N is the number of theoretical plates and t0 is the void 
time. Van Deemter curves were determined by fitting the H versus u0 data with a 
nonlinear curve fitting function in SigmaPlot 12.  
 
The viscosities in the different methanol-buffer mixtures and temperatures were 
calculated according to the empirical relationship derived from the Chen-Horvath 
equation [66]: 
 
                                                  
 
             
 
      
 
where x is the fraction of methanol in the mobile phase and T is the temperature in 
Kelvin.  
 
The calculated viscosities are detailed in Table 1. The diffusion coefficients of the 
solutes were calculated using an expression derived from the Wilke-Chang equation 
[115]: 
 
          
                                     
   
    
 
where xorg and xwater are the molar fractions of the organic component and water in 
the mixtures, respectively, ψorg and ψwater are the association factors of the organic 




MWorg and MWwater are the molecular weights of the organic component and water, 
respectively. VA is the molar volume of the solutes, and these values were obtained 
from ChemSpider (PPA = 141.006 cm
3
, ephedrine = 162.711 cm
3
 and 




Table 2.1 shows the mobile phase compositions employed depending on the pH and 
column temperature, calculated eluent velocities and diffusion coefficients for the 
three compounds. 
 
The pressure drop of the column was investigated by subtracting the experimental 
pressure drop in the connection tubes (ΔPext) from the total pressure drop from the 
instrument (ΔPtot) to yield the effective column pressure gradient (ΔPcol): 
 
                  
 
This value was then used in Darcy’s law equation to obtain u0-based column 
permeability, Kv0, calculated from:  
    
    
     
 
 
where u0 is the velocity of the unretained component, η is the mobile phase viscosity 
in cP, ΔPcol is the pressure drop across the column in Pa. The system pressure values 
required for the calculation of ΔPcol are determined at each temperature by replacing 













































































































































































































































































































































2.4 Results and Discussion 
2.4.1 Method development 
2.4.1.1 LC Optimisation 
Mobile phase pH provides a powerful tool in method development for ionisable 
compounds, although its use has been largely restricted due to the destructive effects 
on silica-based packing materials. In addition, the solubility of the analytes in 
question must also be considered at high pH where they exist in their neutral state. 
Thus, previous approaches to the analysis of basic analytes have relied upon low pH 
conditions so as to suppress the ionisation of residual silanol groups or the use of 
ionic additives and organic modifiers [96, 116, 117]. Unfortunately, such approaches 
are not without their disadvantages, including reduced retention of hydrophilic bases 
at low pH and certain mobile phase additives being incompatible with mass 
spectrometry, such as volatile ion-pairing agents. The chemical stability of new 
hybrid stationary phase materials, however, facilitates the use of mobile phases of 
high pH in order to suppress ionisation of basic analytes, reducing ionic interactions 
with the packing material. The exploitation of pH to render basic compounds in their 
neutral state results in improved retention and peak shape and, therefore, resolution. 
These distinct advantages are evaluated here with the separation of the ephedrines 





2.4.2 Effects of organic modifier on apparent pH 
The Henderson-Hasselbalch equation describes the derivation of pH as a measure of 
acidity, using pKa as the acid dissociation constant: 
 
             
    
    
  
 
where Ka is the acid dissociation constant, pKa = -log Ka, and [HA] and [A
-
] are the 
molarities of the weak acid and its conjugate base. 
 
The pKa is a characteristic constant of an analyte. From the above equation it can be 
seen that by adjusting the mobile phase pH we can vary the relative amounts of 
neutral and ionic forms of the analyte. If the pH is two units above or below the pKa 
of the analyte, more than 99 % of the analyte will either be in its neutral or ionised 
form, depending on the direction of the pH shift. In the case of a basic compound, as 
the mobile phase pH is decreased, a larger proportion of the analyte will become 
ionised, as depicted in the reversed sigmoidal curve in Figure 2.2. Table 2.2 
illustrates how mobile phase pH influences the degree of ionisation for the analytes 
considered in this study. The percentage ionisation may be calculated using the 
analyte pKa and specific pH using the following equations: 
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Figure 2.2. Effect of basic analyte ionisation (ephedrine, pKa = 9.4) as a function of pH. 
 
Table 2.2. Degree of analyte ionisation as a function of pH. 
  PPA Cathine Ephedrine Pseudoephedrine Methylephedrine 












1.0 100.00 100.00 100.00 100.00 100.00 
2.0 100.00 100.00 100.00 100.00 100.00 
3.0 100.00 100.00 100.00 100.00 100.00 
4.0 100.00 100.00 100.00 100.00 100.00 
5.0 100.00 100.00 100.00 100.00 99.99 
6.0 99.96 99.96 99.97 99.98 99.95 
7.0 99.60 99.60 99.75 99.84 99.50 
8.0 96.17 96.17 97.55 98.44 95.23 
9.0 71.53 71.53 79.92 86.32 66.61 
10.0 20.08 20.08 28.47 38.69 16.63 
11.0 2.45 2.45 3.83 5.94 1.96 
12.0 0.25 0.25 0.40 0.63 0.20 
13.0 0.03 0.03 0.04 0.06 0.02 
14.0 0.0 0.0 0.0 0.01 0.00 
* % ionisation values calculated from pKa values using the equation: % ionisation = 100/(1+10^(pH-pKa)) 
 
However, an important consideration is the effect of the organic modifier used in 
RPLC separations on mobile phase pH. It cannot be assumed that the mobile phase 
pH, and therefore the percentage ionisation, will be the same after the addition of 
acetonitrile or methanol. The effects of organic content on pH and analyte pKa have 
already been investigated and reports demonstrate a negative Δ pH for basic buffers 
as the methanol content increases [118]. Buffer pH is typically measured in the 
































system calibrated with aqueous buffers. Therefore, although pH measurements of 
aqueous-organic mixtures will not be accurate, it is useful to measure the apparent 
pH in order to appreciate the degree of change upon addition of an organic modifier. 
Figure 2.3 illustrates this apparent change with the addition of methanol or 
acetonitrile to 10 mM ammonium bicarbonate pH 10, with both solvents causing a 




Figure 2.3. Effect of organic modifier using acetonitrile (A) or methanol (B) on the apparent pH 
of an aqueous 10 mM ammonium bicarbonate buffer solution adjusted to pH 10. 
 
2.4.2.1 Retention 
Initial method development investigates the effects of low, mid and high pH mobile 
phases on peak shape, retention, and hence separation of the ephedrines (PPA, 











































optimum conditions under which to separate the diastereoisomers. Isocratic elution 
at 0.4 mL/min was performed with varying percentages of organic modifier, 
investigating the use of acetonitrile and methanol with an aqueous mobile phase 
buffered to the extremes of pH used, i.e. pH 3 and pH 10. The results are detailed in 
Figure 2.4 and show the effect of organic modifier on the retention of PPA, 
ephedrine and methylephedrine under low and high pH conditions.  
 
It is interesting to note that, as the organic content reaches 70-80 %, retention begins 
to increase again. This phenomenon contradicts traditional RPLC theory, where an 
increase in organic content dictates a decrease in retention. The differences seen here 
can be explained by the fact that the phase is subject to operation in a hydrophilic 
interaction liquid chromatography (HILIC)-type mode. This HILIC behaviour has 
been reported elsewhere, where Tannak et al. showed the HILIC-like properties of 
cyano, butyl and phenyl HPLC phases for the separation of some basic analytes, 
denoted by an increase in retention of polar basic analytes as a function of increased 
organic modifier [119]. This effect is more pronounced at pH 3 than at pH 10, which 
can be attributed to the ionisation of basic analytes and silanol groups in the 
stationary phase at low pH whereas, at pH 10, the analytes are largely in their neutral 
form. When both are ionised, strong ionic interactions are possible and formation of 
the water layer thought to be responsible for partitioning in HILIC is maximised. In 
this instance, at pH 10 the basic analytes are largely unionised and are therefore less 
able to take part in ionic interactions. The effect is more pronounced with acetonitrile 
as the organic modifier as opposed to methanol, as acetonitrile is a weaker solvent in 
HILIC mode. Under basic conditions at 90 % acetonitrile, a change in the order of 




exhibiting weaker retention than the more hydrophilic analyte, ephedrine (Figure 
2.4).  
 
Figure 2.4. Relationship between retention and amount of organic modifier. 
Eluent conditions were acidic (pH 3) with acetonitrile (A) and methanol (B) and alkaline 
(pH 10) with acetonitrile (C) and methanol (D) for PPA (●), ephedrine (□), and methylephedrine 
















































(A) CH3CN pH 3 
(D) CH3OH pH 10 
(B) CH3OH pH 3 




As seen in Figure 2.4, the retention characteristics of three analytes, PPA, ephedrine 
and methylephedrine, demonstrate poor resolution under low pH conditions 
compared with complete separation at pH 10. In addition, better resolution was 
achieved with a higher amount of the weaker organic modifier, methanol, compared 
to acetonitrile; this solvent system was therefore chosen for future investigations. 
 
2.4.2.2 Effect of pH on retention of basic analytes 
Subsequent experiments were performed using methanol as the organic modifier at a 
ratio of 20:80 v/v CH3OH: aqueous buffer, using either ammonium formate (10 mM, 
pH 3, 4, 5), ammonium acetate (10 mM, pH 6, 7) or ammonium bicarbonate 
(10 mM, pH 8, 9, 10). Although these analytes are not fully unionised until pH 11.8 
(2 pH untis above the pKa value), the highest pH evaluated was pH 10 since 
dissolution of the stationary phase and analyte solubility were a concern. Figure 2.5 
illustrates the relationship between pH and analyte retention for PPA, ephedrine and 
methylephedrine. Between pH 3 and 7, retention of the analytes is low, resulting in 
co-elution. As the mobile phase pH is increased to pH 8, we begin to see an increase 
in analyte retention as the degree of analyte ionisation starts to decrease. Suppression 
of the ionisation of these hydrophilic bases at high pH enhances retention on the 
reversed-phase column by facilitating hydrophobic interactions between the analyte 
and C18 ligands of the stationary phase. As pH is increased above the pKa values of 
the analytes, a significant increase in retention is exhibited allowing good separation 
of the analytes. The resulting suppression in analyte ionisation is sufficient to 
enhance retention to permit good separation, despite the partial degree of ionisation 






Figure 2.5. Relationship between pH and analyte retention (ln k).  
Phenylpropanolamine (●) ephedrine (□), and methylephedrine (▲) with aqueous buffer:CH3OH 
(80:20 v/v) performed on an Acquity BEH C18 1.7 µm, 50 x 2.1 mm column at 0.4 mL/min, 
30 °C. 
 
2.4.2.3 Effect of mobile phase pH on selectivity 
Using mass spectrometry to track the peaks, a mix of the five ephedrines was 
injected under the extreme pH conditions of pH 3 and pH 10 to demonstrate the 
impact of pH on selectivity. The chromatograms in Figure 2.6 demonstrate the poor 
retention and co-elution under acidic conditions compared with the substantial 
increase in retention and resolution between each of the analytes, including the 
diastereoisomeric pairs, at pH 10. However, peak fronting is noted for PPA and 
cathine under high pH conditions despite using an injection solvent matched to the 
starting mobile phase conditions. This phenomenon is possibly related to the 



















Figure 2.6. Effect of mobile phase pH on selectivity. 
Isocratic chromatography was performed with 10 mM ammonium formate pH 3 (A) and 
10 mM ammonium bicarbonate pH 10 (B) and CH3OH (80:20 v/v) performed on an Acquity 






2.4.2.4 Peak shape 
Peak tailing is also greatly improved at pH 10 compared to pH 3 or 7. With 0.1 µg of 
material loaded onto the column, isocratic elution of pseudoephedrine at pH 3, 7 and 
10 generated peaks with asymmetry factors of 3.95, 4.75 and 1.96, respectively, 
calculated at 10 % peak height. Peak tailing was most severe at pH 7, where both the 
residual silanol groups of the stationary phase and basic analytes are fully ionised 
and thus ionic interactions between the two are greatest. At pH 3, peak tailing was 
only slightly reduced, since the pH is not low enough to eliminate silanol activity. 
The benefit of increasing the pH appears at pH 10. Although pH 10 is not sufficient 
to completely eliminate interactions with the sorbent surface, it has been clearly 




Overloading of ionised bases on silica-based phases occurs readily at low pH, a 
phenomenon that has been widely discussed in literature. The exploitation of high 
pH mobile phases has previously been reported to enhance the sample loading 
capacity of basic analytes [104-107]. Here, the loading capacity at low, mid and high 
pH is evaluated for pseudoephedrine, with the overlaid chromatograms in Figure 2.7 





Figure 2.7. Effect pH on chromatography with of increasing analyte concentration. 
Overlaid chromatograms of 5-500 ng pseudoephedrine using mobile phases at the following pH 
values: pH 3 (A); pH 7 (B); pH 10 (C) with aqueous buffer: CH3OH (80:20 v/v) performed on 
an Acquity BEH C18 1.7 µm, 50 x 2.1 mm column at 0.4 mL/min, 30 °C. 
 
Increasing the sample mass from 5-500 ng demonstrates rapid deterioration of peak 
shape at pH 3 and 7, whereas at high pH a greater sample mass is tolerated before 
sample overloading becomes apparent (Figure 2.8). Reduced protonation, even if not 
complete, through the use of high pH has previously been documented to improve 
sample loading capacity, for which several explanations have been proposed. Given 
the reduced silanol activity of new generation phases, it is likely that reduced analyte 
ionisation suppresses mutual repulsion of protonated species held on the surface of 
the stationary phase. Alternatively, charged species may simply be unable to fully 
penetrate the stationary phase, therefore by reducing analyte protonation the capacity 













Figure 2.8. Effect of sample mass on peak asymmetry (As at 10 % peak height).  
Values obtained at pH 3 (□), pH 7 (▲) and pH 10 (●) with aqueous buffer:CH3OH (80:20 v/v) 
performed on an Acquity BEH C18 1.7 µm, 50 x 2.1 mm column at 0.4 mL/min, 30 °C. 
 
The ability to tolerate larger sample loading capacities is also reflected in the 
retention times, which are prone to decreasing as sample mass is increased in an 
overload situation as the apex of the peak shifts to the left. This is depicted in Figure 
2.9, where the retention factor shift at pH 10 is small as the amount of sample 
increases, whereas at pH 3 and 7 the slope of the retention plot shows a decrease in 
retention with increased sample mass.  
 
 
Figure 2.9. Effect of sample mass on retention factor (log k).  
Values obtained at pH 3 (□), pH 7 (▲) and pH 10 (●) with aqueous buffer:CH3OH (80:20 v/v) 



























Sample load (µg) 
y = -0.3662x + 0.2205 
y = -0.3680x + 0.3959 
















Figure 2.10 portrays the relationship between column performance and increased 
sample mass under the three pH conditions, showing the ability to maintain high 
efficiency separations as sample mass is increased at pH 10, whereas at pH 3 and 7 
the column efficiency rapidly deteriorates. The additional benefit of operating at high 
pH with these basic compounds is the ability to simultaneously analyse compounds 
present at varying degrees of concentration; for instance being able to detect a low 
level analyte together with an analyte present at a much greater concentration 
without any problems with overloading.  
 
 
Figure 2.10. Effect of sample load on column efficiency N.  
Conditions were pH 3 (□), pH 7 (▲) and pH 10 (●) with aqueous buffer: CH3OH (80:20 v/v) 
performed on an Acquity BEH C18 1.7 µm, 50 x 2.1 mm column at 0.4 mL/min, 30 °C. 
 
2.4.3 Kinetic evaluation under acidic and basic conditions 
2.4.3.1 Van Deemter 
Peak efficiency is typically compromised for basic analytes which exhibit secondary 
ionic interactions causing peak distortion. Here, the same stationary phase support is 
used to investigate the influence of pH on column performance through analysing 
basic analytes in their neutral and protonated states. Van Deemter curves were 


























(pH 10) eluent conditions. Duplicate injections were averaged at each linear velocity, 
performed in the isocratic mode. The organic content of the mobile phase was 
adjusted in an attempt to maintain constant retention factors between the two sets of 
conditions.  
 
The actual data, represented by markers, and the best fit curves to the van Deemter 
equation, are displayed for PPA, ephedrine and methylephedrine at both pH 3 and 
pH 10 (Figure 2.11). Curve fitting was performed using SigmaPlot 12 on the H 
versus u0 data in order to determine the best A, B and C values of the van Deemter 
equation. Figure 2.11 shows the difference in performance between pH 3 and pH 10, 
with pH 10 indicating significantly better efficiency for ephedrine and 
methylephedrine. These coefficients, together with uopt and Hmin values for each 
analyte under pH 3 and pH 10 conditions, are given in Table 2.3. At pH 3, the A, B 
and C coefficients are all similar for each analyte. At pH 10, significantly lower Hmin 
values are gained for ephedrine and pseudoephedrine, while PPA does not seem to 
follow this trend. It is proposed that the poor efficiency and poor fit to the curve for 
PPA is due to the fronting peak shape exhibited by PPA at high pH (outliers in 
Figure 2.11 (A) circled). This could be explained by poor solubility of this 
compound under pH 10 conditions at 30 °C, and it is seen to improve with increased 
temperature, indicating that solubility increases with temperature. The improvement 
in chromatographic performance for ephedrine and methylephedrine at high pH is a 





Table 2.3. Values for van Deemter coefficients. 
Analyte k A B C uopt (mm/s) Hmin (µm) 
pH 3 30 °C       
PPA 5.07 8.23 1.00 0.61 1.29 9.78 
Ephedrine 8.23 7.34 1.36 0.69 1.41 9.29 
Methylephedrine 10.1 7.23 1.61 0.63 1.58 9.25 
       
pH 10 30 °C       
PPA 4.35 7.09 11.5 0.48 4.87 11.8 
Ephedrine 9.49 2.83 3.06 0.80 1.95 5.97 







Figure 2.11. van Deemter plots for PPA (A), ephedrine (B) and methylephedrine (C) under pH 3 
95:5 v/v aqueous buffer: CH3OH () and pH 10 80:20 v/v aqueous buffer: CH3OH conditions () 
performed on an Acquity BEH C18 1.7 µm, 50 x 2.1 mm column, 30 °C. 
u0 (mm/s)

















































2.4.3.2 Kinetic plots 
The data generated from the previous van Deemter experiments was further 
transformed to obtain kinetic plots. Kinetic plots are a useful tool for comparing the 
performance of different chromatographic systems, in this case the effect of pH on 
the analysis of basic analytes, exemplified by PPA, ephedrine and methylephedrine. 
The kinetic plot method can also be used to illustrate the shortest analysis time 
possible to achieve a certain number of theoretical plates. The method uses the two 
equations below to translate the (H, u0) van Deemter data into (N, t0), calculated at 
the maximum obtainable column pressure, ΔPmax:  
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where the viscosity (η) and column permeability (Kv0) are calculated and the plate 
height (H) and linear velocity (u0) are experimentally obtained values, generated 
with one 5 cm column at each mobile phase at pH 3 and 10. Figure 2.12 shows a plot 
of the total measured pressure drop as a function of the flow rate, illustrating the 






Figure 2.12. Experimental pressure drops at different flow rates.  
Measurements taken under the acidic (○ pH 3 95:5 v/v aqueous buffer: CH3OH) and basic (■ 
pH 10 80:20 v/v aqueous buffer: CH3OH) conditions used in this study performed on an 
Acquity BEH C18 1.7 µm, 50 x 2.1 mm column, 30 °C.  
 
There are several members of the kinetic plot family used to represent and compare 
performance limits of different chromatographic systems. The plot of t0 versus N is 
the simplest tool for comparing column performance under different 
chromatographic conditions, in this case the evaluation of different pH eluents 
(Figure 2.13). This plot directly shows the range of plate numbers where the high pH 
system can yield faster separation. For fast separations, the high pH system produces 
a greater number of plates compared with the low pH system for a given dead time. 
Figure 2.13 indicates that it would take approximately three times longer to achieve a 
required plate number with the acidic eluent compared with the basic eluent. As an 
example, to generate 30,000 plates under acidic conditions an analysis time of 
7.5 min would be required, compared with 2.5 min under basic conditions. However, 
as the analysis time increases, the performance of the columns becomes similar.  
 
R² = 0.9995 

























Figure 2.13. Kinetic plots of analysis time (t0) versus efficiency (N).  
Generated from the van Deemter data of the separation of ephedrine under acidic (pH 3 
95:5 v/v aqueous buffer: CH3OH) and basic (pH 10 80:20 v/v aqueous buffer: CH3OH) 
conditions performed on an Acquity BEH C18 1.7 µm, 50 x 2.1 mm column, 30 °C.  
 
The following impedance time plot (Figure 2.14) has several advantages over the t0 
versus N plot, since it yields the most expanded y-scale and immediately shows 
which plate number (referred to as Nopt) a given system achieves its most 
advantageous kinetic performance over pressure cost ratio. The axis of the N-axis is 
reversed to resemble the familiar van Deemter-curve (B-region to the left and C-
region to the right). Although the number of achievable theoretical plates remains the 
same under acidic and basic conditions, the curve obtained at pH 10 is much lower 
than that obtained at pH 3. The number of theoretical plates generated when operated 
at their optimum conditions (Nopt) is the same, but the analysis time and pressure 
required to achieve Nopt is greater under acidic conditions. Basically, higher 
efficiencies (N) can be generated with a shorter retention time and lower pressure 


















Figure 2.14. Kinetic plots of impedance (t0/N
2
) versus efficiency (N).  
Generated from the van Deemter data of the separation of ephedrine under acidic (pH 3 
95:5 v/v aqueous buffer: CH3OH) and basic (pH 10 80:20 v/v aqueous buffer: CH3OH) 
conditions performed on an Acquity BEH C18 1.7 µm, 50 x 2.1 mm column, 30 °C.  
 
The (u0, H) plots can also be readily transformed into plots of analysis time versus 
resolution to evaluate differences in selectivity that exist among systems with 
differing stationary or mobile phase properties. Resolution plots were constructed for 
both eluents by calculating the resolution of ephedrine and methylephedrine at every 
flow rate. From Figure 2.15, it is clearly evident that greater resolution of the critical 
pair can be achieved at pH 10 compared with pH 3, despite a shorter analysis time. 
For the same analysis time, resolution of the critical pair will always be greater at 
pH 10 compared with pH 3, for example for an analysis time of 100 s, the resolution 
between the two analytes is 2.8 at pH 3 and 12 at pH 10. Sample chromatograms 
obtained under the two sets of conditions at the same flow rate (0.4 mL/min) are 
presented in Figure 2.16. 
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Figure 2.15. Plots of analysis time versus resolution (Rs). 
Generated for ephedrine and methylephedrine under acidic (pH 3 95:5 v/v aqueous buffer: 
CH3OH) and basic (pH 10 80:20 v/v aqueous buffer: CH3OH) conditions performed on an 





Figure 2.16. Chromatograms of PPA, ephedrine and methylephedrine acidic (pH 3 95:5 v/v 
aqueous buffer: CH3OH) and basic (pH 10 80:20 v/v aqueous buffer: CH3OH) conditions 






















(A) pH 3 




2.4.4 Increasing temperature with high pH mobile phase 
2.4.4.1 Effect of increasing temperature on retention 
Temperature is another key variable in LC, with the potential to influence retention, 
selectivity, peak shape and efficiency [7, 66, 112-114, 120, 121]. Where high-
throughput, high productivity and high resolution are of great interest in 
pharmaceutical analysis, temperature has been shown to be a powerful tool in 
fulfilling these requirements on conventional instrumentation. The following data 
details the benefits of increasing column temperature with a basic chromatographic 
eluent, impacting on retention, analysis time, peak shape and column efficiency 
(Figure 2.17). Initial method development was performed at a column temperature of 
30 °C. The effects of temperature were then investigated while maintaining the same 
chromatographic conditions and making increments of 5 °C in the column 
temperature. All separations were performed in the isocratic mode using a mobile 






Figure 2.17. Effect of column temperature on chromatography.  
PPA (1), cathine (2), ephedrine (3), pseudoephedrine (4) and methylephedrine (5) with 10 mM 
ammonium bicarbonate pH 10: CH3OH (80:20 v/v) performed on an Acquity BEH C18 1.7 µm, 












The Wilke-Chang equation describes the relationship between the diffusion 
coefficient, solvent viscosity and absolute temperature [115]. An increase in column 
temperature elicits an increase in the diffusion of analytes in the mobile and 
stationary phase, and reduced mobile phase viscosity which also enhances analyte 
diffusivity. Significant reductions in back-pressure are seen with increased 
temperature through reduced viscosity. This feature can be exploited to obtain faster 
analyses by permitting increased flow rates or to generate higher plate numbers by 
using longer or coupled columns [7, 114]. With respect to the van Deemter equation, 
the B- and C-terms are temperature dependent; the B-term being directly 
proportional and the C-term inversely proportional to the diffusion coefficient. It has 
been shown that elevated temperature has a significant effect on the shape of van 
Deemter curves, with a shift in uopt and a flatter curve seen at higher velocities. 
Higher flow rates can therefore be employed at elevated temperatures to gain faster 
analyses without sacrificing efficiency. Whether the use of temperature can be 
employed to produce a gain in efficiency has been debated and no absolute increase 
in efficiency can be attributed to an increase in temperature alone. An improvement 
in efficiency will only be achieved if separations are performed under sub-optimal 
conditions, since the drawbacks of operating a system above its optimal linear 






The van’t Hoff equation can be used to describe the relationship between 
temperature and solute retention factor: 
 
         
   
     
 
   
    
      
 
where ΔH0 and ΔS0 are the enthalpy and entropy of solute transfer, respectively, from 
the mobile phase to the stationary phase, T is the absolute temperature, R is the 
universal gas constant and ø is the phase ratio of the column. Here, the ephedrines all 
show linear van’t Hoff behaviour, displaying a decrease in retention with increased 




Figure 2.18. Variation of log (k) versus 1/T.  
PPA (♦), cathine (■), ephedrine (▲), pseudoephedrine (x) and methylephedrine (○) at 50 µg/mL 
using 10 mM ammonium bicarbonate pH 10 and methanol (80:20, v/v) performed on an 
Acquity BEH C18 1.7 µm, 50 x 2.1 mm column at 0.4 mL/min. 
 
Resolution is often compromised in favour of speed where high-throughput analyses 
are required. Here, resolution between the two pairs of diastereoisomers, PPA-
cathine and ephedrine-pseudoephedrine, is affected by the increase in temperature 




















30 °C and 60 °C (Figure 2.17). A change in temperature does not, however, 
influence resolution between cathine and ephedrine or pseudoephedrine and 
methylephedrine.  
 
Improvements in peak shape are also brought about by increasing temperature. This 
is clearly seen in Figure 2.17 and Figure 2.19, with a particularly dramatic 
improvement seen for the primary amines, PPA and cathine, which exhibit 
significant peak fronting at lower temperatures. For example, As10% for PPA is 0.52 
at 30 °C compared with 1.04 at 60 °C. This aforementioned peak fronting can be 
explained by poor solubility of these analytes in high pH conditions, where they 
exist in their largely neutral forms, which is improved at higher temperatures. The 
slight tailing which is still apparent for the secondary (ephedrine and 
pseudoephedrine) and tertiary (methylephedrine) amines at pH 10 is also reduced as 
temperature is increased, with As10% values all close to 1.0 at 60 °C. In addition to 
the more Gaussian peak shape obtained, peak widths are also affected by increased 
temperature. Due to faster kinetics, peak width decreases as temperature is increased, 







Figure 2.19. Effect of temperature on peak asymmetry (As 10 % peak height).  
PPA (♦), cathine (■), ephedrine (▲), pseudoephedrine (x) and methylephedrine (○) at 50 µg/mL 
in 10 mM ammonium bicarbonate pH 10 and methanol (80:20, v/v) performed on an Acquity 
BEH C18 1.7 µm, 50 x 2.1 mm column at 0.4 mL/min. 
 
2.4.4.2 Effect of varying temperature on kinetic performance 
Van Deemter plots were constructed from experimentally obtained H and u0 values 
for PPA, ephedrine and methylephedrine under pH 10 conditions at 30, 45 and 60 °C 
(Figure 2.20). These plots illustrate the influence of temperature on column 
efficiency, displaying flatter van Deemter curves when the temperature was 
increased. The Chen-Horvath equation explains the relationship between temperature 
and mobile phase viscosity and this can be visualised in Figure 2.21 with a reduction 
in back-pressure as temperature increases, allowing faster flow rates to be realised. 
Optimal linear velocity (u0) is therefore shifted to higher values, although the 
optimal plate height remains virtually unaffected. This phenomenon has been 
extensively investigated, with Horvath reporting that higher temperatures generate 
higher optimal linear velocities and flatter curves, but that minimum plate height is 
not affected for small molecules with fast sorption kinetics [122]. The poor curve 
fitting noted for PPA (Figure 2.11 (A)) at 30 and 45 °C is a result of peak fronting, 






















extent of this peak fronting diminishes with an increase in temperature, which 
explains the more typical curve generated for PPA at 60 °C. As detailed in Table 2.4, 
with the exception of PPA because of the poor curve fitting, uopt increases with an 
increase in temperature. For example, for ephedrine uopt at 30 °C is 1.95 mm/s 
compared with 3.66 mm/s at 60 °C. Hmin, on the other hand, are not subject to any 






Figure 2.20. van Deemter curve for PPA (A), ephedrine (B) and methylephedrine (C) under 
pH 10 conditions (80:20, v/v aqueous buffer:CH3OH) at 30 (), 45 (×) and 60°C (), performed 
on an Acquity BEH C18 1.7 µm, 50 x 2.1 mm column. 
u0 (mm/s)

















































Figure 2.21. Relationship between temperature and back-pressure at 30 °C(♦), 45 °C (□) and 
60 °C (▲). 
 
Table 2.4. Values for van Deemter coefficients determined under pH 10 conditions at 30, 45 and 
60 °C.  
Analyte k A B C uopt (mm/s) Hmin (µm) 
PPA       
30 °C 4.35 7.09 11.5 0.48 4.87 11.8 
45 °C 3.95 12.2 0.23 0.49 0.68 12.9 
60 °C 3.26 5.69 3.31 1.49 1.50 10.1 
       
Ephedrine       
30 °C 9.49 2.83 3.06 0.80 1.95 5.97 
45 °C 8.48 3.64 3.82 0.60 2.52 6.67 
60 °C 6.79 3.22 5.13 0.75 3.66 5.76 
       
Methylephedrine       
30 °C 26.6 1.43 4.77 0.76 2.51 5.25 
45 °C 23.0 2.30 6.35 0.47 2.63 7.13 
60 °C 17.8 2.55 7.66 0.48 3.99 6.38 
 
 
2.4.4.3 Comparison of HPLC and UHPLC 
The trend in decreasing particle size affords several important advantages in 
separation science by maximising column efficiency. The chromatogram in Figure 
2.22 illustrates the gain in efficiency by reducing the particle size of the same 
column chemistry while keeping all other parameters constant. Under the conditions 
R² = 0.9999 
R² = 0.9998 























tested, for the most retained analyte, methylephedrine, 5418 plates on-column are 
generated on the 2.5 µm material, while the 1.7 µm variant generates 9141 plates on 
column. It should be noted, however, that the peak shape between the two column 
formats is not the same, with the fronting PPA and cathine peaks not as pronounced 
with the 2.7 µm material, while a greater degree of tailing is exhibited for ephedrine 
and pseudoephedrine. Although both columns were tested with a neutral test mix 
prior to this study to confirm good chromatographic performance, the 2.7 µm phase 
appears to have more exposed silanols on the surface, giving a greater degree of 
secondary interactions. However, such benefits in chromatographic performance 
realised with UHPLC technologies allow chromatographers to further improve 
separations and speeds of analysis with inherent enhanced resolution and gains in 
sensitivity with sharper peaks.  
 
Figure 2.22. Comparison of HPLC (A) and UPLC
®
 (B).  
Separation of PPA (1), cathine (2), ephedrine (3), pseudoephedrine (4) and methylephedrine (5) 
on an XBridge 2.7 µm, 50mm x 2.1 mm i.d. (A) compared with an Acquity BEH 1.7 µm, 50 mm 
x 2.1 mm (B) columns under isocratic elution with 80:20 v/v pH 10 ammonium 
bicarbonate:CH3OH at 0.4 mL/min. 
2.5 µm 
N = 5418 plates 
1.7 µm 




2.4.4.4 Final conditions 
Although the benefits of using an elevated mobile phase pH and column temperature 
have been clearly illustrated, these parameters are limited by the chemical stability of 
stationary phase materials. During this method development, several columns started 
to exhibit poor efficiencies, severely tailing peaks and split peaks shortly after use 
with high pH eluents. Therefore, in order to preserve column lifetime, the final 
mobile phase conditions comprised ammonium bicarbonate buffered to pH 9.8 
which, although a proportion of the analyte will remain ionised, was found to be 
sufficient for good resolution and peak shape. Similarly, elevated temperature 
accelerates dissolution of the stationary phase, despite the enhanced stability of the 
hybrid material. Therefore, a temperature of 45 °C was chosen as a compromise 
between the benefits of increased temperature and preserving column lifetime. 
Despite the knowledge that smaller particles generate higher column efficiencies and 
provide faster analysis without sacrificing the quality of a separation, with the 
inherently sharp peaks the number of data points can be compromised when coupled 
to mass spectrometric detection unless using an instrument capable of fast scan 
speeds. Hence, the separation was initially performed on the 2.5 µm variant to avoid 
compromising the number of data points, which are required for good peak 
definition, especially where quantification is required. A gradient separation was 
optimised to provide suitable resolution of the five ephedrines while maintaining a 
short analysis time. The final conditions are detailed below with the corresponding 






Table 2.5. Final separation conditions.  
Optimised conditions for the separation of PPA, cathine, ephedrine, pseudoephedrine and 
methylephedrine by LC-MS/MS. 
Column: Waters XBridge C18 2.1 x 50 mm, 2.5 µm 
Mobile phase A: 10 mM ammonium bicarbonate pH 9.8 in water 
Mobile phase B: 10 mM ammonium bicarbonate pH 9.8 in 60 % methanol 
Flow rate: 0.5 mL/min 
Gradient: Time (min) %A %B Curve 
0.0 83.3 16.7 - 
3.2 58.3 41.7 6 
5.2 8.3 91.7 6 
6.5 83.3 16.7 1 
 
Run Time: 6.5 minutes 
Column Temp: 45 °C 
Injection Vol: 10 µL 
 
 
Figure 2.23. Total ion chromatogram (TIC) illustrating the separation of the five ephedrine 
compounds considered in this study using the final gradient conditions.  
PPA (1), cathine (2), ephedrine (3). pseudoephedrine (4) and methylephedrine (5), performed on 







































The results from this work highlight the importance of mobile phase pH for the 
analysis of basic compounds, where the best chromatographic performance is 
achieved under high pH conditions to suppress protonation. The difference in 
performance when operating at elevated pH and temperature can be attributed to a 
reduction in analyte protonation, encouraging hydrophobic retention and reduced 
detrimental secondary interactions and peak tailing. 
  
Enhanced peak shape and retentivity permit good chromatographic resolution of the 
diastereoisomers at pH 9.8, without the need for undesirable additives or the need for 
column regeneration. Even though this is very close to the pKa of the analytes 
presented here, this value was shown to provide reproducible retention times and 
provide an adequate peak shape while preserving the life of the column, which 
would be shortened at higher pH values, especially with an operating temperature of 
45 °C. Finally, in gradient elution, the five ephedrines are separated with good 















CHAPTER 3  
 
 
QUANTITATIVE ANALYSIS OF BASIC COMPOUNDS BY 
HIGH PH REVERSED-PHASE LC-MS/MS; APPLICATION TO 






Chapter 2 investigated the effects of manipulating mobile phase pH and detailed the 
benefits of exploiting high pH eluent conditions for the chromatographic separation 
of basic analytes by reversed-phase liquid chromatography (RPLC). Although 
developed using UV detection, the method for separating the hydrophilic basic 
ephedrine compounds was centred on the use of a volatile buffer to enable MS 
operation. The optimised separation, utilising an ammonium bicarbonate (10 mM) 
eluent buffered to pH 9.8 with methanol using gradient chromatography, resulted in 
complete resolution of the five structurally related ephedrine compounds 
(phenylpropanolamine (PPA), cathine, ephedrine, pseudoephedrine and 
methylephedrine) with suitable retention and peak shape. With the inclusion of 
pseudoephedrine in the Prohibited List, previously not restricted by the World Anti-
Doping Agency (WADA) until 2010, a new validated confirmation method for 
identification and quantification was necessary [123]. Therefore, the aim in this 
chapter is to couple the LC separation with MS detection and validate the method as 
a confirmatory assay for the identification and quantification of ephedrines in doping 
control analysis.  
  
In addition to the benefits of using high pH in achieving enhanced retention, 
resolution and peak shape, the improved sample loading capacity compared with 
conventional acidic eluents is of particular importance in the current application. 
Considering the different threshold concentrations established by WADA, a method 
to analyse ephedrine and pseudoephedrine, together with their respective metabolites 
– PPA and cathine – requires a large dynamic range for reliable quantification [90]. 




method that can accommodate large sample masses is advantageous and also permits 
a single simultaneous sample preparation procedure without the need to tailor a 
higher dilution for pseudoephedrine, with such a high threshold concentration 
(150 µg/mL). 
 
Electrospray ionisation (ESI) remains the most popular mode of ionisation for the 
detection of hydrophilic compounds analysed by LC. However, when interfacing LC 
with MS detection, conditions optimal for chromatographic performance are often 
not the most favourable for ionisation efficiency. For example, often the best ESI 
sensitivity is achieved when the analyte is already ionised in solution by using an 
acidic mobile phase for basic analytes but, as we have seen, this is not conducive to 
optimal LC performance, and hence a compromise must be made between the two. 
Although conventional wisdom tells us that the ionisation of basic analytes would be 
suppressed in a basic environment, it is possible for basic compounds to be ionised 
with positive ESI in a basic environment; as can acidic compounds in an acidic 
environment [124-128]. In fact, in some cases, previous studies demonstrate even 
higher sensitivity for basic compounds in high pH eluents [82, 110, 129]. This 
phenomenon, which has been referred to as “wrong-way-round ionisation,” does not 
support the ion evaporation theory and suggests that alternative mechanisms of 
ionisation are dominant [108]. Alternative ionisation mechanisms which have been 
invoked include charge transfer from protons present in solution to neutral analyte 
molecules, or via redox reactions at the liquid-gas interface of the droplet [80, 109, 
130-132]. This theory is supported by a study of mobile phase additives by Mallet et 
al. [98], where an increase in reagent ions, by increasing the concentration of 




contradicts the ion evaporation theory which is subject to ion suppression as the 
concentration of mobile phase additives is increased [98]. An alternative theory, 
proposed to explain the increase in response of basic analytes under high pH 
conditions, is that as the chromatographic retention of the unprotonated molecules 
increases, they therefore elute later in a more organic-rich eluent, thus aiding more 
efficient ionisation. However, a more recent study confounds this hypothesis, where 
certain neutral analytes do not demonstrate any change in retention with increasing 
mobile phase pH, yet still exhibit an increase in ESI response [110].  
 
Although such improvements in sensitivity have been noted with high pH eluents in 
positive mode ESI, there is limited knowledge of how pH affects signal stability and 
robustness. During this study, initial experiments showed that interfacing with ESI 
did not give adequate reproducibility for the quantification of ephedrines in urine 
over the desired linear dynamic range. Moreover, matrix interferences are a concern, 
particularly for the direct sample dilution and injection approach adopted herein. 
Alternative ionisation techniques, such as atmospheric pressure chemical ionisation 
(APCI) and atmospheric pressure photo ionisation (APPI), are inherently less 
affected by interference from co-eluting matrix components compared with ESI [86, 
133-136]. For this reason, positive APCI is investigated as a comparative mode of 
ionisation to determine the most stable and reproducible response for the 
quantification of basic analytes in diluted urine.  
 
In this chapter, particular focus is applied to understanding the effects of mobile 
phase pH with ESI, which may be detrimental to reliable quantification by LC-MS, 




a better understanding of the effects of mobile phase composition, pH and additives 
on ESI response and spray stability. A comparison is made between acidic and basic 
LC eluents to determine the effects on positive ESI with basic analytes. Since the 
focus here is to investigate the effect of mobile phase composition on ESI sensitivity 
and stability only, post-column infusions and flow injections are performed to 
eliminate any variations caused by chromatography. This approach allows a direct 
comparison of the effects of mobile phase additives and pH on ESI, with a controlled 
amount of organic component in the eluent and no contribution from retention or 
peak shape differences. In this investigation, three of the ephedrines (PPA, ephedrine 
and methylephedrine) were studied, together with salbutamol, clenbuterol and 
formoterol ( 
Figure 3.1), chosen because of their importance in doping control where sensitivity 




































These compounds included in the study of different solvent systems on ESI sensitivity and 
stability. 
Lastly, a preliminary validation for cathine, ephedrine, pseudoephedrine and 
methylephedrine is performed on the optimised method for linearity, selectivity, 
accuracy, precision, carryover and ion suppression due to matrix interferences. The 
validated LC-MS/MS method is then applied to the measurement of the 
concentration of ephedrines in two real urine samples and compared with the 







Methanol (HPLC grade), acetonitrile (HPLC grade), ammonium hydroxide solution 
(35 % w/w), ammonium formate and ammonium bicarbonate were obtained from 
Fisher Scientific (Loughborough, UK). Formic acid (99-100 %) was purchased from 
VWR (Leicestershire, UK). Norephedrine, norpseudoephedrine, ephedrine, 
pseudoephedrine, methylephedrine and clenbuterol, as hydrochloride salts, and 
salbutamol hemisulfate and formoterol fumarate dihydrate were purchased from 
Sigma (Poole, UK). Norephedrine-d3 (used as internal standard) was purchased as a 
free base (1 mg/mL in methanol) from LGC Standards (Teddington, UK). Water was 
purified by an ultra-pure water system (Elga, UK).  
 
3.2.2 Solutions 
3.2.2.1 Mobile phase 
A stock solution of ammonium bicarbonate buffer was prepared at 25 mM in 
purified water and adjusted to pH 9.8 with ammonium hydroxide solution 
(35 % w/w) for the preparation of the final mobile phase, which consisted of 10 mM 
ammonium bicarbonate pH 9.8 in water (A) and 10 mM ammonium bicarbonate 
pH 9.8 in 60 % methanol (B). For the preparation of 1 L of mobile phase A, 400 mL 
of the stock buffer solution was added to 600 mL of water in order to achieve a 
10 mM buffer solution. For the preparation of mobile phase B, 200 mL of the stock 






Stock solutions were prepared at a concentration of 1 mg/mL for 
norpseudoephedrine, ephedrine and methylephedrine and 10 mg/mL for 
pseudoephedrine in methanol and stored at -20 °C. A stock solution of norephedrine-
d3, used as an internal standard (IS), was prepared at 10 µg/mL in methanol. 
Standard working solutions were prepared by diluting stock solutions with water. 
 
A two-step dilution of urine samples was performed before injection: firstly a 
45-fold dilution with water was performed, after which samples were vortexed and 
centrifuged at 76.7 g. Aliquots (200 µL) were then mixed with an equal volume of IS 
solution (norephedrine-d3, 500 ng/mL diluted with water). Vials were vortexed 
before being placed in the autosampler. 
 
3.2.3 LC conditions 
Separations were carried out on an Acquity UPLC
®
 system (Waters, Milford, MA, 
USA) with an XBridge 2.5 µm C18 2.1 x 50 mm column provided with a 0.2 µm 
in-line filter. The run time was 6.5 minutes including re-equilibration time. The 
mobile phase consisted of 10 mM ammonium bicarbonate pH 9.8 in water (A) and 
10 mM ammonium bicarbonate pH 9.8 in 60 % methanol (B). The flow rate was 
500 µL/min and column temperature set at 45 °C. The weak and strong needle wash 
lines of the Acquity UPLC
® 
system were placed in 90:10 H2O/CH3OH 0.2 % formic 
acid and 10:90 H2O/CH3OH 0.2 % formic acid, respectively. The injection volume 
was 10 µL and was performed in the partial loop with needle overfill mode using a 
20 µL sample loop. The gradient conditions started at 16.7 % B, increasing to 41.7 % 






 1.4.2 software from Applied Biosystems was used to 




3.2.4 Mass spectrometry 
Analyte detection was performed using an API 3200 triple quadrupole tandem mass 
spectrometer (Applied Biosystems) equipped with electrospray ionisation (ESI) and 
atmospheric pressure chemical ionisation (APCI) sources in positive ion mode. The 
MS was operated in selected reaction monitoring (SRM) mode with the inlet 
conditions optimised for ESI and APCI. The following optimised source conditions 
were selected for ESI: capillary voltage 5.5 kV; temperature 450 °C; curtain gas 
(nitrogen) 10 psi; nebuliser gas (nitrogen) 45 psi and auxiliary gas (nitrogen) 80 psi. 
The conditions selected for APCI were: nebuliser current 3 µA; temperature 400 °C; 
curtain gas (nitrogen) 10 psi and auxiliary gas (nitrogen) 45 psi. Data acquisition was 
divided into four segments based on the expected retention times, with a dwell time 
of 100 msec for each transition giving sufficient data point sampling and sensitivity. 
Three ion transitions and the precursor ion are all monitored for each analyte in order 
to satisfy the WADA requirements for identification [137]. Acquisition segments, 
selected reaction monitoring (SRM) transitions, dwell times and MS parameters are 
detailed in Table 3.1. 
 
As a comparative instrument, an Agilent 6410 LC-MS/MS system was used. The 
same LC conditions were applied, but the MS parameters were optimised for this 
instrument. The same SRM transitions were acquired using ESI in the positive mode 
with the following conditions: capillary voltage 1.5 kV, temperature 350 °C, 




Table 3.1. Acquisition segments, SRM transitions and MS parameters.  
Declustering potential (DP), entrance potential (EP), collision cell exit potential (CXP) and 
collision energy (CE) for the ephedrines considered in the study. The dwell time of each ion 







DP (V) EP (V) CXP (V) CE (V) 
      
Cathine 2.3-2.9 152.1
*
 27 5.0 - - 
  134.1
**
   9 15 
  117.2   9 24 
  115.2   9 32 
Ephedrine 2.9-4.4 166.1
*
 30 6.5 - - 
  148.3
**
   12 16 
  133.0   9 30 
  117.1   11 26 
Pseudoephedrine 2.9-4.4 166.1
*
 30 6.5 - - 
  148.2
**
   12 16 
  133.1   9 30 
  117.1   11 26 
Methylephedrine 4.4-6.5 180.2
*
 35 6.0 - - 
  162.2   14 17 
  147.1
**
   12 27 
  135.2   10 21 
  117.2   10 26 
IS (norpehedrine - d3) 0-2.3 155.1
* 
30 5.0 12 12 
  137.2
**
     
         
*Precursor ion used,
 
**Transitions used for quantification. 
 
3.2.5 Calibration 
A six-point calibration curve including 50-200 % of the threshold concentrations was 
constructed by spiking blank human urine at 1, 2.5, 5, 10, 15, 20 µg/mL for cathine, 
2.5, 5, 10, 20, 30, 40 µg/mL for ephedrine and methylephedrine and 25, 50, 100, 
200, 300, 400 µg/mL for pseudoephedrine (Table 3.2). Quality control (QC) samples 
were prepared at concentrations equal to the WADA threshold levels (cathine 
5 µg/mL, ephedrine 10 µg/mL, pseudoephedrine 150 µg/mL and methylephedrine 




Table 3.2. The concentrations of the calibrants and QC (µg/mL) prepared in blank urine.  
(Eph = ephedrine, Peph = pseudoephedrine, Meph = methylephedrine). 
 
Calibrant 




Cathine Eph Peph Meph Cathine Eph Peph Meph 
1 0 0 0 0 10 0 0 0 0 
2 200 50 50 50 20 1 2.5 25 2.5 
3 250 50 50 50 10 2.5 5 50 5 
4 500 100 100 100 10 5 10 150 10 
5 500 100 100 100 5 10 20 200 20 
6 750 150 150 150 5 15 30 300 30 
7 1000 200 200 200 5 20 40 400 40 




The method was validated for linearity over the dynamic range, selectivity, accuracy, 
precision, carryover, and ion suppression due to matrix interferences. Ten blank 
urine samples obtained from different volunteers were analysed as described above 
to ensure selectivity of the method. Linearity was determined with the six-point 
calibration and repeatability was assessed by analysing six replicates of a urine 
sample spiked with each analyte at the threshold concentration. Accuracy and 
between-assay precision were determined by analysing three replicates of the three 
different spiked urines on different days.  
 
3.2.7 Post-column infusion 
Where used, the post-column acidification reagent was 10 % formic acid in purified 
water, infused at 20 µL/min between the LC outlet and MS inlet using a T-
connection by means of a JASCO PU-1585 HPLC pump (JASCO, Tokyo, Japan). 
For infusion at 20 µL/min with a mobile phase flow rate of 500 µL/min, a 10 % 




full analyte ionisation in solution. For comparison, analysis with no post-column 
acidification was performed with an infusion of purified water at the same flow rate 
to compensate for any dilution effects.  
 
3.2.8 Flow injection 
Phenylpropanolamine (PPA), ephedrine, methylephedrine, salbutamol, clenbuterol 
and formoterol were used as basic test probes to evaluate ESI sensitivity and stability 
with different mobile phase systems. Flow injection was performed using a zero-
volume connector to eliminate any variations from chromatographic contribution. An 
Acquity UPLC
®
 system was used with a Xevo QTOF (Waters, Manchester, UK) 
mass detector. The amount of organic content was kept constant, using 20 % 
acetonitrile or methanol with the particular aqueous mobile phase investigated; 0.1 % 
formic acid in water, 0.1 % ammonium hydroxide in water, 10 mM ammonium 
formate pH 3 or 10 mM ammonium formate pH 10. The QTOF mass spectrometer 
was operated in full scan mode and the source parameters tuned for the protonated 
molecular ion for each analyte by infusion under each set of conditions. The 
optimised conditions for each analyte are detailed in Table 3.3. A flow rate of 
0.5 mL/min was used throughout the investigation. Prior to injection, samples were 








Table 3.3. Optimised MS source parameters.  
Cone voltage (CV), sample cone (SC), extraction cone (EC), source temperature (ST), 
desolvation temperature (DT), cone gas (CG) and desolvation gas (DG), for each compound 
under each set of mobile phase conditions. 
 
PPA Ephedrine Methylephedrine Salbutamol Clenbuterol Formoterol 
Cone voltage (kV) 0.5 0.5 0.5 0.5 0.5 0.5 
Sample cone (V) 15 15 15 20 20 25 
Extraction cone (V) 2 2 2 4 2 2 
Source temp. (°C) 120 120 120 120 120 120 
Desolvation temp. (°C) 600 600 600 600 600 600 
Cone gas (L/h) 10 10 10 10 10 10 









3.3.1 Interfacing with Mass Spectrometry (LC-MS/MS) 
Since MS detection is necessary for analyte identification, a compatible eluent 
composition was carefully selected to avoid undue compromise of the LC separation. 
Additives and high buffer concentrations, although frequently used to improve 
chromatographic separations, are incompatible with MS since they often cause ion 
suppression. Ammonium bicarbonate, at a concentration of 10 mM, was selected for 
its buffering capacity at high pH and volatility, hence amenable to MS detection. The 
buffer component was also added to the organic solvent to maintain a uniform 
concentration throughout the chromatographic gradient. Gradient conditions, 
temperature and flow rate were optimised in order to obtain the best separation 
within a maximum analysis time of 10 minutes.  
 
Figure 3.2 illustrates the final chromatographic separation of the four ephedrines of 
interest at the WADA threshold levels (cathine 5 µg/mL, ephedrine 10 µg/mL, 








Figure 3.2. Total ion chromatogram (TIC) illustrating the separation of cathine, ephedrine, 
pseudoephedrine and methylephedrine. 
Analytes spiked at the WADA threshold concentrations in urine (cathine 5 µg/mL, ephedrine 
10 µg/mL, pseudoephedrine 150 µg/mL, methylephedrine 10 µg/mL) and with the IS 
norephedrine-d3 (250 µg/mL). Separation performed on an XBridge C18 2.5 µm, 50 x 2.1 mm 
column at 0.5 mL/min. 
 
Since the ephedrine compounds considered in this study have similar structures, they 
share common fragmentation patterns (Figure 3.3), hence the requirement for 
chromatographic separation prior to detection. However, despite the 
chromatographic optimisation in order to achieve this being performed with a 
volatile MS compatible buffer system, preliminary experiments with positive ESI 
indicated poor signal stability and repeatability. Various stages of the analysis were 
investigated to determine the cause of these poor results. Overloading of the column 
or detector and inaccuracy or losses in the sample preparation were all investigated 











Figure 3.3. ESI product scan spectra of cathine (A), norephedrine-d3 (B), ephedrine and 








The precursor ions highlighted in Table 3.1. were used. 
3.3.1.1 Sample preparation 
The influence of sample pre-treatment is paramount in the speed and simplicity of 
analysis, as well as adding potential sources of error. The sensitivity of LC-MS 
provides the possibility of directly diluting and injecting the sample, without the 
need for pre-concentration and derivatisation, particularly considering the high 
concentrations being analysed here. However, as explained in the previous chapter, 
the effect of large sample masses injected on column can have severe negative 
implications for the chromatographic performance, even though this is less apparent 
with basic analytes in a basic eluent. In an overload situation, peaks exhibit large 
tailing factors which confound accurate peak integration. With such high 
concentrations of pseudoephedrine being injected on column, various dilution factors 
were applied to ensure column overload was not contributing to poor quantification. 
The dilution factor was determined in order to simultaneously identify the lowest 
abundant ion for cathine at the lowest calibration concentration (1 µg/mL) while not 
overloading the column or saturating the detector with the highest concentration of 
pseudoephedrine (400 µg/mL). A 90-fold dilution was determined suitable for 
satisfying these criteria.  
 
The dilution approach adopted comprises a two stage dilution; firstly a 1:45 dilution 
with water, followed by a 1:1 dilution with norephedrine-d3 internal standard 
(500 ng/mL in mobile phase). Dilution was performed with purified water instead of 
mobile phase to eliminate possible evaporation of the methanol-containing diluent 
during the dilution steps. Using water as the diluent did not have any negative effect 




and water acts as an even weaker eluent. Following the first stage of the dilution, the 
samples were centrifuged at 76.7 g to remove any particulate matter from the urine 
samples. The dilution procedure involves the use of Gilson and Eppendorf multi-
dispensing pipettes, and these were eliminated as a source of error by taking 10 
measurements with each and calculating % RSD values, found to be < 0.76 %.  
 
3.3.1.2 Instrumentation 
Having not been able to determine any sources of error during the sample 
preparation procedure, the next approach was to investigate the instrumentation. The 
same samples were run on an alternative LC-MS/MS system with a different source 
design to determine whether the instrumentation was contributing to any error. 
However, the same problem was replicated on both instruments, omitting the 
possibility of an instrumentation issue.  
 
3.3.1.3 Comparison of ESI and APCI 
Since the use of APCI is more appropriate for the analysis of relatively semi/non-
polar compounds, and in this case the ephedrine compounds are entering the source 
in a largely deprotonated state, this mode of ionisation was investigated as a 
comparator. It is also well known that APCI is less susceptible to matrix 
interferences, which is particularly important in this instance whereby urine is 
diluted and injected directly without any extensive sample clean-up procedures.  
 
A 6-point calibration was performed ranging from 50-200 % of the threshold 




was made was the quantification ion for pseudoephedrine. Considering the large 
threshold limit for pseudoephedrine (150 µg/mL), which expands the dynamic range 
of the assay, the resulting signal is tenfold greater for pseudoephedrine than the other 
compounds. Quantification of pseudoephedrine using the
 13
C isotope was therefore 
investigated to reduce the mass spectrometric signal to the same magnitude as the 
other ephedrine compounds. This approach was effective in reducing the signal by a 
factor of 10 compared with the 
12
C isotope, although it did not have any significant 
influence on linearity. 
 
For both ESI and APCI, linearity plots were generated from the most abundant ion 
transition of each compound (Figure 3.4). ESI signals were determined to be less 
stable, being either non-linear or having significantly reduced linear ranges 
compared with APCI. APCI yielded a linear and stable signal for each analyte over 
the wide calibration range, with a correlation coefficient (r
2
) greater than 0.995 for 













Figure 3.4. Linearity plots for the ephedrine compounds in urine using ESI (A) and APCI (B).  
Response calculated using analyte peak area divided by internal standard peak area. 
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The variation in response with ESI compared with APCI is illustrated by overlaid 




Figure 3.5. Overlay of pseudoephedrine from replicate injections using ESI (A) and APCI (B).  
Urine sample spiked at the threshold level (150 µg/mL), (n = 6). 
 
Although first experienced with standard solutions without the presence of matrix 
components, this difference was particularly noticeable for pseudoephedrine in 
spiked urine, with r
2
 values of 0.9858 and 0.9992 generated with ESI and APCI 
respectively. The errors between the determined and the actual concentrations were 
outside of our acceptable limit with ESI, whereas APCI illustrated acceptable errors, 
with values for pseudoephedrine of 49.3 % (n = 6) compared with 15.4 % (n = 6) at 







Table 3.4. Comparison of ESI and APCI for the quantification of pseudoephedrine.  
Dynamic range 25-400 µg/mL in urine using the 166 →148 m/z transition. 
  
Conc. 




conc. (µg/mL) Error (%) 
ESI 
25 
0.0132 0.1926 0.9858 
12.7 -49.3% 
50 45.1 -9.8% 
100 112 12.4% 
200 225 12.7% 
300 275 -8.2% 
400 404 1.0% 
APCI 
25 
0.0413 -0.4604 0.9992 
28.8 15.4% 
50 46.7 -6.6% 
100 103 3.3% 
200 195 -2.4% 
300 297 -1.0% 
400 404 1.0% 
 
The greater variability with ESI seen with samples in matrix compared with standard 
solutions suggests some interference from matrix components. It was initially 
proposed that, in this case, the direct dilution and injection approach was not 
amenable to ESI, whereas APCI offered an alternative in eliminating matrix effects 
without requiring an extraction procedure. Therefore, matrix effects were quantified 
using both ESI and APCI to compare the contribution from endogenous 
interferences. This was evaluated using 10 different blank urine samples spiked at 
threshold concentration levels with each analyte. Matrix effect was calculated by 
comparing the response of each analyte spiked in urine to standards prepared in 
mobile phase. The matrix effect value of < 100 % indicates ion suppression and 
> 100 % indicates ion enhancement. However, the results indicated that both ESI and 
APCI are affected to a similar extent, with ion suppression from possible matrix 







Figure 3.6. Matrix effects evaluated in 10 different spiked urine samples using ESI (A) and 
APCI (B).  
Cathine (♦), ephedrine (□), pseudoephedrine (▲) and methylephedrine (x). 
 
3.3.1.4 Post-column infusion 
Several studies report the effect of eluent composition on ESI signal intensity, 
however there is limited information available concerning the effect on ESI signal 
stability. The poor stability noted here with basic mobile phase and ESI instigated an 
evaluation into the effect of mobile phase pH on the signal stability of ephedrines 
with ESI. In order to determine whether the eluent pH of the solution entering the ion 
source affects the stability of analyte ionisation with ESI, post-column infusion to 
acidify the basic eluent was also investigated. In order to acidify the high pH mobile 
phase, post-column acidification was performed to investigate the effects of pH on 
signal intensity and stability. Infusion of a 10 % formic acid at 20 µL/min was 








































column acidification are presented in Figure 3.7. These indicate that ESI response is 
significantly affected by pH, with a higher response obtained for each analyte under 
acidic eluent conditions. This is supported by traditional theories that analytes will 
be detected more easily if they are ionised in solution prior to MS detection. 
However, more recent reports have shown that higher sensitivities can be achieved 
for basic analytes using basic eluents with ESI in the positive mode [82, 110, 129]. 
This phenomenon is likely to be analyte specific, and one theory suggests that 
enhanced response under high pH conditions is a result of the longer retention of 
unprotonated analytes with high pKa values which therefore elute later in a higher 
organic content. Whereas more recent studies illustrate that, even if retention is 
unaffected by mobile phase pH, sensitivity is still improved under basic conditions 
[110]. However, the primary concern in this study is the robustness of the ionisation 
technique, not necessarily the intensity of the signal, since sensitivity is not a 
concern. However, although the variation in signal was found to be slightly higher 

















Figure 3.7. Effect of post column acidification (PCA) on signal and intensity (A) and stability 
(B) with ESI.  
Analytes considered were phenylpropanolamine (PPA), ephedrine and pseudoephedrine (n=10), 
* = statistically significant (p < 0.05). 
 
3.3.1.5 Effect of source conditions on ESI response with basic eluent 
The optimisation of ESI source parameters, including capillary voltage, cone voltage 
and gas and temperature settings, is largely influenced by the mobile phase used and 
the flow rate of the eluent. Following the optimisation of MS conditions which are 
analyte specific, including collision energy, which is typically performed by infusion 
of the analyte, infusion with mobile phase flow should be performed to determine the 
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of compounds with different properties or eluting in different amounts of organic 
content, conditions must be generic and often a compromise between analytes. The 
importance of capillary voltage on ESI spray is highlighted by the following data 
under basic conditions. During this study, the effect of capillary voltage on stable 
spray was investigated by injecting each analyte at voltages ranging from 1.0-5.5 kV, 
taking average intensities and % RSD values over 10 replicate injections. The 
results, illustrated for the precursor ions in Figure 3.8 (A) and (B), show an 
interestingly significant increase in signal intensity at a low capillary voltage of 
1.0 kV, yet no significant differences were noted in signal stability. The significant 
increase in signal at lower capillary voltages with the basic eluent can be explained 
by the surfactant nature of ammonium bicarbonate, acting to decrease the surface 
tension of the droplets in the source and therefore making it easier for evaporation to 
occur, hence increasing ion transfer and detector response (Figure 3.8). In addition to 
the [M+H]
+
 ion, the [M-H2O]
+
 ion for each analyte was monitored to determine 
whether dehydration was related to capillary voltage, affecting the signal intensity of 
the [M+H]
+
 ion monitored. However, this data was similar to the [M+H]
+
, 












Figure 3.8. Influence of capillary voltage and ESI signal intensity (A) and stability (B).  
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3.3.1.6 Comparison of mobile phase additives 
The importance of optimising ESI source conditions and MS parameters for 
sensitivity and stability has been previously highlighted. In addition to analyte 
properties, optimal conditions are dependent on chromatographic conditions, 
including mobile phase composition, pH, buffer concentration, additives and flow 
rate. The effect of a variety of viable mobile phases on ESI sensitivity and stability 
was investigated. In this study, another alternative instrument, equipped with a 
source design which can accommodate flow rates up to 2.0 mL/min, is used to 
further evaluate the effect of mobile phase pH and additive on ESI response signal 
intensity and stability. Additives, including 0.1 % ammonium formate, ammonium 
formate (10 mM) adjusted to pH 3, 0.1 % ammonia and ammonium bicarbonate 
(10 mM) adjusted to pH 10, were evaluated with either acetonitrile or methanol as 
the organic modifier.  
 
Given the different source designs available between different instruments and 
manufacturers, conditions will vary from instrument to instrument. In order to 
maximise ESI sensitivity and stability, parameters should be tuned for each analyte 
under the appropriate mobile phase conditions and flow rate used. Since SRM 
conditions are traditionally optimised by infusion prior to developing the optimal 
chromatographic separation, the mobile phase conditions may be quite different from 
those used in the initial MS optimisation. ESI source conditions were, therefore, 
optimised for each analyte under each set of conditions with the appropriate mobile 
phase at a flow rate of 0.5 mL/min (Table 3.3). Again, a low capillary voltage 




this was not a reflection of the mobile phase used, rather the chemistry of the 
analyte. 
 
Signal response was determined by peak area, which is the most commonly used 
measure of signal intensity in quantitative analyses. While signal-to-noise ratio can 
be a useful measure between different systems, large variations can be experienced, 
especially in highly sensitive instrumentation where electronic noise is apparent. Ten 
replicate injections were made of each analyte under each set of conditions and the 
integrated peak areas averaged for statistical evaluation. Mean peak areas of these 10 
replicate injections are presented in Figure 3.9. For all of the analytes studied a 
greater response is elicited when using a high pH mobile phase compared with an 
acidic mobile phase, although the degree of the increase is analyte specific. The 
increase in response with either 0.1 % ammonium hydroxide or 10 mM ammonium 
bicarbonate pH 10 was as great as three-fold for certain analytes (PPA, salbutamol 
and formoterol). However, there was no significant difference between the use of a 
buffered mobile phase or the simple addition of acid or base. Additionally, although 
there are some minor differences between the organic modifiers used, with a 
tendency for a slightly increased signal with methanol, this does not contribute 









Figure 3.9. Effect of pH and mobile phase additive on peak area.  



























































































































Formoterol (345 m/z) 




.   
4  









In addition to ESI response, stability was also evaluated for the different solvent 
systems over 10 replicate injections. The results of the stability experiments are 
represented as % RSD values in Figure 3.10, which demonstrate that there are no 
significant differences in ESI spray stability with the different solvent systems 
studied. The maximum % RSD value found was for PPA using 10 mM ammonium 
formate pH 3 with acetonitrile at 6.07 % (n = 10). All other values were calculated to 
be less than 3.94 % RSD (n = 10). 
 
Since chromatographic effects have been eliminated in this study, it can be 
concluded that the increased response with high pH mobile phases is not a result of 
elution in a higher organic area of the chromatogram due to enhanced retention, nor 
due to differences in peak shape. One hypothesised contributing factor is the 
surfactant behaviour of ammonium hydroxide in the high pH eluents, acting to 
reduce the surface tension of solvent droplets which aids desolvation and, therefore, 








Figure 3.10. Effect of pH and mobile phase additive on peak area stability.  
Flow injection ESI +ve ionisation using CH3CN (blue) and CH3OH (red) was employed. For 
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Since the LC-APCI-MS/MS method showed good linearity over the dynamic range 
for each analyte, this assay was validated in terms of linearity, selectivity, accuracy 
and precision, carryover and ion suppression due to matrix effects. Multiple analyses 
of a quality control (QC) sample at the threshold concentration for each analyte were 
obtained. Cathine was analysed at 5 µg/mL, ephedrine and methylephedrine were 
analysed at 10 µg/mL and pseudoephedrine at 150 µg/mL. The QCs were prepared 
by spiking analytes into blank urine at the same time that the calibrants were 
prepared. Validation consisted of three preparations on three different days. The 
concentration of each QC was calculated against a calibration curve (prepared 
freshly for each batch). The following parameters were used to ensure that adequate 
accuracy and precision were obtained from the assay: 
 
         
                  
                     
      
 
 
                      
 
                                        
                           
      
 
 
                       
 
                                          
                             






A six-point calibration curve including 50-200 % of the WADA threshold levels has 
been generated to confirm linearity over the range for quantification. Correlation 
coefficients (r
2
) were greater than 0.9992 (Table 3.5). Errors (calculated as the 
difference between the determined and actual concentration) ranged between -7.5 
and 2.1 % over a concentration range corresponding to 50-200 % of the WADA 
threshold levels for cathine (5 µg/mL), ephedrine (10 µg/mL), pseudoephedrine 
(150 µg/mL) and methylephedrine (10 µg/mL).  
 






(µg/mL) Slope Intercept r
2
 Equation 
Cathine 134 1.0-20 0.0445 -0.0045 0.9997 y = 0.0445x - 0.0045 
Ephedrine 148 2.5-40 0.0658 -0.0206 0.9992 y = 0.0658x - 0.0206 
Pseudoephedrine 148 25-400 0.0583 -0.5223 0.9995 y = 0.0583x - 0.5223 
Methylephedrine 147 2.5-40 0.0079 -0.0024 0.9999 y = 0.0079x - 0.0024 
 
3.3.2.2 Selectivity 
Selectivity was determined through the analysis of 10 different blank urines with no 
interference being detected at the expected retention times of the analytes. 
 
3.3.2.3 Accuracy and precision 
The method was tested for accuracy and precision through the analysis of three 
repeats of urine spiked with each analyte at the WADA threshold level performed on 
three different days. The results for accuracy, reported as % bias between the 




for within- and between-assay variation are less than 7.54 and 5.77 (n = 3), 
respectively (Table 3.6). 
 
Table 3.6. Within- and between-assay precision (% RSD) and accuracy (% bias) for the 
ephedrines in urine at QC concentrations (n = 3). 
Compound (µg/mL) 











      
Cathine (5 µg/mL) 
Day 1 4.98 -0.47 3.22 
4.14 Day 2 4.64 -7.13 7.54 
Day 3 5.01 0.13 4.20 
      
Ephedrine (10 µg/mL) 
Day 1 10.4 3.50 3.51 
5.20 Day 2 9.36 -6.37 2.19 
Day 3 9.64 -3.60 5.08 
      
Pseudoephedrine (150 µg/mL) 
Day 1 155 3.09 1.48 
3.65 Day 2 153 1.90 1.21 
Day 3 164 9.03 1.65 
      
Methylephedrine (10 µg/mL) 
  
Day 1 11.0 9.50 3.71 
5.77 
  
Day 2 9.89 -1.07 2.14 




Carryover was determined by injecting urine samples spiked with the analytes at a 
concentration corresponding to five times the WADA threshold, followed by 
injection of blank mobile phase. No peak was detected in the blank sample. 
 
3.3.2.5 Matrix effects 
The importance of ion suppression due to matrix components in the urine is 
emphasised, since no extraction was performed before injection. This was 




each analyte at the WADA threshold level with a spiked standard at the same 
concentration prepared in water. For all compounds, the matrix effect was less than 
13%.  
 
3.3.3 Application to real samples 
The suitability of the method is demonstrated by the analysis of two samples 
previously determined positive for cathine and ephedrine respectively by using a 
validated GC-MS method. LC-MS/MS chromatograms are reported in Figure 3.11. 
The estimated concentrations are 7.56 µg/mL and 283 µg/mL of cathine and 
pseudoephedrine in sample C, and 48.3 µg/mL ephedrine in sample D. These mean 
values are similar to those obtained by GC-MS, estimated at 7.85 µg/mL and 
44.7 µg/mL for cathine and ephedrine respectively, all measured in triplicate. With 
the LC-MS/MS method, pseudoephedrine was detected and quantified in sample A, 
while the corresponding GC-MS data is not available since the substance was not 
prohibited in sport when the original analysis was performed. This illustrates the 
need for a simultaneous confirmation method since multiple ephedrine compounds 







Figure 3.11. Extracted ion chromatograms (XIC) for the analysis a real sample. 
A blank (A), a quality control sample (B) and actual samples previously determined positive for 
cathine and pseudoephedrine (C) and ephedrine (D) was analysed. Separation performed on an 








The data presented here emphasises the difficulties in selecting eluents optimal for 
both chromatographic performance and MS ionisation. In this case, the 
incompatibility was overcome through the use of APCI, which provided a more 
reliable and reproducible mode of ionisation compared with ESI. The benefits of 
mobile phase pH optimisation for maximum MS performance, in addition to 
chromatographic performance, have been illustrated. Results from the flow injection 
studies with various mobile phase additives using positive ESI confirm the 
significant effect of pH on signal intensity, although no considerable effect on signal 
stability was noted. For all of the basic analytes studied, the addition of a base or 
high pH buffer provides significant benefits for LC-MS analysis. Without the use of 
chromatography, these results illustrate that the increase in MS response with a basic 
eluent is not a result of later elution in a higher organic eluent. However, in addition 
to the increase in ESI response seen for all of the basic analytes studied, the inherent 
enhanced retention of polar bases under high pH conditions does enable improved 
separation from early eluting matrix interferences to reduce the risk of ion 
suppression.  
 
A new, simple LC-APCI-MS/MS method has been developed and validated for the 
identification and quantification of ephedrines in urine for doping control analysis. 
The use of a high pH mobile phase has allowed for improved chromatographic 
separation of the basic compounds without undesirable additives or the need for 
column regeneration required when using highly aqueous mobile phases. A direct 
dilution and injection approach circumvents the time- and labour-intensive sample 




sensitivity and selectivity required. Moreover, the method requires a small sample 
volume and permits the accurate quantification of cathine, ephedrine, 
pseudoephedrine and methylephedrine in a single injection, the results of which 














CHAPTER 4  
 
 
COMPARISON OF REVERSED-PHASE AND HYDROPHILIC 
INTERACTION LIQUID CHROMATOGRAPHIC FOR THE 
QUANTIFICATION OF EPHEDRINES USING HIGH 






While reversed-phase liquid chromatography (RPLC) has become the predominant 
method of choice for bioanalytical separations, the analysis of hydrophilic basic 
compounds continues to challenge this mode of chromatography. This is a particular 
problem for quantitative assays where the complex matrices involved are composed 
of many polar constituents, such as metabolic wastes, biological salts and polar 
organic compounds. Early elution of analytes, often with interfering endogenous 
species in biological matrices in the void volume, and asymmetrical peak shape 
hamper precise and accurate quantification. As previously discussed, under 
traditional RPLC conditions highly aqueous mobile phases [24, 96, 97] or ion-
pairing additives [98, 138, 139] are required for sufficient retention, resolution and 
adequate peak shape. However, such approaches are associated with stationary phase 
de-wetting and subsequent phase collapse under highly aqueous conditions and poor 
desolvation and ion suppression when coupled to mass spectrometric (MS) detection 
[99]. 
 
With the introduction of chemically stable hybrid stationary phase materials, 
manipulation of mobile phase pH in RPLC represents a powerful tool to suppress 
analyte ionisation and chromatograph ionisable analytes in their largely neutral 
forms [48, 100, 101]. The use of a high pH mobile phase with RPLC has previously 
been investigated to separate the ephedrines (see Table 4.1 for analyte properties), 
resulting in good chromatographic separation with acceptable retention and peak 
shape for identification and quantification in urine for doping control analysis [140]. 
Highlighted in this study, however, it was found necessary to utilise APCI rather 




Table 4.1. Properties of the compounds considered in this study. 
Compound pKa
























































* pKa values obtained from Clarke’s Analysis of Drugs and Poisons 
** LogP values obtained from ChemSpider 
*** LogD values calculated from pKa and logP values using the equation:
 
 
Since the introduction of hydrophilic interaction liquid chromatography (HILIC) by 
Alpert in 1990 [58], this mode of chromatography has received increasing attention 
as an alternative to RPLC for the retention and separation of polar or ionisable 
compounds [48, 141-145]. This complementary technique is defined by a 
hydrophilic stationary phase used with a highly organic mobile phase, providing 
orthogonal separation mechanisms to RPLC and therefore different selectivity. In 
addition to the good retention of very polar analytes, the large percentage of organic 
modifier in the HILIC mobile phase offers enhanced ion spray in ESI-MS and hence 
increased sensitivity, as well as lower back-pressures for use of faster flow rates or 
longer columns [146, 147]. The inherent low viscosity mobile phases in HILIC also 
have a positive influence on the kinetic performance of separations [148]. A previous 
comparison between a HILIC and a RPLC approach for the separation of the 
ephedrines in terms of kinetic performance demonstrated that HILIC outperforms a 

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high pH RPLC system, providing van Deemter curves with lower C-term 
coefficients due to improved diffusion with the low viscosity mobile phase [141, 
148]. As referred to previously, this permits the use of higher linear velocities 
without sacrificing efficiency, measured by the height equivalent to a theoretical 
plate (HETP). The lowest Hmin values obtained for ephedrine with pH 10 RPLC and 
HILIC were 7.4 µm and 4.9 µm respectively, highlighting the benefits of HILIC over 
the RPLC system in this case. Nevertheless, the technique holds certain 
disadvantages compared with RPLC, in particular regarding the complex and poorly 
understood retention mechanisms, which complicate the prediction of retention 
values in HILIC [59, 149, 150]. HILIC has also been associated with limited 
flexibility and applicability compared with RPLC, long re-equilibration times and 
problems with sample solubility. However, many studies report the success of HILIC 
as a powerful alternative where RPLC fails to provide appropriate retention or peak 
shape [151], and is particularly amenable to applications coupled to MS detection.  
 
Due to its unrivalled selectivity and sensitivity, tandem triple-quadrupole mass 
spectrometry coupled to HPLC in selected reaction monitoring mode has 
traditionally been the primary tool for screening and quantification in the 
bioanalytical arena. However, with improved modern technologies, high resolution 
accurate mass spectrometry (HRAMS) has recently emerged as an attractive 
alternative for simultaneous qualitative and quantitative analysis [22, 152, 153]. 
Hybrid quadrupole time-of-flight (QTOF) instruments now offer high resolution and 
mass accuracy, fast scan speeds and MS/MS capabilities, together with improved 
linear dynamic range and sensitivity. In doping control analysis, several publications 




quantitative analysis [24, 154-156] of small molecules in complex matrices. In 
addition, high resolution full scan data does not require any prior knowledge of the 
target analytes or MS/MS parameter optimisation and allows retrospective 
generation of extracted ion chromatograms.  
 
This study will directly compare high pH RPLC and HILIC conditions for accurate 
and robust quantitative LC-MS analysis of ephedrines for the purpose of doping 
control. The relative merits and limitations of each approach are evaluated, 
comparing retention, peak shape, resolution, linearity, accuracy, and precision and 
matrix interferences. In addition, there is a focus on the potential of a medium-
resolution (10,000 full width at half maximum (FWHM)) accurate mass instrument 




4.2 Experimental  
4.2.1 Materials 
Acetonitrile (LC-MS grade) and methanol (HPLC grade), propan-2-ol (HPLC 
grade), ammonium bicarbonate, ammonium hydroxide solution (35 % w/w), formic 
acid (99-100 %) and trifluoroacetic acid (TFA, ≥ 98.5 %) were obtained from Fisher 
Scientific (Loughborough, UK). Ammonium acetate was purchased from Sigma 
(Poole, UK). Norephedrine, norpseudoephedrine, ephedrine, pseudoephedrine and 
methylephedrine were purchased as hydrochloride salts from Sigma (Poole, UK). 
Norephedrine-d3 (used as internal standard) was purchased as a free base (1 mg/mL 
in methanol) from LGC Standards (Teddington, UK). Water was purified by an 
ultra-pure water system (Millipore, UK).  
 
4.2.2 Solutions 
4.2.2.1 Reversed-phase mobile phase 
Ammonium bicarbonate buffer (10 mM) was prepared in purified water and adjusted 
to pH 10 with ammonium hydroxide solution (35 % w/w).  
 
4.2.2.2 HILIC mobile phase 
Mobile phases were pre-mixed using a 200 mM stock buffer of ammonium acetate 
prepared in purified water and adjusted to pH 5. Mobile phase A consisted of 
95:5 v/v CH3CN:200 mM buffer prepared by taking 50 mL of the 200 mM stock 
buffer using a glass pipette and adding to 950 mL acetonitrile. Mobile phase B 




the 200 mM stock buffer and adding to 550 mL purified water and 400 mL 
acetonitrile. The pre-mixed mobile phase was then sonicated and allowed to reach 
room temperature to ensure complete dissolution of the buffer salt in the organic 
phase.  
 
4.2.3 Sample preparation and pre-treatment 
Stock solutions were prepared at a concentration of 100 µg/mL for 
norpseudoephedrine, 1 mg/mL ephedrine and methylephedrine and 10 mg/mL for 
pseudoephedrine in methanol and stored at -20 °C. A stock solution of 
norephedrine-d3, used as an internal standard (IS), was prepared at 10 µg/mL in 
methanol. Standard working solutions were prepared by diluting stock solutions with 
the appropriate mobile phase for either reversed-phase or HILIC operation. 
 
A two-step dilution of urine samples was performed before injection: firstly a 45-
fold dilution with mobile phase was performed, after which samples were vortexed 
and centrifuged. Aliquots (200 µL) were then mixed with an equal volume of IS 
solution (norephedrine-d3, 500 ng/mL diluted in mobile phase). Vials were vortexed 
before being placed in the autosampler. 
 
4.2.4 LC conditions 
4.2.4.1 Reversed-phase conditions 
All separations were carried out on an Acquity UPLC
®
 system (Waters Corp., 




1.7 µm, 2.1 x 50 mm column equipped with a 0.2 µm in-line filter. The mobile phase 
consisted of 10 mM ammonium bicarbonate adjusted to pH 10 (A) and methanol 
(B). Gradient chromatography was performed starting at 10 % B, increasing to 25 % 
B after 2.70 min, 55 % B at 5.00 min, 95 % B at 5.50 min and returning to 10 % B 
for a 1 min re-equilibration. The flow rate was 0.6 mL/min and the column 
temperature was set at 45 °C. The weak and strong needle wash lines of the Acquity 
UPLC
®
 system were placed in 90:10 v/v H2O:CH3OH (v/v) and 60:30:10 v/v/v 
C3H8O:CH3CN:H2O with 0.1% TFA, respectively. The injection volume was 2 µL 
performed in full loop mode. This UPLC
® 
method was modified from a previously 
reported HPLC separation [140]. 
 
4.2.4.2 HILIC conditions 
The HILIC separation was performed on an Acquity BEH HILIC 1.7 µm, 2.1 x 100 
mm column (Waters, Milford USA) using a 0.2 µm in-line filter and isocratic 
conditions. The mobile phase comprised pre-mixed 95:5 v/v CH3CN:200 mM 
ammonium acetate pH 5 (A) and 50:45:5 v/v/v CH3CN:H2O:200 mM ammonium 
acetate. A flow rate of 0.5 mL/min was used and the column temperature was set at 
50 °C. The weak and strong needle wash lines of the Acquity UPLC
®
 system were 
placed in 95:5 v/v CH3CN:H2O and 50:50 v/v CH3CN:H2O respectively, so as not to 
cause any interference with the sample plug. The injection volume was 2 µL 





4.2.5 Mass spectrometry 
Mass spectrometric detection was performed using a Waters Xevo QTOF instrument 
operated in positive mode with ESI. The MS data acquisition was performed in MS
E
 
mode, collecting two channels of data throughout the run, one with low collision 
energy (4 V) and one high (ramp from 10-20 V) in order to obtain both the precursor 
and product ions. Source conditions were optimised for each mobile phase 
composition and, for the reversed-phase separation, the capillary voltage was set at 
0.5 kV, sample cone 15 V and extraction cone 2.0 kV. In HILIC the capillary voltage 
was set at 0.7 kV, sampling cone 15 V and extraction cone 4.0 kV. For both LC 
setups the source temperature was 120 °C, desolvation temperature was 500 °C, cone 
gas flow was set at 10 L/h and the desolvation gas was set at 800 L/h. The micro-
channel plate detector was operated at 2275 V. Data was collected in centroid mode 
over an m/z range of 50-600 Da with a scan time of 0.1 sec. Leucine enkephalin 
(5 ng/mL) was used as the accurate mass reference material, infused through a 
LockSpray probe at 5 µL/min and data was acquired every 30 seconds with a 0.5 sec 
scan time (3 scans were averaged). A mass window of 0.005 Da was used to extract 
mass traces. MassLynx
TM
 V4.1 software (Waters Corp., Milford, USA) was used for 
data acquisition and analysis. 
 
4.2.6 Calibration 
A six-point calibration curve including 50-200 % of the WADA threshold 
concentrations was constructed from a stock calibration solution containing cathine 
10 µg/mL, ephedrine 20 µg/mL, pseudoephedrine 300 µg/mL and methylephedrine 




calibration points at 1.25, 2.5, 3.75, 5.0, 7.5, 10.0 µg/mL for cathine, 2.5, 5.0, 7.5, 
10.0, 15.0 and 20.0 µg/mL for ephedrine and methylephedrine and 37.5, 75.0, 112.5, 
225 and 300 µg/mL for pseudoephedrine. Quality control (QC) samples were 
prepared at concentrations equal to the WADA threshold levels (cathine 5 µg/mL, 
ephedrine 10 µg/mL, pseudoephedrine 150 µg/mL, methylephedrine 10 µg/mL).  
 
4.2.7 Validation 
The validation was performed on three different days, with mobile phase, calibrants 
and QCs prepared on each individual day. The method was validated for linearity 
over the dynamic range, selectivity, accuracy, precision, carry-over and ion 
suppression due to matrix interferences. Ten blank urine samples obtained from 
different volunteers were analysed as described above to ensure selectivity of the 
method. Linearity was determined with the six-point calibration and accuracy and 
between-assay precision were determined by analysing three replicates of a urine 








The use of a high pH mobile phase was previously investigated for the separation of 
ephedrines by RPLC to suppress ionisation of the basic analytes and inhibit 
undesirable secondary interactions with residual silanols on the surface of the 
stationary phase [140]. Although this approach enabled improved separation and 
peak shape compared with traditional low pH RPLC methods, some important 
factors in coupling solvent systems optimal for LC separation with mass 
spectrometric (MS) detection were highlighted. When interfaced with MS detection 
it suffered from problems with poor ESI spray and non-linear, irreproducible data. 
APCI was therefore employed to overcome this and the resulting LC-APCI-MS 
method was validated. However, here HILIC is evaluated as an alternative approach 
for the separation of the polar and ionisable diastereoisomeric pairs, well known for 
its advantages when coupled to MS detection. The parameters affecting HILIC 
separation including organic content, buffer concentration, pH and temperature have 
been previously optimised for the separation of ephedrines for an evaluation of 
kinetic performance and these conditions are used here as the comparative method 
[148]. Although speed of analysis is a critical factor in method development, the 
main objective here was to develop the most accurate, precise and robust 
quantification assay for ephedrines in doping control analysis. Some considerations 
for HILIC method development are discussed and a comparison is made between the 






4.3.1 Comparison of chromatographic parameters 
The previously reported RPLC method has been modified to enable transfer from 
HPLC (Waters XBridge C18 2.5 μm, 50 x 2.1 mm i.d.) to UPLC
®
 (Waters BEH C18 
1.7 μm, 50 x 2.1 mm i.d.) technology. The final chromatographic conditions of the 
methods compared here are detailed in Table 4.2 and the resulting chromatograms in  
Figure 4.1 with the corresponding chromatographic parameters in Table 4.3. 
Although both approaches show adequate retention of all analytes, the pH 10 RPLC 
provides stronger retention (k values ranging from 6.0-15.5) despite the use of 
gradient chromatography compared with the HILIC isocratic method (k values 
ranging from 4.3-6.9). With RPLC, operating at high pH suppresses analyte 
ionisation which enables hydrophobic interactions to dominate the mechanisms of 
retention. In contrast, under HILIC conditions at pH 5, where the basic analytes are 
fully ionised, this protonation aids interaction with the aqueous layer on the surface 
of the silica as well as ionic interactions with exposed silanols on the polar stationary 
phase. It is interesting to note that the elution order only changes with respect to 
methylephedrine; it is not reversed for the other ephedrines between RPLC and 
HILIC, indicating that the two approaches are not orthogonal. The pH 10 RPLC 
offers greater resolution between each of the analytes, with a minimum Rs value of 
2.4, compared with the HILIC method with a minimum Rs value of 1.8. 
Nevertheless, HILIC offers the major advantage of improved peak shape, essential 
for accurate integration and therefore quantification. Additionally, with the low 
viscosity mobile phase used under HILIC conditions, the possibility of using a 





Table 4.2. Chromatographic conditions of the final RPLC pH 10 and HILIC methods used in 
this comparative study. 
 RPLC pH 10 HILIC 
Column Waters BEH C18 1.7 μm, 50 x 2.1 mm i.d. Waters BEH HILIC 1.7 μm, 100 x 2.1 mm i.d. 
Mobile phase A 10 mM ammonium bicarbonate pH 10 40:55:5 CH3CN:H2O:200 mM ammonium acetate pH 5 
Mobile phase B CH3OH 95:5 CH3CN:200 mM ammonium acetate pH 5 
Flow rate 0.6 mL/min 0.5 mL/min 
Column temp. 45 ºC 50 ºC 
Injection vol. 2 μL 2 μL 
Gradient Time (min) A (%) B (%) 
0.0 90 10 
2.70 75 25 
5.00 45 55 
5.50 5 95 
6.5 90 10 
 
Time (min) A (%) B (%) 
0.0 0 100 
5.0 0 100 
5.5 100 0 
6.0 0 100 













Figure 4.1. Comparison of pH 10 RPLC (A) and HILIC (B).  
Chromatograms illustrate separation of PPA (1), cathine (2), ephedrine (3), pseudoephedrine 
(4) and methylephedrine (5) generated using standards prepared at 500 ng/mL in the 
appropriate mobile phase. RPLC performed on an Acquity BEH C18 1.7 µm, 50 x 2.1 mm 
column operated under gradient conditions at 0.6 mL/min and 45 °C. HILIC separation 
performed on an Acquity BEH HILIC 1.7 µm, 100 x 2.1 mm column operated under isocratic 
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Table 4.3. Chromatographic parameters of RPLC and HILIC approaches.  




4.3.2 HILIC robustness and reproducibility 
Despite the advantages of the HILIC method, replicating the separation was a 
challenge due to variable retention times, co-eluting and even distorted peaks. 
Modification of the surface silica from a build-up of matrix contaminants from the 
injection of diluted urine was initially considered to be the cause, resulting in peak 
broadening, peak tailing, retention time drift and split peaks. The importance of 
adequate column conditioning with up to 10 injections of sample matrix before a run 
has been reported elsewhere to avoid changes in retention throughout a run [157]. 
The unbonded hybrid silica used here was washed before and after use with 50:50 
CH3CN:H2O and equilibrated for up to an hour with the mobile phase to ensure good 
establishment of the water layer on the surface. Several blank urine samples were 
injected to condition the column and ensure the matrix was not contributing to 
Analyte 
RPLC 
wb (min) w5% (min)  tR (min) t0 (min) k Rs α 
d3-norephedrine 0.13 0.12 1.60 0.23 6.0 - - 
Cathine 0.15 0.14 2.00 0.23 7.7 2.9 1.3 
Ephedrine 0.15 0.14 2.55 0.23 10.1 3.7 1.3 
Pseudoephedrine 0.15 0.14 2.91 0.23 11.7 2.4 1.2 
Methylephedrine 0.12 0.11 3.80 0.23 15.5 6.6 1.3 
Analyte 
HILIC 
wb (min) w5% (min)  tR (min) t0 (min) k Rs α 
d3-norephedrine 0.15 0.14 3.35 0.57 4.9 2.3 1.1 
Cathine 0.16 0.15 3.63 0.57 5.4 1.8 1.1 
Ephedrine 0.19 0.18 4.07 0.57 6.1 2.5 1.1 
Pseudoephedrine 0.20 0.19 4.48 0.57 6.9 2.1 1.1 




changes in retention. Following the isocratic elution, a wash gradient up to 40:60 
CH3CN:aqueous buffer was employed to remove any polar matrix components 
remaining on the silica surface. These measures ensured that there was no surface 
modification or matrix interference and that direct injection was suitable, omitting 
the need for extensive time-consuming sample preparation procedures.  
 
4.3.3 HILIC mobile phase preparation  
The adopted mobile phase from the previous study utilises a buffered acetonitrile 
eluent. This was used in order to control the extent of electrostatic interaction 
between ionised analytes and silanols on the silica surface. Moreover, it is important 
to maintain the eluent pH and a constant charge state of ionisable analytes to ensure 
retention reproducibility. The previous method development study detailed the high 
sensitivity of retention to the slightest change in pH and/or percentage of organic 
modifier. Meticulous preparation is therefore necessary to ensure reproducible 
retention. The 200 mM aqueous ammonium acetate stock buffer, adjusted to pH 5, 
was stored at 4 ˚C and left to reach room temperature and the pH then measured 
again. To prepare 1 L of mobile phase, 50 mL of 200 mM stock buffer was measured 
using a glass pipette and 950 mL of acetonitrile was added. This was sonicated for 
10 minutes to ensure complete dissolution of the ammonium acetate in the 
acetonitrile. The exact measurement of each of these components was found to be 
critical in reproducing the same retention times and separation. Once the separation 
had been replicated, this same procedure was repeated several times on different 
days, using different preparations of stock buffer, in order to evaluate the 




4.3.4 Retention time reproducibility 
Poor reproducibility can be a major disadvantage associated with HILIC. This was 
apparent in the present study where several factors were investigated as potential 
causes of variation. Mobile phase preparation and storage, column conditioning, re-
equilibration times and injection solvent were all considered critical. Retention time 
reproducibility deteriorated over time when mobile phase was not prepared daily and 
left stored on the instrument. This resulted in retention drifts as large as 0.2 min 
(Figure 4.2), whereas for mobile phase stored in tightly sealed bottles, retention was 
stable for more than one week.  
 
    
Figure 4.2. Change in retention factors over 5 days with different storage conditions. 
Solvent reservoirs were stored tightly capped (A) or with a duran stopper (B) and retention 
changes evaluated for methylephedrine (♦), PPA-d3 (□), cathine (▲), ephedrine (x), and 
pseudoephedrine (○).  
 
The increase in analyte retention, seen in Figure 4.2, is thought to be related to the 
pH changes over time when the mobile phase is left exposed, with evaporation of the 
organic phase expected to result in stronger elution in HILIC. In HILIC, a retention 
increase is observed as the amount of organic is increased, hence this increase in 

























alone. Therefore, the possibility that mobile phase pH is affected by the evaporation 
of acetonitrile with the pre-mixed volatile ammonium acetate buffer was 
investigated. The apparent pH of the mobile phase was measured on each day for 
12 consecutive days by storing mobile phase both tightly sealed and left open. The 
results indicate an apparent pH change occurring when the HILIC mobile phase is 
exposed, an effect which is not seen in the pure aqueous buffer containing no organic 
modifier (Figure 4.3). This supports the proposed theory that evaporation of 
acetonitrile causes a decrease in the apparent pH, bringing it closer to that of the pure 
aqueous buffer. An additional consideration is that the decrease in pH is due to 
carbon dioxide absorption from the solvent reservoir, leading to the formation of 
carbonic acid and decrease in pH. However, since the change in pH is only noted in 
buffer containing acetonitrile, this evidence suggests that evaporation of the organic 
portion is accountable for the decrease in pH.  
 
 
Figure 4.3. Change in apparent pH of HILIC mobile phase.  
Apparent pH was measured daily for mobile phase (95:5 AcN:10 mM ammonium acetate pH 5) 
was stored tightly capped (□) and with a Duran stopper (♦) and aqueous 10 mM ammonium 




























However, if mobile phase is freshly prepared and stored appropriately, retention 
times have been shown to be stable and reproducible. Variation was calculated on 
three separate days using three different preparations of buffer and mobile phase. 
The results are expressed in Table 4.4 and show that inter-day retention times do not 
vary by greater than 0.17 %.  
 
Table 4.4. Retention times of analytes spiked in urine on three different days using three 
different preparations of mobile phase, n = 6. 
    Day 1 Day 2 Day 3 
Inter-
day 
Methylephedrine Ave (min) 2.98 3.01 2.98 2.99 
 STDEV 0.01 0.01 0.00 0.01 
 % RSD 0.21 0.20 0.11 0.17 
      
Norephedrine-d3 Ave (min) 3.37 3.39 3.37 3.38 
 STDEV  0.01 0.00 0.00 0.00 
 % RSD 0.23 0.01 0.08 0.11 
      
Cathine Ave (min) 3.56 3.58 3.57 3.57 
 STDEV 0.00 0.00 0.00 0.00 
 % RSD 0.00 0.01 0.12 0.04 
      
Ephedrine Ave (min) 4.02 4.04 3.99 4.02 
 STDEV 0.01 0.00 0.00 0.00 
 % RSD 0.20 0.00 0.01 0.07 
      
Pseudoephedrine Ave (min) 4.43 4.45 4.39 4.42 
 STDEV 0.00 0.01 0.00 0.00 
  % RSD 0.01 0.17 0.00 0.06 
 
It has been documented that HILIC requires longer re-equilibration times than 
RPLC, typically 10-20 column volumes, and was therefore optimised following the 
wash gradient to permit stable retention. At a flow rate of 0.5 mL/min, four minutes 
re-equilibration was suitable for chromatographic stability and repeatable retention. 
Retention was reproducible with as little as two minutes re-equilibration, but the 




resulted in co-elution with the analytes and inaccurate quantification. This can be 
seen in  
Figure 4.4, which indicates the change in retention of matrix components over 
consecutive injections of the same spiked sample (highlighted with *). This is 
thought to be caused by the steep wash gradient at the end of the run as this 
phenomenon is not seen when operation is performed solely in the isocratic mode. 
The problem was rectified by extending the re-equilibration time, the results of 
which can be seen in Figure 4.5 where the interference (highlighted with *) is 
eliminated when a four minute re-equilibration is employed. This is considerably 
longer than the 1.5 minute re-equilibration for the pH 10 RPLC method, resulting in 
final run-time of 10 minutes for the HILIC method compared with 6.5 minutes for 
the pH 10 RPLC method. This is a clear disadvantage of the HILIC approach as the 
throughput is significantly poorer than for the RPLC approach, and should be taken 







Figure 4.4. Repeat injections of a spiked urine sample indicating change in the retention of 
matrix interferants between consecutive injections. 
Experiments performed on an Acquity BEH HILIC 1.7 µm, 100 x 2.1 mm column operated at 

















Figure 4.5. Effect of increasing re-equilibration time on matrix interferants seen with diluted 
blank urine.  
Experiments performed on an Acquity BEH HILIC 1.7 µm, 10 x 2.1 mm column operated at 
0.5 mL/min and 50 °C. Matrix interferants highlighted with *.  
 
4.3.5 Loading 
The sample loading capacity of reversed-phase type B silica columns has been 
extensively reported, portraying poor loading capacity of basic compounds under 
acidic conditions [104-106]. This has been attributed to rapid saturation of exposed 
negatively charged silanol groups on the surface of the stationary phase. However, it 
has been shown that under high pH conditions where basic analytes are largely 
unionised the loading capacity is much improved, with higher concentrations 
tolerated before the characteristic “shark fin” peak shape is noted [107]. Here, the 
loading capacity of the HILIC BEH material is compared to the BEH C18 material 
under basic conditions. The results are illustrated in Figure 4.6, which depicts the 
 (C) 4 min re-equilibration 
 (A) 2 min re-equilibration 






preservation of Gaussian peak shape under HILIC conditions with increasing sample 
load compared with pH 10 RPLC conditions. Although high pH mobile phase offers 
a significant advantage over traditional acidic RPLC conditions in terms of improved 
retention and peak shape with increasing sample [104, 140], HILIC was better able 
to maintain retention time and symmetrical peak shape with increases in the amount 
of sample on column compared with RPLC at pH 10. This is illustrated in Figure 4.6 
for pseudoephedrine, where at 500 ng on column, HILIC gave an asymmetry value 
at 10 % peak height (As10%) of 1.67 compared with 2.39 using pH 10 RPLC. 
Retaining peak shape with large amounts of solute on column is particularly 
beneficial for this application where there is great interest in analysing the lower 
threshold level ephedrines (cathine, ephedrine and methylephedrine) together with 









Figure 4.6. Overlay of pseudoephedrine with increasing concentration under RPLC pH 10 (A) 
and HILIC pH 5 (B) conditions. 
Pseudoephedrine injected at 20, 50, 100, 200, 250, 300, 400 and 500 ng on column under high pH 
RPLC (A) and HILIC conditions (B) at 210 nm. RPLC performed on an Acquity BEH C18 
1.7 µm, 50 x 2.1 mm column; HILIC performed on an Acquity BEH HILIC 1.7 µm, 100 x 
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4.3.6 Quantification using high resolution accurate mass 
A transition from the use of tandem mass spectrometry to high resolution accurate 
mass spectrometry (HRAMS) has recently been adopted in drug discovery and 
screening laboratories to enable full scan accurate mass data acquisition. The 
introduction of fast scanning quadrupole time-of-flight (QTOF) instrumentation 
represents an attractive tool for comprehensive screening and confirmation of 
analytes coupled to UHPLC. Modern HRAM technologies, equipped with enhanced 
sensitivity and linear dynamic range, offer the potential for quantitative analysis 
together with confirmation via accurate mass measurements, analyte elemental 
composition and the high selectivity required for analysis of complex matrices. With 
the QTOF mass analyser used here it was possible to acquire two channels of data 
with different collision energies to obtain both molecular and fragment ion data for 
confirmation. A low collision energy (CE = 4V) was applied in one channel to obtain 
molecular ions and in the other a higher collision energy (CE = 10-20V ramp) to 
generate fragmented ions (Figure 4.7). In addition, the improved sensitivity and 
dynamic range allowed for simultaneous quantification, with good linearity, 






Figure 4.7. Mass spectra of function one (molecular ions) and function two (fragment ions) for 
cathine.  
 
The ions used for quantification and identification are listed in Table 4.5. The 
protonated molecules obtained from the low collision energy channel were used in 
quantification, while the additional fragment ions created in the high collision energy 
channel were included for confirmation analysis. 
 
A scan time of 0.1 sec/scan was used here, optimised to give sufficient data points 
for good peak shape definition and mass accuracy. With both the RPLC and HILIC 
methods, a sufficient number of scans were obtained per peak for quantification 
(≥ 18 data points per peak). This is especially important for quantification, where 12-
15 data points per peak are required for good peak definition accurate peak area 
measurement. On each day of the validation, accurate mass measurements were 
performed and the errors between the expected and measured mass values (mDa and 
ppm) were calculated, given in Table 4.5.  
 (A) Function one 
 (B) Function two 
CE = 4 V 


























































































































































































































































































































































































































































































































































































































































Once shown to be reproducible, a validation of the quantitative HILIC method was 
performed to evaluate linearity, accuracy and precision, repeatability, specificity and 
matrix effects – and the method applied to a real sample. The same process was 
applied to the high pH RPLC UHPLC method transferred and modified from the 
previously validated HPLC version, and the results were compared for a reliable and 
robust quantification method.  
 
4.3.7.1 Linearity 
A calibration curve was generated covering 50-200 % of the WADA threshold 
concentrations for the prohibited ephedrines (cathine 5 μg/mL, ephedrine 10 μg/mL, 
pseudoephedrine 150 μg/mL, methylephedrine 10 μg/mL). The use of a high pH 
RPLC method has previously been reported where difficulty in coupling to ESI-MS 
detection was highlighted. This was noted again here with pseudoephedrine showing 
non-linearity and poor reproducibility over the calibration range. Reducing the 
concentration of the pseudoephedrine calibrants from 37.5-300 µg/mL to 3.75-
30 µg/mL, bringing them into the same dynamic range as the other analytes, 
remedied this phenomenon, indicating that at higher concentrations some peak 
tailing resulting from a degree of column overloading is still apparent, complicating 
peak integration. The results, shown in Table 4.6, illustrate the differences obtained 





Table 4.6. Average calibration statistics for the RPLC pH 10 (A) and HILIC (B) methods, n = 3. 
(A) RPLC pH 10 
Compound Ion (m/z) Linear Range (µg/mL) Slope Intercept r
2
 
Cathine 152.1075 1.25-10 0.0187 0.0112 0.9973 
Ephedrine 166.1232 2.5-20 0.0512 0.0181 0.9967 
Pseudoephedrine 166.1232 3.75-30 0.0402 0.0130 0.9935 
Methylephedrine 180.1388 2.5-20 0.0635 0.0253 0.9947 
 
(B) HILIC 
Compound Ion (m/z) Linear range (µg/mL) Slope Intercept r
2
 
Cathine 152.1075 1.25-10 0.0290 0.0052 0.9967 
Ephedrine 166.1232 2.5-20 0.0585 0.0206 0.9939 
Pseudoephedrine 166.1232 37.5-300 0.0304 0.3244 0.9959 
Methylephedrine 180.1388 2.5-20 0.1241 0.1555 0.9943 
 
4.3.7.2 Selectivity 
Selectivity was determined through the analysis of 10 different blank urine samples 
with no interference being detected at the expected retention times of the analytes. 
 
4.3.7.3 Accuracy and precision 
Accuracy and precision were calculated on three separate days for both techniques 
using QCs at threshold concentrations for each analyte. The results are detailed in 
Table 4.7. Accuracy ranged from 0.0-7.5 % and 0.9-7.6 % with RPLC and HILIC, 
respectively. RSD values for within-assay variation ranged from 1.3-7.0 % (n = 6) 
with RPLC and 1.8-10.3 % (n = 6) with HILIC and between-assay variation ranged 


























































































































































































































































































































































































































































































































































































































































Carryover was determined by injecting urine samples spiked with each analyte at a 
concentration equivalent to the highest point of the calibration followed by injection 
of blank mobile phase. The washes were optimised to minimise carryover and the 
Acquity UPLC
®
 was operated with a 2 µL loop in full loop mode to maximise the 
strong wash cycle. Following this optimisation, no carryover was observed. 
 
4.3.7.5 Sensitivity 
One of the major advantages of using HILIC over RPLC with ESI is the gain in 
sensitivity owing to improved desolvation from the high organic content of the 
mobile phase. It was therefore anticipated that HILIC would enable lower limits of 
detection compared with the RPLC approach. For this application the limits of 
detection were determined by the lowest point of the calibration curve, so sensitivity 
was measured by the signal-to-noise ratio. Cathine at the lowest point of the 
calibration (11.1 ng/mL following dilution), had S/N values for the RPLC pH 10 and 
HILIC methods of 9.72 and 59.6, respectively, illustrating a 6-fold increase in 
sensitivity with the HILIC approach (Figure 4.8). Although sensitivity is not a 
problem for these high threshold level compounds, a gain in sensitivity permits a 
larger dilution of sample to reduce the possibility of sample overload and detector 
saturation, and also minimises matrix interference. The gain in sensitivity, however, 
becomes interesting when analysing low level analytes, or where longer windows of 











Figure 4.8. Extracted ion chromatograms (XIC) illustrating the difference in sensitivity with 
RPLC pH 10 (A) and HILIC (B).  
Chromatograms illustrate difference in sign-to-noise ratio (S/N) for cathine at the lowest point 
of the calibration (mass 152.1075 Da with a 0.02 Da mass window). RPLC performed on an 
Acquity BEH C18 1.7 µm, 50 x 2.1 mm column operated under gradient conditions at 
0.6 mL/min and 45 °C. HILIC separation performed on an Acquity BEH HILIC 1.7 µm, 100 x 
2.1 mm column operated under isocratic conditions at 0.5 mL/min and 50 °C. 
 
4.3.7.6 Matrix effects 
Both approaches were evaluated for matrix interference using 10 different blank 
urine samples spiked at WADA threshold concentration levels with each analyte 
considered. Matrix effect was calculated by comparing the response of each analyte 
spiked in urine samples to standards prepared in mobile phase. Ion suppression from 
possible matrix interference was shown to be negligible for both methods, with 
maximum matrix effect values of 106.2 % and 87.0 % for RPLC pH 10 and HILIC, 
respectively (Figure 4.9). Response factor plots of peak area/concentration versus 
concentration are also given in Figure 4.10 to evaluate low level matrix effects. The 
lower the r
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(B) HILIC pH 5 




from these plots, therefore, that in this case RPLC is affected slightly more by matrix 






Figure 4.9. Graphical representation of matrix effects.  
10 different blank urine samples were evaluated using RPLC pH 10 (A) and HILIC pH 5 (B). 









































 (A) RPLC pH 10 









Figure 4.10. Response factor plots of peak area/concentration versus concentration for RPLC 
(A) and HILIC(B). 
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4.3.7.7 Application to a real sample 
Both methods were applied to the analysis of a suspect ephedrine sample. The results 
correlate well with one another at 9.34 µg/mL and 9.76 µg/mL with the RPLC pH 10 














Figure 4.11. Analysis of an ephedrine suspect sample with the RPLC pH 10 method (A) and the 
HILIC method (B) (0.02 Da mass window). RPLC performed on an Acquity BEH C18 1.7 µm, 
50 x 2.1 mm column operated under gradient conditions at 0.6 mL/min and 45 °C. HILIC 
separation performed on an Acquity BEH HILIC 1.7 µm, 100 x 2.1 mm column operated under 
isocratic conditions at 0.5 mL/min and 50 °C. 
 (A) RPLC pH 10 





A new HILIC-QTOF-MS method has been developed and validated as a 
complementary alternative to traditional RPLC approaches for the separation and 
quantification of ephedrines. A comparison was presented between high pH RPLC 
and HILIC methodologies for the quantitative analysis of hydrophilic basic analytes, 
exemplified by the ephedrines for doping control analysis. Both approaches 
demonstrate sufficient retention and resolution of the critical pairs, but HILIC mode 
offers improvements in peak shape and enhanced sensitivity with ESI-MS detection. 
In addition, the greater dynamic range offered by HILIC in this application illustrates 
the potential to analyse samples where components are present over a wide range of 
concentrations without saturating the stationary phase. With the dilution of 
pseudoephedrine, no significant differences were noted for linearity, accuracy and 
precision between the two approaches. Both methods are amenable to a quick and 
simple dilution and injection of urine samples, omitting time consuming and 
laborious sample preparation treatment. Ionisation variability from possible matrix 
interference was negligible for both sets of conditions, although slightly more 
variation was observed in HILIC mode. One major drawback of HILIC is the 
expensive solvent system required, and therefore future efforts may be made in 
fostering alternative organic components or the use of micro scale separations for 
reduced mobile phase consumption.  
 
Despite initial challenges with retention time reproducibility, HILIC illustrates a 
robust and reliable alternative for the accurate quantification of hydrophilic bases. 
Quantification using UHPLC-QTOF mass spectrometry provided linear, accurate 




5 µg/mL following a 1:90 dilution step. The advantage of HRAMS over traditional 
triple quadrupole MS/MS systems is that little MS method development time is 
needed, qualitative and quantitative analysis on the same samples can be acquired in 
the same analysis and full scan data can be acquired without compromising the 
number of data points per peak despite the number of analytes detected at one time. 
Continuous SRM intuitively gives better signal-to-noise ratios, however such 
instruments can suffer from limited dynamic range, whereas the type of detector 
used here has the means of attenuating the ion intensity thereby offering an extended 
dynamic range. Modern QTOF instrumentation offers fast scanning capabilities for 
use with UHPLC technology at an affordable cost. This medium-resolution type of 
detector coupled with prior UHPLC separation provides sufficient resolution to 















CHAPTER 5  
 
 
COLUMN SWITCHING FOR THE COMPREHENSIVE 
ANALYSIS OF POLAR AND NON-POLAR COMPOUNDS  
 
  




The issues relating to the analysis of polar compounds are apparent in a variety of 
fields. Small, highly polar compounds have recently come to the forefront in 
pharmaceutical and biomedical applications, alongside an increased interest in the 
separation of highly polar metabolites in drug metabolism and pharmacokinetic 
(DMPK) studies and emerging metabolomics approaches. Consequently, the need to 
screen samples for a diverse range of unknown analytes is often presented. The 
separation of polar and non-polar solutes is a challenge, typically requiring a 
combination of several approaches, including reversed-phase liquid chromatography 
(RPLC), normal-phase chromatography (NPC), hydrophilic interaction liquid 
chromatography (HILIC), supercritical fluid chromatography (SFC) or capillary 
electrophoresis (CE). However, with more and more analytes to separate and the 
need for fast turnaround times, high-throughput methodologies are becoming 
essential. A generic approach which encompasses a wide range of physiochemical 
properties, permitting simultaneous screening in a single run, is therefore highly 
desirable.  
 
As discussed in previous chapters, the retention and separation of hydrophilic 
compounds is an ongoing challenge for RPLC. Alternatives, including NPC, ion 
exchange chromatography (IEC) and ion pair chromatography (IPC), have 
significant drawbacks which are mainly associated with mobile phase solvents, 
additives and high salt buffers that are incompatible with mass spectrometric 
detection, thus restricting their use. Although alleviated to some extent by the 
development of highly aqueous-stable phases and the advent of HILIC, the issues 
relating to the analysis of very polar compounds still remain. HILIC has so far 
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proven to be the most successful phase for the analysis of very polar analytes and has 
evolved as an effective technique for the analysis of amino acids, proteins, vitamins 
and compounds of pharmaceutical interest [145, 150, 158, 159]. However, there 
remains no single solution that provides a separation for a wide variety of compound 
polarities, particularly when interfacing with MS.  
 
Two-dimensional liquid chromatography (2D-LC) has demonstrated benefits in 
generating high peak capacities for a wide range of compounds through the use of 
orthogonal stationary phases or conditions. 2D-LC employs the use of two 
independent chromatographic systems that are applied to the same sample. Driven by 
the necessity for greater resolving power with complex samples, 2D-LC has assumed 
a popular role in fields such as metabolomics and proteomics where large peak 
capacities are desired. Although multidimensional separation systems have been 
largely used to characterise peptides and proteins, such workflows have also been 
applied to the separation of small molecules in complex mixtures [160] and 
traditional Chinese medicines [161, 162]. In order to achieve orthogonality, phases 
with different separation mechanisms should be employed in 2D-LC. Commonly 
employed workflows include the use of RPLC in the second dimension with IEC, 
strong cation exchange (SCX), anion exchange (AX), size exclusion chromatography 
(SEC) or RPLC under different operating conditions in the first dimension. Although 
NPLC-RPLC is highly orthogonal, NP mobile phases are often immiscible with the 
RP mobile phases, therefore such a combination is rarely reported. RPLC performed 
in both dimensions by using different columns or mobile phase pH [163, 164] 
provides large peak capacities but less orthogonality, and can also suffer from 
mobile phase incompatibility unless an isocratic elution is performed in the first 
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dimension. Where the drive is to separate extremes of polarity, the most 
complementary techniques are HILIC and RPLC, which offer high orthogonality and 
high peak capacity. Although HILIC has the advantage of being MS compatible for 
application in the second dimension, the highly organic mobile phase of this 
technique suffers from incompatibility with those employed in RPLC. Although they 
are miscible, mobile phases employed in HILIC typically comprise 75-95% organic 
solvent, whereas RPLC separations start with low percentages of organic and 
increase over the gradient. As a result, it is not easy to couple RPLC and HILIC for 
comprehensive on-line 2D-LC. Again, dilution would be required with a highly 
organic solvent for the HILIC mode and analytes must be soluble in a high 
percentage of organic modifier, which is often difficult when considering highly 
polar analytes that have limited solubility in acetonitrile. The direct coupling of 
RPLC with HILIC in series has been demonstrated as one approach to broadening 
the elution window for the analysis of polar and non-polar pharmaceutical 
ingredients [165]. Although the chromatography did not suffer from being subjected 
to two different modes of separation by the serial coupling of these phases, the 
incompatibility of the two mobile phase systems results in an in-line dilution by 
infusion of acetonitrile to provide the HILIC mobile phase. 
 
With the need for fast, high-throughput methods, UHPLC has been widely used to 
improve peak capacity and analysis times in one-dimensional separations. The 
difficulty with employing UHPLC in 2D workflows is that any interface must also 
tolerate ultra-high pressures which, until recently, were either unavailable or very 
expensive. For this reason, few recent studies exploit the application of UHPLC for 
2D separations, which are capable of further enhancing resolving power, reducing 
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elution time and increasing sensitivity [166-169]. One approach for complex 
impurity analysis is that reported by Huidobro et al, who used off-line RP x RP with 
UHPLC in the second dimension [167]. An alternative approach is reported by 
Alexander and Ma et al. who use a fused-core material as an alternative in the 
second dimension as an in order to achieve fast separations at ambient temperature 
without excessive back-pressure for the analysis of pharmaceutical samples [170]. 
 
Small molecules with many polar groups have been shown to be well retained on 
polymeric resins compared with the poor retention exhibited on bonded silica phases. 
Compared with the bonded phases, polymeric sorbents typically have higher specific 
surface areas and increased capacity due to the greater percentage of organic 
material. Frequently used as solid phase extraction (SPE) sorbents or as monolithic 
materials, strong hydrophobic (SH) resins can illustrate significant retention of 
highly polar solutes [171, 172]. However, such materials are inherently inefficient 
and, as such, are not widely used as particulate materials for separation platforms. 
However, polystyrene-divinylbenzene (PS-DVB) is a comparatively robust polymer 
material, and is used as a polymeric HPLC packing material. The high degree of 
cross-linking in this polymer gives it an extremely durable nature and enables it to 
withstand HPLC pressures and resist swelling when used with organic solvents 
better than alternative polymeric materials. The surface is highly hydrophobic and is 
frequently modified to produce ion exchangers, such as sulfonated resins which are 
useful for the retention of polar organic compounds [173]. There are reports of using 
these supports in chromatographic columns where they have been shown to operate 
with “reversed-phase” like retention characteristics when using hydrophilic solvents 
as mobile phases [174]. The inherent stability over a wide temperature and pH range 
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is a distinct advantage of these materials, despite being inefficient compared with 
silica-based packing materials and not as mechanically strong. For this reason, PS-
DVB materials are often reserved for monolithic column formats.  
 
In addition, porous graphitic carbon (PGC) has been demonstrated as a viable phase 
for the retention and separation of polar analytes [49, 175-177], glycans [178] and 
several pharmaceutically relevant applications [179-182]. Due to its highly 
hydrophobic nature, PGC behaves as a strong reversed-phase packing material and is 
suitable for the chromatography of very polar compounds. The stability of PGC 
renders it resistant to extremes of pH and temperature and, furthermore, has been 
shown to offer shape selectivity and the potential to separate positional isomers. One 
disadvantage of such highly hydrophobic material is the difficult desorption of non-
polar compounds adsorbed on the surface, limiting the window of potential 
polarities. The complex mechanisms of interaction have been shown to involve a 
combination of hydrophobic and electrostatic interactions between polarisable or 
polarised functional groups in the analyte with graphite [183]. Hennion et al. 
reported that, in the retention of polar analytes, electronic interactions are more 
important than hydrophobic interactions [184]. According to Knox and Ross, this 
effect is particularly strong when the stereochemistry of an analyte forces the polar 
group close to the graphite surface, known as the polar retention effect by graphite 
[50, 184]. However, PGC has, to date, largely been unexplored in 2D workflows 
despite the alternative mechanisms of interaction to conventional RPLC phases, 
resulting in differences in selectivity. Recently, Griffiths et al. illustrated the 
orthogonality of PGC and RPLC for peptide analysis and highlighted the advantages 
of PGC over SCX in a 2D-LC workflow for proteomic studies [185].  
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The ultimate goal in this study is to develop a generic, high-throughput method for 
the simultaneous retention and separation of hydrophilic and hydrophobic solutes 
within a single chromatographic analysis. The objective is to design a switching 
system comprising two different stationary phase materials for the fast separation of 
a diverse range of small molecules, one for the separation of polar analytes and a 
complementary phase to separate the more non-polar analytes. Despite the 
disadvantages of polymeric materials, due to the high retentively of PS-DVB, a 
proprietary column packed with 7 µm particles was evaluated to determine its 
applicability in retaining and resolving very polar small molecules. The potential of 
this phase was investigated as a complementary phase to reversed-phase C18 
material. In addition, the high retentivity of PGC towards polar molecules makes this 
phase an attractive option for this application and is also evaluated. 
 
Due to pressure constraints, until recently it has been difficult to construct a column 
switching system where UHPLC can be used in the first dimension, requiring 
interface valves able to withstand operation at ultra-high pressures (up to 15,000 psi). 
With the ultra-high pressure switching valves employed here, the use of UHPLC in 
this column switching design is investigated in order to achieve faster analysis times.  
  




5.2.1 Materials  
Acetonitrile (HPLC grade) and methanol (HPLC grade) were purchased from Fisher 
Scientific (Loughborough, UK) and formic acid (99-100 %) was purchased from 
VWR (Leicestershire, UK). Uracil and guanine were purchased from Fluka (UK). 
Acetophenone, adenine, aminoimidazole carboxamide ribonucleotide (AICAR), 
atenolol, benzoic acid, caffeine, clobestalol, cytidine, cytosine, diclofenac, 
ethacrynic acid, flumethasone, formoterol, hexanophenone, oxycodone, p-
hydroxyamphetamine, salmeterol, sotalol, terbutaline, testolactone, testosterone, 
thymine and uridine were obtained from Sigma-Aldrich (Gillingham, UK). Water 
was purified by an ultra-pure water system (Milli-Q, UK).  
 
Stock solutions were prepared at a concentration of 1 mg/mL in methanol water for 
all compounds except cytosine, cytidine, uracil and uridine, which were prepared at 
1 mg/mL in water, and adenine, guanine and thymine, which were prepared at 
1 mg/mL in 75:25 v/v CH3CN:CH3OH and stored at 4 °C. Standard working 
solutions were prepared by diluting stock solutions to the desired concentration with 
mobile phase (95:5 v/v H20:CH3CN with 0.1 % formic acid).  
  
5.2.2 LC conditions 
Separations were carried out on a Jasco X-LC gradient pumping system equipped 
with a JASCO X-LC autosampler (JASCO Corporation, Tokyo, Japan). Two six-port 
ultra high pressure valves were used on the switching system (Rheodyne, CA, USA 
and Valco Instruments Co., Houston, TX) each operated by an automatic actuator. 
Columns evaluated in this study included: a proprietary polystyrene-divinylbenzene 
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(PS-DVB) 7 µm, 100 x 2.1 mm (PolymerLabs, UK), a material which was facing 
ongoing evaluation in the research laboratories of Dr. Boughtflower at GSK, 
Phenomenex C18 5 µm, 50 x 2.0 mm (Phenomenex), XBridge C18 3.5 µm, 50 x 
2.1 mm (Waters), Acquity BEH C18 1.7 µm 50 x 2.1 mm (Waters), Acquity BEH C18 
1.7 µm 50 x 3.0 mm (Waters), and Hypercarb 5 µm, 100 x 4.6 mm (Thermo). The 
mobile phase consisted of 0.1 % formic acid in purified water (A) and 0.1 % formic 
acid in acetonitrile (B). The injection volume was 10 µL and the needle wash was 
methanol. Separations were performed at ambient temperature.  
 
Analytes were detected by ultra-violet (UV) detection using an Applied Biosystems 
783A Programmable Absorbance Detector equipped with a micro flow cell (2.4 µL). 
Analytes were detected at a wavelength of 254 nm with a rise time of 200 msec. 
Instrument control and data acquisition were performed by ChromPass software 
(JASCO Corporation, Tokyo, Japan). To minimise system volume, 0.0005” i.d. 
tubing was used of the minimum length possible between the valves and the columns 
and between the column and the detector cell. Figure 5.1 illustrates the configuration 
















Figure 5.1. Schematic of the instrumental switching design comprising two 6-port ultra high 
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Position B Position B 
Position B Position A 
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The proof-of-principle experiment was performed with nine compounds chosen to 
cover a wide range of polarities. The optimised conditions employ the use of a BEH 
C18 1.7 µm, 50 x 3.0 mm as the first column and a Hypercarb 5 µm, 100 x 4.6 mm as 
the second column. The sample was introduced onto the first column at a flow rate of 
0.1 mL/min at 5 % B followed by the gradient profile detailed in Table 5.1. Valves 1 
and 2 were switched between positions A and B at the times detailed in Table 5.1 to 
enable loading, elution from column 1 and 2 and re-equilibration of the whole 
system.  
 
Table 5.1. Gradient profile and valve switching for method used in the proof-of-concept study. 
Time (min) Flow rate 
(mL/min) 
%B Valve 1 Valve 2 
0.0 0.1 5 Position A Position A 
6.0 0.1 5 Position B Position B 
6.1 0.6 5   
7.0 0.6 5   
17.0 0.6 95   
17.1 0.6 5   
20.0 0.6 5 Position B Position A 
23.0 0.6 95   
23.1 0.6 5   
25.0 0.6 5   
26.0 0.1 5 Position A Position A 
35.0 0.1 5   
 
 
To evaluate the applicability of the column switching approach, a mixture of 12 
doping agents spanning the polarity range was then studied. The optimised method 
was based upon that described above, using the same columns and mobile phase 
compositions. The gradient program and valve switching times are detailed in Table 
5.2. 
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Table 5.2. Gradient profile and valve switching times for analysis of polar and non-polar doping 
agents. 
Time (min) Flow rate 
(mL/min) 
%B Valve 1 Valve 2 
0.0 0.1 5 Position A Position A 
5.0 0.1 5 Position B Position B 
5.1 0.6 5   
6.0 0.6 5   
9.0 0.6 5   
13.0 0.6 20   
16.0 0.6 95   
16.1 0.6 5   
19.0 0.6 5 Position A Position B 
20.0 0.6 20   
23.0 0.6 95   
24.0 0.6 95   
24.1 0.6 5   
26.0 0.6 5 Position A Position A 
27.0 0.1 5   
34.0 0.1 5   
  




5.3.1 Suitability of stationary phase materials 
The initial part of this investigation was intended to evaluate the suitability of the 
proprietary PS-DVB for the retention and separation of polar analytes. For use in this 
instrumental set-up where UHPLC pressures are desirable, the phase was evaluated 
for its ability to retain and separate highly polar test probes with suitable efficiency 
and its ability to withstand the UHPLC pressures without compressing. 
 
5.3.2 Polymeric phase (PS-DVB) 
Polar compounds which are difficult to retain by RPLC have previously 
demonstrated good retention behaviour on highly cross-linked PS-DVB sorbents 
which display strong hydrophobic characteristics [186]. Very polar nucleobases were 
used as test probes to evaluate this phase, which was then compared with a hybrid 
C18 material operated under the same conditions. The chromatographic differences 
towards the same analytes are illustrated in Figure 5.2. The strong retention 
characteristics of the PS-DVB material, compared with the lack of retention 














Figure 5.2. Chromatograms illustrating differences in retention characteristics towards 
nucleobases of the PS-DVB phase (A) and a BEH C18 phase (B).  
Conditions were isocratic using 95:5 v/v H20:CH3CN 0.1 % formic acid.  
 
 
Figure 5.3. Retention factor of polar analytes on the PS-DVB resin (blue) and on C18 (red).  


































































































(A) PS-DVB  (B) BEH C18 
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Despite the great potential of this material in retaining highly polar analytes, due to 
the inherent poor chromatographic efficiency of the 7 µm gel, susceptibility to 
swelling and shrinkage when running gradient chromatography and inability to 
withstand high pressures created with the prior UHPLC phase, it was not suitable for 
this application. This was seen by a gradual decrease in efficiency and distorted peak 
shapes. On investigating the packed bed, a large void at the head of the column was 
noted, which confirmed the inability of this phase to withstand the required 
pressures.  
 
5.3.3 Porous graphitic carbon (PGC) 
As a result of the poor physical stability of the PS-DVB phase investigated, PGC 
(Hypercarb) was evaluated as an alternative due to its previously reported success in 
the analysis of very polar molecules [49, 175]. Despite the disadvantages in its 
unpredictable behaviour and lack of efficiency compared with other materials, such 
as HILIC, the ability to retain polar analytes while operating under reversed-phase 
mobile phase conditions is a distinct advantage. Since good retention and peak 
shapes were obtained for the nucleobases on Hypercarb, three of these analytes were 
chosen as test probes for a proof-of-principle investigation to establish the feasibility 
of combining this with the second C18 column for a comprehensive switching system 
for the analysis of a wide range of polarities. 
 
5.3.4 System design 
The column switching system was configured to incorporate two complementary 
stationary phases for the comprehensive analysis of polar and non-polar analytes in a 
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single run. The set-up was designed to operate with compatible mobile phases for 
facile switching between the two stationary phase components. The resulting system 
is a simple set-up comprising two ultra-high pressure 6-port switching values, one 
binary gradient pumping system and a single detector. Whereas typical orthogonal 
2D-LC configurations require two pumping systems for two different solvent 
systems, in this instance both stationary phases were selected for their ability to 
operate under reversed-phase conditions, hence only necessitating one UHPLC 
pump.  
 
Figure 5.1 shows the schematic of the instrumental design, where columns 1 and 2 
were chosen for their ability to retain and separate non-polar and polar analytes, 
respectively. Column 1 is a C18 phase for the analysis of less polar compounds, while 
Hypercarb was used as column 2 for its potential to analyse very polar compounds 
under reversed-phase conditions and the ability to withstand the fast flow rates and 
UHPLC pressure required.  
 
 
Figure 5.1 illustrates the workflow with the three switching steps required. In 
Stage 1, both valve 1 (V1) and valve 2 (V2) are in position A, allowing mobile phase 
to flow through column 1 (BEH C18) and column 2 (Hypercarb). In Stage 1, the 
sample is loaded with 5 % B where the polar analytes not retained by the C18 ligands 
and are eluted from column 1 and onto column 2, while the more non-polar 
compounds are trapped on column 1. In Stage 2, both V1 and V2 are switched to 
position B, allowing mobile phase to flow through column 2 only. In this stage, a 
gradient programme is employed to elute the polar analytes from column 2, before 
returning to the starting composition for a re-equilibration step. In Stage 3, V1 is 
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then switched back to position A, allowing flow through column 1 only. This stage 
therefore allows elution of the non-polar analytes from column 1 under gradient 
conditions, followed by a brief re-equilibration. The positions as in Stage 1 are then 
resumed for re-equilibration of the whole system before injection of the next sample. 
 
5.3.5 Proof-of-principle 
The proof-of-principle investigation was performed using a test mixture of analytes 
covering a wide range of polarities, comprising acids, bases and neutral analytes, as 
detailed in Table 5.3. Of the analytes investigated, the criteria for separation on the 
Hypercarb phase was a k < 2 on the C18 phase. The separation of the polar analytes 
(cytidine, uracil and uridine) and the more non-polar analytes (caffeine, benzoic acid, 
acetophenone, salmeterol, diclofenac, hexanophenone) were developed separately on 
the Hypercarb phase and C18 phase respectively, as shown in Figure 5.4.  
 
Table 5.3. Chemical structures and logP values for the analytes considered in the proof-of-
concept study. 






































































* LogP values were obtained from ChemSpider. 
 









Figure 5.4. Separation of polar analytes on Hypercarb (A) and less polar compounds on C18 (B).  
Cytidine (1), uracil (2) and uridine (3) caffeine (4), benzoic acid (5), acetophenone (6), 
salmeterol (7), diclofenac (8) and hexanophenone (9). The Hypercarb 5 µm, 100 x 4.6 mm 
column (A) and Acquity BEH C18 1.7 um, 50 x 2.1 mm column were operated under isocratic 
using 95:5 v/v H20:CH3CN 0.1 % formic acid.  
 
5.3.6 Influence of valve switching on the separation 
Having developed the separation of each set of analytes on the two phases 
independently, the next challenge was to couple them together with the switching 
interface for analysis of the complete mixture in one injection. An example of the 
gradient profile is shown in  
Figure 5.5. The sample was loaded with 5 % B onto column 1 (C18), and both valves 
switched after 1 min, by which time the polar analytes (k < 2) had eluted onto 
column 2 (Hypercarb). The first gradient therefore relates to the separation of the 
polar analytes on the Hypercarb column before V1 is switched back to position A to 
allow the less polar analytes to be eluted from the C18 phase and separated during the 
second gradient. In the first instance, the polar analytes were injected alone with a 


















 (A) Hypercarb  
 (B) Acquity UPLC
®
 BEH C18 
  CHAPTER 5 
188 
 
(pressure 1117 psi with 5 % B at 0.6 mL/min). This was performed to ensure that the 
chromatography was not affected by the valve switching. Chromatograms illustrating 
a blank injection and the polar test mix injected are shown in Figure 5.6. Injection of 
mobile phase shows that the spikes seen at 1, 14 and 17 min correspond to the valves 
switching, causing a fluctuation in the baseline of the absorbance detector. Figure 5.6 
(B) illustrates that the chromatography of the polar compounds is not compromised 
by switching the valves, with each analyte showing the same retention time as in 




Figure 5.5. Elution profile of the column switching system.  







Figure 5.6. Profile obtained with injection of mobile phase with valve switching (A) and the 
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For the separation of the polar compounds, cytidine (1), uracil (2) and uridine (3) a zero volume 
connector in placed in column position 1 (B). A Hypercarb 5 µm, 100 x 4.6 mm was used as 
column 2. 
5.3.7 Influence of pressure and flow rate on the separation profile 
Since no change in the retention times of the polar analytes were established with the 
instrumental set-up using a zero volume connector as column 1, this was replaced 
with a UPLC
®
 BEH C18 1.7 µm, 50 x 2.1 mm i.d. column to enable the inclusion and 
separation of the more non-polar analytes in the test mixture. As no retention of the 
polar analytes was noted on the C18 phase, the results were expected to be similar to 
those generated using the zero volume connector. However, a marked difference in 
the retention of the polar analytes was experienced when the UHPLC C18 column 
was employed, Figure 5.7 (A).  
 
Since there is no retention of the polar analytes with the C18 phase, contribution from 
the column chemistry can be eliminated as a cause of this problem. Therefore, two 
hypotheses were proposed as contributing to this retention shift – either lack of 
column re-equilibration, which would lead to a shift in retention and affect the early 
eluting compounds to a greater extent, or the large pressure difference between the 
two columns as the configuration was switched from Stage 1 to Stage 2 due to 
contribution by the sub-2 µm particle UHPLC column. It should be noted that the 
shift in retention of the polar analytes was only experienced with the UHPLC 
column when valve switching was introduced. For instance, when the UHPLC 
column and the Hypercarb column were coupled together in series to analyse the 
polar mix, the same chromatography was gained as in Figure 5.6 (B). This suggests 
that it is not the high back-pressure alone that is responsible for the retention shift, 
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but the large difference in back-pressure when the valves are switched to divert the 
flow through the Hypercarb phase only, bypassing the UHPLC column.  
 
Poor re-equilibration was investigated as a potential cause, which could feasibly be 
confounded in this set-up with the extra-column volume, valve switching and two 
columns. Increase in re-equilibration times for each column and the overall starting 
set-up were investigated, but increasing re-equilibration time was shown to have no 
effect on the shift in retention, which remained constant.  
 
Consequently, the sub-2µm column was substituted with a larger particle size 
column (5 µm) to determine whether the large difference in column back-pressure 
between the two columns was contributing to the shift in retention. The results noted 
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Figure 5.7. Separation profile of polar compounds with a UPLC
®
 BEH C18 1.7 µm, 
50 x 2.1 mm i.d. (A) and a HPLC Phenomenex C18 5 µm, 50 x 2.0 mm i.d. (B) as column 1.  
Cytidine (1), uracil (2) and uridine (3) caffeine (4), benzoic acid (5), acetophenone (6), 
salmeterol (7), diclofenac (8) and hexanophenone (9). Separation performed using a Hypercarb 
5 µm, 100 x 4.6 mm as column 2. 
 
 
It therefore appears that the shift in retention is related to the large pressure 
difference between the two phases upon the first switching event (8412 psi across the 
UPLC
®
 BEH C18 column at the beginning of the analysis, compared with 740 psi 
across the Hypercarb column, when operated with 5 % B at 0.6 mL/min). This is 
supported by the fact that there is no difference in the retention profile where there 
was only a negligible difference in the pressure drop between the phases, for 
example when a zero volume connector or a HPLC C18 5 µm, 50 x 2.0 mm column 
were used, Figure 5.7 (B).  
 
The pressure difference between the two phases was further investigated in order to 
overcome the problem. A variety of C18 columns of different particle size were 
evaluated as potential alternatives to the UHPLC sub-2 µm phase for column 1. The 
differences in pressure drop across these phases as a function of flow rate, compared 
with the Hypercarb column, are in shown in Figure 5.8. Intuitively, as particle size 
decreases there is an increase in the back-pressure generated and therefore there is a 
greater pressure difference between the smaller C18 particle columns and the 
Hypercarb column. Assuming that the greater the pressure difference, the greater the 
contribution to the retention shift, each of these phases was investigated at various 
flow rates with the Hypercarb column to determine the acceptable pressure 
difference where no retention shift is experienced.  
 





Figure 5.8. Relationship between flow rate and pressure for the different columns studied. 
Hypercarb 5 µm, 100 x 4.6 mm (♦), Phenomenex C18 5 µm, 50 x 2.0 mm (□), XBridge C18 3.5 µm, 
50 x 2.1 mm (▲), BEH C18 1.7 µm, 50 x 3.0 mm (○), BEH C18 1.7 µm, 50 x 2.1 mm (x). 
 
The effect of flow rate and system pressure on the separation profile using a HPLC 
3.5 µm column is show in Figure 5.9. These chromatograms illustrate the effect of 
reducing flow rate, and therefore back-pressure, on the retention shift of the polar 
analytes (1-3). At 0.3 mL/min, a sufficiently low back-pressure is achieved for 
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Figure 5.9. Separation profile using 50 x 2.1 mm XBridge C18 3.5 µm operated at 0.6 mL/min 
(A), 0.4 mL/min (B) and 0.3 mL/min (C).  
Compounds numbered as above. Separation performed using an XBridge C18 3.5 µm, 50 x 
2.1 mm as column 1 and a Hypercarb 5 µm, 100 x 4.6 mm as column 2. 
 
 
The same process was repeated with the 1.7 µm UPLC
®
 column and the results are 
demonstrated in Figure 5.10. Using this column, even a flow rate of 0.1 mL/min still 
generates a back-pressure too high to prevent repeatable retention of the polar 
analytes. This column was therefore deemed unsuitable as column 1 in this 



























 (A) 0.6 mL/min, pressure = 3234 psi 
(B) 0.4 mL/min, pressure = 2016 psi 







































Figure 5.10. Separation profile using 50 x 2.1 mm BEH C18 1.7 µm operated at 0.6 mL/min (A), 
0.3 mL/min (B), 0.2 mL/min (C) and 0.1 mL/min (D). 
Compounds numbered as above. Separation performed using an Acquity BEH C18 1.7 µm, 50 x 
2.1 mm as column 1 and a Hypercarb 5 µm, 100 x 4.6 mm as column 2. 
 
 
However, the benefits of sub-2 µm particles in increased peak capacity and reduced 

































(A) 0.6 mL/min, pressure = 8528 psi  
(B) 0.3 mL/min, pressure = 4554 psi 
(C) 0.2 mL/min, pressure = 3234 psi 
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particles packed into a different column format in order to generate lower back-
pressures was investigated. A UPLC
®
 BEH C18 1.7 µm 50 x 3.0 mm i.d. column 
operated under the same conditions as the 2.1 mm variant demonstrates a lower 
back-pressure at a particular flow rate (Figure 5.8). The chromatograms in Figure 
5.11 illustrate the separation profile of the test mix and valve switching method with 
varying flow rates. At 0.2 mL/min, the back-pressure generated creates too large a 
pressure difference between the Hypercarb phase when the first valve switching 
event occurs (1653 psi across the column 1 compared with 740 psi across column 2), 
resulting in the familiar retention shift of the polar analytes. However, at 
0.1 mL/min, the lower back-pressure generated across column 1 (899 psi) is 
sufficiently low not to cause a large disturbance between the two stages, as shown in 








Figure 5.11. Separation profile using 50 x 3.0 mm BEH C18 1.7 µm operated at 0.2 mL/min (A) 
and 0.1 mL/min (B). 
Compounds numbered as above. Separation performed using an Acquity BEH C18 1.7 µm, 50 x 

















(B) 0.1 mL/min, pressure = 899 psi  
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5.3.8 Method optimisation  
From the previous results it can be deduced that a large and instant pressure drop 
when the valves switch between Stage 1 and Stage 2 is detrimental to the separation 
profile of the polar analytes eluted from column 2. This can be overcome by using a 
suitable phase and appropriate flow rate so as to reduce the difference in pressure 
across the two columns as much as possible. Therefore, with the pressure difference 
in mind, but also considering the long elution time required if a low flow rate was 
used, the analytes were loaded onto the first column at 0.1 mL/min, and then after 
the switching of the values the flow rate was increased to 0.6 mL/min for faster 
analysis. At the end of the run, a flow rate of 0.1 mL/min was resumed for pressure 
re-equilibration before the next injection, following the profile shown in Figure 5.12. 




Figure 5.12. Elution profile of the final separation.  










































Figure 5.13. Final separation with low loading at a flow rate.  
Samples loaded at 0.1 mL/min for 6 minutes before increasing to 0.6 mL/min for elution. 
Compounds numbered as above. Separation performed using an Acquity BEH C18 1.7 µm, 50 x 
3.0 mm as column 1 and a Hypercarb 5 µm, 100 x 4.6 mm as column 2. 
 
5.3.9 Reproducibility of separation 
As discussed in previous chapters, a stable system must be ensured to provide valid, 
robust data. Instability is reflected in shifts in retention time, therefore the 
reproducibility of the switching method was evaluated over 10 repeat injections. 
Overlaid chromatograms illustrate the good reproducibility (Figure 5.14), with 
retention times showing less than 0.06 % RSD (n = 10) (Table 5.4). 
 
 
Figure 5.14. Overlaid chromatograms illustrating good reproducibility of the final switching 
method (n = 10). 
Compounds numbered as above. Separation performed using an Acquity BEH C18 1.7 µm, 50 x 
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Table 5.4. Retention times of analytes used for proof-of-principle and %RSD values (n = 10). 
Analyte Ave tR (min) Standard deviation % RSD  
Cytidine 11.1 0.007 0.06 
Uracil 11.8 0.007 0.06 
Uridine 12.9 0.007 0.06 
Caffeine 22.0 0.005 0.02 
Benzoic acid 22.4 0.005 0.02 
Acetophenone 22.6 0.005 0.02 
Salmeterol 22.9 0.005 0.02 
Diclofenac 23.1 0.005 0.02 
Hexanophenone 23.4 0.005 0.02 
 
5.3.10 Application to doping control screening 
Doping control analysis is just one example of where there is a real need to separate 
a wide range of polarities in a single sample while achieving high analytical 
throughput. Additionally, it is necessary to gain sufficient retention of highly polar 
analytes to prevent co-elution with the noisy solvent front which can result in 
significant ion suppression. Therefore, a mix of 12 compounds screened in doping 
control analysis covering a range of polarities is analysed here with the column 
switching technique described previously. Sufficient retention can be empirically 
described as k > 2, therefore an analyte which did not meet this criterion when 
analysed on a C18 stationary phase material with a generic 5-95 % B linear gradient, 
was considered in the highly polar fraction for analysis on column 2 (Hypercarb). 
The mixture of test compounds considered is given in Table 5.5, together with the 
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Table 5.5. Chemical structures and logP values of the doping agents considered as the test 
probes in this study. 


















































































































*LogP values were obtained from ChemSpider. 
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Figure 5.15 (A) illustrates the chromatography of the test mixture which is achieved 
on a C18 phase alone, illustrating no retention or separation of the polar analytes, 
compared with the retention and separation possible when using the column 
switching approach with Hypercarb in order to retain and separate the polar analytes 
(Figure 5.15 (B)). The same solvent system as that employed in the proof-of-
principle separation was used for the doping compounds, with a modified gradient. 
The samples were loaded under the same starting conditions with 5 % B at 
0.1 mL/min. 
  








                                  
 
 
Figure 5.15. Separation of the doping test mix using the column switching approach. 
Comparison of a C18 phase alone (A) and the column switching approach with Hypercarb and 
C18 as the two complementary phases (B). Terbutaline (1), p-hydroxyamphetamine (2), 
oxymorphone (3), sotalol (4), atenolol (5), AICAR (6), formoterol (7), testolactone (8), 
















































 (A) C18 only 
(B) Column switching with Hypercarb and C18 
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The work presented here highlights some of the challenges facing the comprehensive 
analysis of compounds with a diverse range of polarities. A switching system 
enabling a broader window of analysis has been designed and tested with two 
complementary stationary phases enabling the retention and separation of polar and 
non-polar compounds. Where resources are limited, it is of primary importance to 
maximise the use of available instrumentation. This approach allows the analysis of 
a wide range of compounds in a single analysis with one binary pumping system, a 
single detector and operated by standard software. 
 
The downsides of such an approach are the large amounts of extra-column volume 
posed by the tubing required in the plumbing of the system, which negatively 
influences the potential efficiency gain with sub-2 µm materials. Although 
Hypercarb is not itself an ideal phase for this application with regard to efficiency, it 
demonstrates the possibility of coupling together two complementary phases for the 
analysis of a wide range of polarities in a single run while maintaining MS operation. 
The advantage of this combination, compared with previous methodologies, is that 
both phases can be operated under reversed-phase conditions, thereby only 
necessitating a single mobile phase system with one solvent manager and, as a result, 
does not involve any in-line sample dilution. Here, efficiency is compromised due to 
the large particle size of the Hypercarb material (5 µm) and large column 
dimensions, together with the inherently large extra-column volume contributing to 
band broadening. However, the principle of using Hypercarb to retain and separate 
highly polar analytes under reversed-phase conditions is presented. It is important to 
highlight the possibility of coupling complementary phases to C18 without 
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introducing incompatible mobile phases requiring additional pumping systems and 
inherent sample dilution. Further work should therefore centre on developing a 
suitable phase for this application in order to improve efficiency and miniaturisation 














CHAPTER 6  
 
  





6.1 Conclusions and Future Work 
The evolution of LC-MS instrumentation over the last 15 years has significantly 
impacted upon analytical strategies for targeted screening in bioanalysis. Gas 
chromatography coupled with mass spectrometry (GC-MS) has previously been 
considered as being the preferred method for the analysis of small molecular weight 
analytes. In many areas, including doping control analysis, GC-MS was historically 
the “gold standard,” providing a sensitive and selective technique with good 
reproducibility, resolution and an inherent ease of coupling with MS detection. 
However, LC-MS has now become an extremely powerful tool for the high 
efficiency separation of a wide range of analytes. Increased LC resolution with the 
use of sub-2 µm particles and the development of UHPLC, together with modern fast 
scanning mass spectrometers have resulted in LC-MS becoming widely adopted. 
LC-MS techniques now offer several advantages over GC-MS, including the ability 
to analyse thermolabile or non-volatile compounds, simple sample preparation with 
no derivatisation, faster analysis and the ease of directly injecting samples in 
solution. Consequently, LC-MS has become particularly popular where high-
throughput analyses are required with minimal sample pre-treatment to minimise 
additional sources of variation. 
 
However, the separation of very polar and/or basic compounds remains problematic 
for LC-MS. The generation of novel stationary phase materials offers certain 
improvements, although there is still no one simple solution. The importance of pH 
in RPLC is demonstrated here as a powerful chromatographic variable used to 
suppress analyte ionisation and hence reduce detrimental secondary interactions. 




where good retention and peak shape are required for resolution of the 
diastereoisomeric pairs and accurate quantification.  
 
Volatile buffer systems, such as ammonium formate and ammonium bicarbonate, 
enable the manipulation of the ionisation state of an analyte in order to produce good 
chromatography, while maintaining MS operation. Temperature has also been 
investigated as an important additional variable in LC. The combination of high pH 
and elevated temperature, now feasible with chemically stable hybrid column 
materials, is shown to have a significant influence on the peak shape of basic 
analytes, improving both peak fronting and tailing while also increasing sensitivity 
and enabling faster analysis. An increase in temperature does not provide an increase 
in separation efficiency, but renders the use of longer or coupled column formats 
feasible in generating higher plate numbers as a result of reduced mobile phase 
viscosity. 
 
Additionally, HILIC has been evaluated as an alternative mode of separation for 
hydrophilic bases, presenting further advantages over RPLC. Kinetic benefits are 
obtained from the highly organic mobile phases employed, providing low mobile 
phase viscosities and better mass transfer characteristics leading to higher efficiency 
separations. The highly organic mobile phase employed also provides enhanced ESI 
desolvation resulting in higher sensitivity and lower detection limits, as well as 
permitting the use of longer columns or increased flow rates without the back-
pressure constraints presented by RPLC solvents. For the compounds studied, more 
symmetrical peak shapes and improved sample loading capacity were noted with 




approaches, HILIC provided a six-fold increase in signal-to-noise and was better 
able to tolerate high sample masses on column, affording a greater linear dynamic 
range. However despite these advantages, HILIC has been associated with poor 
reproducibility, the sources of which have been investigated and overcome to 
provide a robust and repeatable quantification method. As HILIC evolves and further 
efforts focus on the elucidation of mechanism of interaction, this technique is fast 
becoming a widely adopted tool of polar analytes. There has recently been a surge of 
interest in this field, and this is reflected by the variety of stationary phase 
chemistries now available for HILIC, which were previously limited to unbonded 
silica supports. To further the diversity which HILIC can offer, future work should 
also consider alternative solvent systems for added selectivity and a more 
environmentally friendly mobile phase. 
 
An important factor in the sensitivity of a LC-MS method, in addition to the inherent 
sensitivity of the mass spectrometer, is the efficiency of ionisation and transmission. 
Although the chemical and physical properties of an analyte have a major influence 
on ionisation, the use of mobile phase additives and optimisation of source 
parameters also play a substantial role in ionisation efficiency. The importance of 
selecting a solvent system for optimal chromatography and MS performance has 
been described, as well as the influence of source conditions which can be mobile 
phase and analyte specific. Converse to conventional theory, high pH eluents have 
been show to elicit up to a three-fold increase in MS response for basic analytes. In 
addition, with ESI basic analytes have been shown to ionise more effectively using 




Sample pre-treatment is especially important for the analysis of complex matrices 
such as biofluids, where co-eluting endogenous components compete with the 
analyte for charge in the ion source, possibly resulting in ion suppression or 
enhancement. The result of ion suppression may be reduced through the use of 
UHPLC technology, offering better chromatographic resolution of analytes of 
interest from any endogenous species. Since sample preparation is a major 
bottleneck with the high-throughput analysis now available, there is even more focus 
on minimal sample pre-treatment, such as the direct dilution and injection of urine 
which is presented in this study, and therefore the importance of evaluating matrix 
effects is paramount. The use of high pH RPLC or HILIC serves to enhance the 
retention of hydrophilic basic analytes, separating them from the noisy solvent front. 
However, the extent of ion suppression or enhancement should always be evaluated 
for a robust and accurate assay. 
 
Although high pH RPLC and HILIC illustrate several advantages for the analysis of 
hydrophilic and/or basic analytes, where large peak capacities or a combination of 
different materials are required for the analysis of a diverse range of compounds, 
these modes cannot easily be coupled with traditional RPLC systems for column 
switching or 2D LC approaches. Such techniques using these modes of LC require 
an in-line dilution because of the differing strength solvent systems, which reduces 
sensitivity. Therefore, polymeric phases have been evaluated for their potential as 
platforms for the analysis of very polar analytes operated under traditional acidic 
RPLC conditions. Hypercarb has proven to be a successful material for such a 
purpose, and permits a facile means of coupling the separation of very polar analytes 




switching system has been designed to enable the separation of a wide range of 
polarities in a single injection. Although this proof-of-principle design was 
performed coupled with a UV detector, future work would focus on coupling this 
configuration with MS. The mobile phase system was designed to enable MS 
operation, providing a useful approach for the separation and unequivocal 
identification of samples comprising a wide range of components, such as generic or 
untargeted screening approaches, or where highly polar metabolites are to be 
detected in the presence of more non-polar parent compounds. Polymeric stationary 
phase materials illustrate good retention characteristics towards very polar analytes, 
although the efficiency of these separations is poor, mainly as a result of poor 
pressure stability which leads to unstable packing beds. The development of 
additional alternative stationary phase materials for very polar analytes which can 
operate under RPLC conditions and at UHPLC pressures is therefore necessary.  
 
The recent shift from the use of tandem triple quadrupole mass spectrometry to high 
resolution accurate mass spectrometry is becoming widely adopted, especially in 
areas such as generic screening where high-throughput separations demand UHPLC 
coupled with fast scanning MS detection. As illustrated in this thesis, with advances 
in technology there have been significant improvements in the resolution, mass 
accuracy, sensitivity and linear dynamic range of such instrumentation, permitting 
quantification as well as qualitative analysis by platforms such as hybrid QTOF MS 
detectors. Such equipment offers medium resolution and acceptable mass accuracy at 
a reasonable cost, which when coupled to UHPLC separation permits fast data 




particles. With growing popularity and acceptance, HRAMS will become a valuable 
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